Program Review
Marshall University
Joan C. Edwards School of Medicine
Medicine
November 2010
MARSHALL UNIVERSITY
2
Program Review
Marshall University
Date: ____October 7, 2010_____________
Program:_Doctor of Medicine__________
Degree and Title
Date of Last Review: ____2005__________________________________________________
Recommendation
Marshall University is obligated to recommend continuance or discontinuance of a program and to
provide a brief rationale for the recommendation.
Recommendation Code (#): 1.
1.
Continuation of the program at the current level of activity; or
2.
Continuation of the program at a reduced level of activity or with corrective action: Corrective action
will apply to programs that have deficiencies that the program itself can address and correct. Progress
report due by November 1 next academic year; or
3.
Continuation of the program with identification of the program for resource development: Resource
development will apply to already viable programs that require additional resources from the
Administration to help achieve their full potential. This designation is considered an investment in a
viable program as opposed to addressing issues of a weak program. Progress report due by
November 1 next academic year; or
4.
Development of a cooperative program with another institution, or sharing of courses, facilities, faculty,
and the like; or
5.
Discontinuation of the program
Rationale for Recommendation: (Deans, please submit the rationale as a separate document. Beyond
the College level, any office that disagrees with the previous recommendation must submit a separate
rationale and append it to this document with appropriate signature.)
___1______
___Karen L. Bledsoe____________________________________
Recommendation: Signature of person preparing the report:
_11-1-10________
Date:
____1_____
_________________________________________________
Recommendation: Signature of Program Chair:
_11-1-10________
Date:
____1____
Charles H. McKown, Jr., M.D. _______________________________
Recommendation: Signature of Academic Dean:
_11-1-10________
Date:
________
__________________________________________________
Recommendation: Signature of Chair, Academic Planning Committee: (Baccalaureate pgms only)
______________
Date:
________
_________________________________________________
Recommendation: Signature of President, Faculty Senate/ Chair, Graduate Council:
______________
Date:
________
_________________________________________________
Recommendation: Signature of the Provost and Senior Vice President for Academic Affairs:
______________
Date:
_______
__________________________________________________
Recommendation: Signature of the President:
______________
Date:
________
_________________________________________________
Recommendation: Signature of Chair, Board of Governors:
______________
Date:
3
College/School Dean’s Recommendation
Deans, please indicate your recommendation and submit the rationale.
Recommendation:
Recommend continuation at the current level
Rationale:
(If you recommend a program for resource development identify all areas for specific development)
Marshall University Joan C. Edwards School of Medicine continues to provide high quality
medical education, especially to West Virginia students, with an emphasis on primary care. The
school is accredited by the Liaison Committee on Medical Education (LCME) and undergoes
constant and stringent internal and external review.
In addition to education, the faculty continues to contribute to the betterment of society by
conducting leading-edge research, providing medical care to the tri-state area and contributing
to community service. The medical school serves as a catalyst for economic development,
enhances Marshall University’s ability to recruit and retain high quality faculty and contributes to
the overall reputation of the tri-state area.
New outstanding physical facilities, with improved contemporary learning capacities, during the
period of this review have distinctly strengthened our medical education activities, contributed to
the addition of new services and made possible a modest increase in class size.
______Charles H. McKown, Jr., M.D. ________________________11-1-2010________
Signature of the Dean
Date
4
Marshall University
Program Review
For purposes of program review, the academic year will begin in summer and end in spring.
Program: _____Medicine_______________________________________
College: ______Medicine_______________________________________
Date of Last Review: _____2005_________________________________
I
CONSISTENCY WITH UNIVERSITY MISSION
Provide your program’s mission statement. Explain how your mission supports
the mission of your college and the mission of Marshall University.
The Marshall University Joan C. Edwards School of Medicine, a community-based
medical school, strives to meet the special needs of a largely rural population in a state
which historically has been economically and educationally disadvantaged.
As a community-based medical school, Marshall has a curriculum that more accurately
reflects the national trends in health care by conducting a greater degree of ambulatory
clinical education than traditional in-patient education. All clinical departments require
students to complete ambulatory care as part of their educational experiences. Prior to
the clinical years, students are exposed to the philosophy of ambulatory care, reflecting
the educational mission of Marshall. Early pre-clinical experiences further support the
institutional perspective of the importance of ambulatory medicine.
Recognition of other disciplines as resources for team-building, an emphasis on
presentation skills, and commitment to community service contribute to the generation
of lifelong learning habits. Exposure to the team-building concepts during the formative
years increases the likelihood that graduates will use other health care and allied health
professionals as vital and valued contributors to the patient care team. Communication
and presentation skills are necessary components of medical education for present and
future practice. To integrate the students into the community and to provide them with
proper service values, community service projects are required as part of rural
experiences. Exposing students to community service, promotes this value as a lifelong
habit.
In fulfilling its mission of primary care medical education, the School of Medicine has
become an outstanding and cost-effective investment for the state of WV by coupling its
award-winning educational and clinical training programs with extensive health care
delivery services to West Virginians and other area citizens, especially armed forces
veterans. As a participant in West Virginia’s Rural Health Education Partnership
5
Program, the medical school has also developed educational and health delivery
outreach programs in more than 73 rural West Virginia sites.
II
ACCREDITATION INFORMATION
(NOTE: If your program has been accredited by a national organization, supply the
following information. If your program is not accredited, skip to section III. Use the
appendix numbers as indicated in each section. If you skip a section do not renumber
the appendices. )
Provide the following information about the program’s accreditation status:
A
Name and description of the accreditation organization:
The Liaison Committee for Medical Education (LCME) is the accreditation
agency for all United States medical schools. The committee is
comprised of members from the Association of American Medical
Colleges (AAMC), the American Medical Association (AMA) and public
members.
B
Most recent year program accredited: (include a copy of the letter
conferring accreditation.)
2005
C
Accreditation status: (regular, probationary, unaccredited, other)
Continued Accreditation
D
Attach a copy of the accreditation organization’s report to the University if
different from B.
E
If program deficiencies were noted, attach the report to the accrediting
agency outlining the deficiencies and corrective action taken or proposed.
F
Provide 1 hard copy of the most recent self-study report to the Office of
Assessment and Program Review.
The School of Medicine is conducting a self-study as part of the
requirements for the LCME accreditation site visit scheduled for March 11,
2011. A copy of the self-study is attached.
6
III
PROGRAM STATEMENT on Adequacy, Viability, Necessity and
Consistency with University/College Mission
A.
ADEQUACY Provide a narrative summary for each of the following in
addition to the requested appendices.
1. Curriculum: Summarize degree requirements and provide
commentary on significant features of the curriculum. In Appendix I,
list required courses, elective courses, and total hours required. The
list of courses must provide specific course titles and numbers.
Requirements for the Degree of Doctor of Medicine
The doctor of medicine degree is conferred upon students who have satisfactorily
completed the equivalent of four years of study in the medical sciences. All courses
and clerkships, required and elective, must have been completed with a passing grade.
A minimum of the final two years of study must be completed as a student at the
MUJCESOM.
Continuous and successful progression toward the requirements for graduation
throughout the curriculum is expected. In compliance with the LCME, students have a
maximum of six years to complete the M.D. requirements. Maximum time for completing
requirements may only be waived to permit the student to engage in research or other
scholarly pursuits.
The concept of satisfactory progress mandates monitoring of a student's academic
performance through grades, professional behaviors, the number of credits successfully
completed, and timely passage of the USMLE licensing examinations. The Academic
Standards Committee may also set conditions for meeting satisfactory academic
progress.
The M.D. degree is awarded by Marshall University upon certification by the school’s
faculty that the student has successfully completed all requirements.
GRADUATION REQUIREMENTS FOR MUSOM
Requirements specific to Year 1:
 Successful completion of all required courses
Requirements specific to Year 2:
 Successful completion of all required courses
 Successful completion of OSCE
 Successful passage of USMLE Step 1
Requirements specific to Year 3:
 Successful completion of all required clerkships
 Successful completion of Clinical Competency Examination
Requirements specific to Year 4:
7









Successful completion of ACLS
Successful completion of 12 weeks required rotations
Successful completion 8 weeks rural rotations
Successful completion 22 weeks of electives
Successful passage of USMLE Step 2 CK
Successful passage of USMLE Step 2 CS
Successful passage of the Radiology Exam
Successful completion of patient logger requirements
Successful completion of procedure logger requirements
2. Faculty: Summarize significant points relating to faculty teaching
courses within the major (percentage of faculty holding tenure, extent
of use of part-time faculty, level of academic preparation, faculty
development efforts, books & journal articles, papers & attendance at
state, regional and national professional organization meetings).
Include part-time faculty and graduate assistants you employed during
the final year of this review. Prepare an Appendix II Faculty Data
Sheet for each full-time faculty member, part-time faculty member and
adjunct faculty member. For part-time faculty members and adjuncts,
prepare data through question one on the Faculty Data Sheet. Use
Appendix II-A for all graduate teaching assistants.
All faculty are appointed by the individual department chairs, with approval of the Dean.
Full-Time Faculty
Prof
Associate
Asst
Professor
Prof
Inst/O
M
Total
M
F
M
F
M
F
F
Basic Science Faculty
12
5
5
6
8
9
Clinical Faculty
33
10
34
13
30
17
1
4
142
Total
45
15
39
19
38
26
1
4
187
45
The School of Medicine maintains a good mix of basic and clinical sciences faculty to
adequately train the current level of students. They are satisfactorily published, actively
engage the medical students and residents in research projects and present their
findings at professional society meetings around the world.
8
3.
Students: NOTE: If your program is accredited, refer to the
appropriate page numbers in your accreditation report.
Entrance Standards: Describe the admission standards and procedures employed for
making the admission decision. (GPA, ACT, other tests).
The Admissions Committee, which is made up of school of medicine faculty, faculty
from the main campus and community representatives interview prospective students
and make recommendation to the full committee. Selection criteria include the
following:
1) Academic Background. Both quantity and quality are assessed with a
four-year program of study suggested. Exceptionally well-qualified
applicants may be considered after ninety semester hours of academic
work if other requirements are met. Specific entrance requirements
include one year each of English, Zoology or Biology with lab, Inorganic
Chemistry with lab, Organic Chemistry with lab, Physics with lab and
Social or Behavioral Sciences. A major criterion is the overall grade
point average for undergraduate studies with particular emphasis in
correlating the grade point average in science and science related
courses.
2) Medical College Admission Test. The value of the MCAT is as follows:
evaluates an applicant’s ability to retain knowledge acquired from his/her
undergraduate curriculum; assesses his/her ability to exercise practical
application of his/her acquired knowledge through a comprehensive
testing program; and equates the applicant’s performance with a
nationwide ranking from which some correlation may be established
from applicants of varying undergraduate backgrounds.
3) Recommendations. Three written recommendations from professors are
required. Two of these references must be science faculty and one
reference must be from the applicant’s major department. Additional
pertinent references are welcomed, but not required.
4) Interviews. Interviews are arranged only by invitation of the Admissions
Committee. Personal qualities, which are deemed essential for a career
in medicine, include, but are not limited to, logical and coherent thinking,
sound judgment, personal insight, and appropriate perception.
Candidates are notified in writing if they have been accepted or rejected.
9
a. Entrance Abilities: Identify potential ability of students admitted
to the program as measured by standardized tests (ACT, SAT,
GED, TOEFL, etc.) and high school GPA.
In Appendix III
b. Exit Abilities: Identify abilities of students who graduate from the
program (GPA, licensure exam, certification tests, etc.).
Immediately following medical school graduation, students enter into residency
programs to continue required training. This is achieved via the National
Residency Matching Program (NRMP) overseen by the Association of American
Medical Schools (AAMC). Students and residency programs submit a “ranking”
of preferred matches. The NRMP runs an algorithm to compare student choices
with residency program choices. A final match list is then generated. This
additional training is required by all 50 states before a graduate can become a
practicing physician; some states require as much as three years for licensure.
Students match at a rate of between 90 – 95%. If a student does not match
during the NRMP they “scramble” for a residency position based on unfilled
positions available after the match. All students enter a residency program.
The school conducts an exit survey of each graduating class in which our
graduates are asked to rate their preparedness for residency training in several
areas. These surveys indicate that our graduates see themselves as generally
well-prepared for residency training. The graduates are surveyed again while
they are in residency and the same self-assessment is borne out. In the AAMC
annual Graduation exit survey, students cite their hands-on-experiences as a
strength of the school. The School of Medicine sends an evaluation survey to
the residency program directors after the student has completed their first year of
residency. Residency directors generally rate the clinical performance of our
graduates in the top 25th percentile.
After graduation, and during residency training, alumni take the USMLE Step 3
examination. Graduates performance on the USMLE is comparable to the
national standard. Results are reported in Appendix IV.
10
4.
Resources: NOTE: If your program is accredited, refer to the
appropriate page numbers in your accreditation report.
a.
Financial: Provide information related to financial support of
the program, including what portion of the unit’s resources
was devoted to this program. Include state-appropriated
funds, grants, contracts, supplemental state funds or student
fees. If this program were terminated as a major, what
resource changes would occur, e.g., reduced faculty, staff,
space, courses taught, etc. If this program were reduced or
terminated, what changes would occur and how would it
affect the university?
The School of Medicine’s M. D. educational program is supported from its unrestricted
operating budget which is comprised primarily of State appropriated funds, student fees,
hospital support, practice plan educational support and other miscellaneous revenue.
For FY 2010 the SOM’s total unrestricted operating revenues are estimated at $34.5
million. Although this budget supports a multitude of additional educational, research,
clinical service and public service initiatives the M.D. program provides the foundation
for all of these activities. In addition, the M.D. program and these budgetary resources
provide the catalyst to generate more than $80 million in additional economic activity
through patient care activities, contractual medical services, sponsored research,
private giving and affiliated programs. In addition, the community hospitals who partner
with the SOM to offer its medical education and graduate medical education and patient
care programs also receive more than $25 million in enhanced federal and state
reimbursement for education and indigent care provision. Termination of the M.D.
program would not only deprive the State and southern West Virginia of its major source
of future doctors, but would cripple a very substantial health care delivery system and
stifle an economic engine of growth and development.
Because medical education is provided symbiotically in the context of ongoing patient
care, medical research, advanced residency and fellowship training and critical public
service programs it is impossible to separate the costs associated with the purely
educational portion of the M.D. program, but its termination would surely cripple
programs such as the joint regional trauma service, high risk obstetrics and
gynecological sub-specialty care, the Neonatal Intensive Care Unit (NICU), Pediatric
Intensive Care Unit (PICU) and other pediatric sub-specialty programs all of which are
unique in the region.
Although balanced for FY 2010 the School of Medicine’s Unrestricted Operating Budget
experienced a $418,196 reduction in state funding for the current year. This reduction
required all of the School’s student fee increase to be applied to cover this reduction.
Although indications are that federal stimulus funding may be available to offset some or
all of this reduction by mid-year, the uncertain nature of these funds and the potential for
future State funding reductions are very worrisome. Given the significant leveraging of
economic activity for which the M.D. program serves as a foundation and the critical
service programs which are dependent on it, further funding cuts could be truly
counterproductive, and the reduction or elimination of the program almost unthinkable.
11
b.
Facilities: Describe facilities available for the program
including classrooms, laboratories, computer facilities, library
facilities, or equipment needed for program delivery.
Type of Room1
Byrd Clinical Center
Auditorium Room 1025
Byrd Clinical Center
Rooms 1020&1021
Rooms 1022&1023
Byrd Clinical Center
Clinical Skills Lab Room
1037
Byrd Clinical Center
Standardized Patient Training
Room 1030 (with kitchen)
Byrd Clinical Center
Rooms 1031-1036
Byrd Clinical Center
Room 1028
Byrd Clinical Center
6 conference rooms (2 per
floor)
Coon MEB Gross Anatomy
Lab
Coon MEB Class Room (2)
Coon MEB Conference
Rooms
Biotech Building
Room 101
Room 102
Room 203
Room 204
Room 205
Room 206
Biotech Building 3rd & 4th
floor conference rooms
Biotech Building labs
Room 125
Room 127
Room 128
Room 130
MU Medical Center
Harless Auditorium
MU Medical Center
Seating
Capacity
125
40
40
50
25
3
Main Educational Use(s)2
Lectures, presentations
Small-groups, testing, study
Can be set up as 4 rooms of 20 or
2 rooms of 80
Training demos, lectures, small
groups, clinical skills practice
testing, etc
Training room for standardized
patients, lectures, small groups
8-20
Six fully equipped complete
patient examination rooms
Used by evaluators for Clinical
Competency Exam, small groups;
has 8 computers
Small groups, testing, lectures
80
Lab, dissection
80 & 50
8-30
Lectures
Small groups, testing, lectures
94
75
12
12
12
8
15 each
lectures
small groups, study
17
27
28
28
225
Labs
12
8-20
Small groups, study, lectures
Lectures, conferences, multimedia presentations
Lectures, small groups
12
10 conference rooms
The new Erma Ora Byrd Clinical Center, developed as part of Marshall University's
Robert C. Byrd Center for Rural Health, is an 80,000 square foot, four-story Clinical
Education & Outreach Center, which houses major new medical student teaching
facilities and clinical education patient care clinics. The ground floor of the new facility
contains state-of the-art medical education teaching resources, including a 125- seat
tiered classroom and several smaller classrooms. Most significantly, a Clinical Skills
Center is included where medical students and residents can develop and hone their
patient care skills using both computer-based models and live simulated patients,
before moving into the "live" patient care settings contained on the upper floors. Three
floors of patient care and clinical education space above provide expanded patient care
capacity for up to 75,000 patient visits per year.
The main floor of the building is dedicated to the educational activities of the medical
school. In addition to the rooms listed above, there is additional study space, lockers
and other amenities for the students. There are two large areas dedicated to student
study space. One area is the quiet study room, complete with 12 individual study
carrels, each with a computer. The second area is a more open lounge/study area with
vending machines, a copy machine, kitchen area, etc.
The Robert C. Byrd Biotechnology Science Center is located along Third Avenue
across from the Science Building, bringing together faculty, staff and students from both
the Joan C. Edwards School of Medicine and the College of Science. Labs were built for
biotechnology research and teaching. Seminar rooms for small group meetings and
faculty and student offices are on the second floor. The third and fourth floors have
similar layouts and are used exclusively by students and faculty of the School of
Medicine. Facilities on these two floors include cancer research facilities, rooms for
equipment and offices for graduate students and faculty.
Information technology resources and wireless network access is provided to
authenticated network domain users (SOM students, staff, faculty and administrators) in
all classroom, lab, study, lounge and common space in all School of Medicine buildings.
The following represents the number of public access PC workstations available to
students in each of the SOM buildings
i. MEB: 10 (down from 17 workstations prior to the opening of the
Biotech Center)
ii. Biotech Center: 24 (up from 0 prior to the opening of the Biotech
Center)
iii. Byrd Clinical Center: 10 (up from 0 prior to the opening of the
Fairfield Building)
iv. HSL: 10 (up from 6 as of July 2008)
Our total number of PC workstations has more than doubled from 23 to 54 as the class
size has increased. This has improved the Student-to-PC ratio from 10.4 (assuming 4
class years of 60 students) to 5.9 (assuming 4 class years of 80 students).
13
We have an integrated system in all three main SOM lecture classrooms (MEB, Biotech
& Byrd Clinical) to capture and seamlessly/automatically post audio recordings of all
SOM lectures.
The main Health Science Library is located on the 2nd floor of the MU Medical Center
and offers 24 hour access for students. The Library subscribes to approximately 300
journals in the biomedical research and clinical medicine disciplines. A fifteen year run
is kept for most journals. The book collection contains approximately 8,000 volumes.
The VA maintains a small library in the Coon Medical Education Building (MEB) which
provides resources and study areas for medical students.
Additionally, The John Deaver Drinko Library, located on the western side of Marshall’s
main campus, melds a full range of traditional library services with state-of-the-art
computer and advanced technological education facilities that include multimedia
training and presentation rooms, workstations, distance education and computer
carrels. There is a 24-hour reading room/computer lab with computer consultation
stations and assistive technology. The collection includes books, bound periodicals, and
a wide variety of media and Internet accessible electronic materials. The Drinko Library
has study rooms, conference collaboration rooms, and an auditorium, and also houses
offices of Information Technology, University Libraries, Instructional Technology,
University Computing Services, and Telecommunications.
All three of the community hospitals have recently undergone growth, expansion of new
clinical facilities and renovations. The five-story, $88 million North Patient Tower at
Cabell Huntington Hospital is now open and accepting patients.
14
5.
Assessment Information: NOTE: This section is a summary of
your yearly assessment reports.
a.
Provide summary information on the following elements.
Please include this information in Appendix V.





Student learning outcomes
assessment tools/measures
standards/benchmarks
results/analysis
action taken
August 11, 2008 was the inauguration of the newly integrated systems-based second
year curriculum for Marshall University Joan C. Edwards School of Medicine. The
block- based curriculum is the culmination of 15 months of work by the Curriculum
Integration Committee (CIC), a subset of the Curriculum Committee.
In December of 2006 the Curriculum Committee initiated discussion regarding changing
the discipline-based second year curriculum to a more integrated systems-based
curriculum. Over the next several months multiple meetings, phone calls and
correspondence laid out the framework for the revisions and a formal presentation was
given on April 1, 2007 to the second year faculty regarding the proposed change. On
April 26, 2007 the Curriculum Committee officially approved a proposal to establish the
Curriculum Integration Committee (CIC) to reorganize the second year curriculum into
an integrated systems-based model. The CIC consisted of second year course
directors, selected second year faculty, medical students, and representatives from the
Office of Medical Education. From May 25, 2007 – August 14, 2008 monthly CIC
meetings were held to reorganize the existing content into the proposed systems-based
format. Additional goals for the CIC included enhancing vertical and horizontal
integration, improving institutional objectives such that they are competency-based and
rewriting test questions to reflect NBME format.
Obviously one of the first tasks for the CIC was to review the content of the second year
curriculum to identify redundancy and gaps. Through the CIC meetings, several hours
of material were eliminated; allowing for the addition of important topics and more
comprehensive coverage of others. Secondary to this process, individual second year
faculty gained greater insight and understanding for synergistic and complementary
programs of education with ongoing emphasis on content and sequencing. Several
new topics were incorporated or expanded in a thematic way including new lectures on
Bioterrorism, Clinical Genetics, Law and Medicine, Geriatrics, Nutrition, Occupational
Medicine, Pain Management and Transplantation & Organ Donation.
As the pace of biomedical discovery continues to accelerate an evolving need for
additional exposure to ongoing scholarly activity, particularly at our institution, was felt to
be appropriate, therefore emphasis on research and the importance of scholarly activity
was enhanced. While previously discussed in the Biostatistics & Epidemiology course,
a more complete introductory presentation for students was needed. One full hour of
IRB training was added in the B&E section and to increase insight, students are now
15
required to complete their Comprehensive IRB Training Initiative (CITI) requirement
prior to the actual lecture. This training is web-based and can be reviewed at
http://www.marshall.edu/research/ori/education.asp.
General introductory lectures were added including two hours on “Introduction to
Laboratory Tests” and two hours on “Introduction to Radiology Tests”, with greater
emphasis on sensitivity, specificity, and indications for the various lab and diagnostic
imaging elements. These occur in block 2 to assist students in understanding the
various lab and diagnostic elements discussed throughout the year. A summary of new
or expanded topics is listed below:
New or Expanded Topics
Biostatistics/Epidemiology
Bioterrorism
Electronic Health Record
Ethics
Clinical Genetics
Geriatrics
Integrative Medicine
Health Care Reimbursement
Law & Medicine
Medical Informatics
Nutrition
Occupational Medicine
Pain Management
Pediatrics
Research
Transplantation & Organ Donation
# of Hours
14
4
1
12
24
2
7
2
2
1
13
2
3
14
1
4
The new curriculum is divided into ten blocks, each 3-4 weeks in length. The total year
two curriculum increased from 34 to 35 weeks. However, the total curriculum hours
including class, laboratory and testing time only increased by ten hours (from 752 to 762
hours). The one additional week is due to the addition of a NBME miniboard in the
Approach to Patient Course and the increase in the OSCE exam from one day to three
days. The new Byrd Clinical Facility contains 6 dedicated standardized patient rooms
and has allowed for expansion of the exam which has eliminated undue strain on the
preceptors, students and the standardized patients.
Pedagogical methods largely remained the same. Previously we had an adequate
balance of sessions including didactic, small group, lab, workshop, problem solving,
case-based and so on which have remained.
Although the curriculum in now systems-based, courses largely remained the same.
This was accomplished by merging of some smaller courses into our Approach to
Patient Care Course (APC). The Clinical Skills course was revamped making our total
number of courses seven. Also, there was general consensus that students could
benefit from greater exposure to musculoskeletal pathology, as well as clinical practice
in musculoskeletal physical examination. The Department of Orthopaedics now
16
provides eight hours of lecture and introductory clinical experience to students in
concert with the Clinical Skills course.
In addition to the basic science faculty, nearly all courses continue to use clinicians to
present material to the medical students. The Approach to Patient Care course is taught
almost exclusively by practicing physicians from the departments of internal medicine,
family medicine, pediatrics, obstetrics and gynecology, and surgery. The Microbiology
course extensively uses the services of one of our Infectious Disease specialists. The
Immunology course uses our Allergy/Immunology specialist to present topics on asthma
and allergy. The Pathology course is heavily taught by practicing clinical pathologists.
Pharmacology uses cardiologists, neurologists and a practicing Pharm D to help
connect the pharmacological principles and practices with clinical medicine.
Although changing to a block, systems-based curriculum there were several aspects of
the curriculum we wanted to maintain and possibly enhance; one in particular was the
early patient exposure for students in the mentoring program. In the Approach to
Patient Care course students are required to work with mentors on three different
occasions each semester accumulating at least 24 total hours of mentoring experience.
In addition, they are to write two mentor reflections focusing on their mentoring
experience in an effort to enhance their training in medical humanities. While voluntary,
Community Service opportunities are offered throughout the school year. The majority
of Tuesday afternoons are unscheduled to give students time off to participate in these
activities.
As with all medical schools we are constantly striving to most appropriately educate the
students. One concern has been the passive learning style of students and the need to
improve their lifelong learning habits. As a way of encouraging the students to reference
their textbooks more effectively and develop better study habits, the faculty have pared
handouts down to outlines and are providing background reading assignments for their
lectures. Our Clinical Skills course is using extensive observational sessions and
homework assignments to challenge students to critically think and develop clinical
competence to better prepare them for the clinical clerkships. The Biostatistics and
Epidemiology portion of the Approach to Patient Course Care is deriving their grade
almost exclusively from homework assignments and class problem-solving cases,
eliminating to a great extent the usual didactic formats.
Overall, the new integrated curriculum will provide a more realistic approach to the ways
in which students will recognize and manage their patient's problems as physicians,
while strengthening the connection between the basic sciences and clinical medicine.
Under the original curriculum, medical principles and concepts were presented in free
standing discipline-based courses (e.g. Medical Microbiology, Medical Immunology,
Medical Pharmacology, Clinical Medicine, Pathology etc.). In the new curriculum,
although the discipline-based courses will be retained, concepts will be presented in a
disease-based or organ-based format in which material from all second year courses
will be integrated in a logical fashion.
Testing will occur also in a block format with ten block exams. Each exam is three
hours in length and contains 150 questions. Students will be required to pass five
17
NBME miniboard exams, given at the end of the school year, in addition to a required
OSCE. In an effort to improve our test and faculty communication, faculty work together
to improve their questions and will meet prior to the block exam to review all questions
for the test. This has helped eliminate ambiguous and “bad” questions and required
rewriting of some questions to be consistent with an established NBME format.
In the previous discipline-based curriculum all faculty maintained their questions
separately, but now they are pooled into one large password protected web-based
question bank that all faculty can access. Questions can be reviewed, created or
revised when needed. The question bank offers a built in keyword search feature which
gives faculty the ability to track the content, the type of questions we are using to test a
concept and the balance of the material we are testing. The search feature utilizes over
1,500 terms which includes disease, symptoms, and medications.
A unique student feedback system has been established to complement the new
curriculum. Seven student liaisons have been selected and each is linked with a
particular course director. At the end of each block the student liaison will meet with the
course director to review the block to provide feedback and on-going evaluation. Also,
the Office of Medical Education and the associate dean for academic affairs will review
and evaluate each block as it is completed. The Curriculum Committee will monitor
grades, NBME miniboard results, USMLE pass rates, etc. to ensure students continue
to perform well as the new second year curriculum progresses.
Now that the main work has been completed on the second year curriculum, there has
been an initial session with the first year faculty regarding integrating their content in a
similar systems-based fashion. The ultimate goal is to have in place by 2011 a fouryear fully integrated, competency based curriculum
Outcome Measures Documenting the Impact of the New Curriculum
Step 1 Outcomes
Below is a chart depicting the Step 1 results at MUJCESOM since 2000. The 92% pass
rate for first time takers this past May was the second highest since 2000. The 212
average was the third highest since 2000.
2009
2008
2007
2006
2005
2004
#
Pass
59
50
53
41
40
43
#
Sat
64
65
55
45
44
48
USMLE Step 1
%
% Ntl.
Pass
Pass
Average
92% Pending
212
77%
93%
205
96%
94%
210
91%
93%
215
91%
93%
213
90%
92%
210
Ntl.
Ave.
Pending
222
222
218
217
216
Min.
Pass
185
185
185
182
182
182
18
Test Questions & Format
Members of the teaching faculty met approximately one week before each of 10 block
exams during which each of the 150 test questions was reviewed. These sessions
served as opportunities to greatly improve the quality of the test questions through an
integrated working environment between scientists and clinicians. Several benefits were
noted from these interactions including:





Improved ability to meet course objectives through improved question writing
More clinically relevant and up-to-date questions in basic science course
questions
Enhanced basic science material in clinical course questions
Elimination of redundant question topics when, for example, microbiology and
pathology were both asking the same question about Lyme disease.
Improved camaraderie and esprit de corp among faculty members
In its initial year, the integrated systems-based Year 2 curriculum provided innumerable
benefits for the students and faculty. Many improvements have been put into place for
next year based on the feedback received. The pass rate and board score averages are
reassuring and we hope to continue to improve the curriculum in efforts to continue to
enhance the medical education even further.
b.
Other Learning and Service Activities
Provide a summary of learning and service activities not
covered explicitly in section a.
In light of Marshall University Joan C. Edwards School of Medicine's commitment to our
community and to the greater good, the Community Service Organization (CSO) was
established to make available, promote, and encourage opportunities for medical
students to participate in service-learning activities. The CSO is composed of
representatives from each year of medical education. Students are elected as
Community Service Liaisons by their peers each year and are responsible for making
their classmates aware of service opportunities as well as taking leadership roles in the
development and implementation of service learning.
The CSO has created a mechanism by which to promote awareness and encourage
opportunities for medical students to participate in service-learning activities. A proposal
by the CSO to establish recognition for community service was approved by the
Curriculum Committee and the Dean of the SOM. Students who annually complete 40
hours of community service and two “Service Reflections” will be recognized for “Honors
in Community Service” at our award ceremonies and by other means deemed
appropriate by Administration.
Volunteer activities do not interfere with students’ academic responsibilities but are
intended to enhance the medical education of our students. Students seeking “Honors
in Service” report their service hours via the Community Service website and the Office
of Student Affairs will monitor the program. Faculty and students are encouraged to
review the website which has already been populated with information about the
19
organizations with which students have worked over the years and will be updated by
students involved in community service projects and by liaisons from the CSO. Once
a semester, students from all years of medical education who are working toward
“Honors in Service” will gather to share their community service experiences and the
needs of the community they feel need more focus.
c.
Plans for Program Improvement
Based on assessment data, provide a detailed plan for
program improvement. This plan must include a timeline.
The curriculum committee conducts yearly reviews of all the courses. Subcommittees
are assigned to review the courses, which encourages course directors to self-reflect
and implement changes recommended by the subcommittee. Courses are to undergo
full peer review every 5 years.
d.
Graduate and Employer Satisfaction: Provide evidence and
results of follow-up studies to indicate graduate and
employer satisfaction with the effectiveness of the
educational experience. Indicate the number of individuals
surveyed or contacted and the number of respondents.
Approximately one-year post-graduation, the School of Medicine sends an evaluation
questionnaire to program directors who have trained our graduates for the first year of
residency. The return rate is approximately 50%. Program directors rank Marshall
students high in professionalism, clinical skills, and medical knowledge.
e.
Attach the previous five years of evaluations of your annual
assessment reports provided by the Office of Assessment.
See attachments behind appendix section
6.
Previous Reviews: Describe the last program review action
(including committee recommendation). Identify weaknesses and
deficiencies noted in the last program review and provide
information regarding the status of improvements implemented or
accomplished.
At its meeting in April 2005, the Marshall University Board of Governors voted to
continue the program at its current level of activity, with the designation of “program of
excellence.”
7.
Strengths/Weaknesses: Identify the strengths and weaknesses of
the program. Describe program plans for removing the
weaknesses.
20
Redundancy of material and gaps in essential medical knowledge has been identified
as a weakness in the overall curriculum. The curriculum committee has made a
concerted effort to correct these issues. A curriculum inventory has been conducted
and plans have been implemented to eliminate any redundancy; the new systemsbased curriculum has enabled the committee to identify these areas.
Strengths of the educational program include a solid applicant pool, a thoughtfully
evaluated curriculum that reflects institutional learning objectives, faculty with advanced
expertise both in primary care and subspecialty fields, early clinical experience with
mentoring from the first year and frequent simulated practice sessions using leadingedge technology, active faculty involvement in direct teaching, and a community-based
learning environment that provides students with experiences that are very reflective of
most professional careers.
B.
VIABILITY Provide a narrative summary for each of the following items in
Addition to requested appendices.
1. Articulation Agreements: Describe program specific articulation
agreements with other institutions for delivery of this program.
N/A
2. Off-Campus Classes: Describe/Summarize off-campus (other than the
Huntington, or South Charleston campuses) courses offered. (Include
locations, courses, enrollments, in Appendix VI.) This information will
be provided by the Office of Institutional Research.
N/A
3. Online Courses: Describe/Summarize online courses offered. (Include
courses and enrollments in Appendix VI.) This information will be
provided by the Office of Institutional Research.
N/A
4. Service Courses: Describe/Summarize departmental courses that are
required for students in other majors and support programs outside the
major. (Include enrollment data for these courses in Appendix VI.) This
information will be provided by the Office of Institutional Research.
N/A
5. Program Course Enrollment: Describe/Summarize program area
courses taken by students who are majors and include enrollment by
semester for the past 5 years. Indicate required or elective courses. The
purpose of this section is to indicate the availability and relative strength of
the program area courses. Include all students enrolled in the courses,
21
whether majors or not. (Include enrollment data for these courses in
Appendix VI.) This information will be provided by the Office of
Institutional Research.
See Appendix VI
6. Program Enrollment: Summarize data indicating the number of new
students admitted, number of principal majors enrolled from your
college, number of second majors, the number of students enrolled as
majors from other colleges (i.e., College of Education specialization
majors), the number of minors, and the number of graduates for the
program for each of the past five years. (Include a chart as Appendix
VII and provide separate data for each option offered under the
program.) This information will be provided by the Office of
Institutional Research. Finally, provide trend lines for total number of
students enrolled in the program and number of graduates (Figure 1)
for the period of the review.
See Appendix VII and Figure 1
Appendix VI & VII are combined since medicine does not offer a
“major” and only medical students are allowed to take courses.
7. Enrollment Projections: Identify trends that will influence enrollment
over the next five years. Provide enrollment projections.
The School of Medicine has increased the freshman class to 75
students per year. There are no plans to increase beyond this level
during the next 5 years.
C.
NECESSITY: NOTE: If your program is accredited, please refer to the
appropriate page numbers in your accreditation report. Provide a
narrative summary for each of the following items in addition to
requested appendices.
1. Advisory Committee: Identify whether the program has an
Advisory Committee, and, if so, briefly indicate the role and impact
of the Committee.
N/A
2.
Graduates: Provide information on graduates in terms of places of
employment, starting salary ranges (where appropriate and known),
number employed in field of specialization, and/or acceptance into
baccalaureate or graduate programs. (NOTE: Do not identify
students by name.) Include this information in Appendix VIII.
22
Please see response to (3) below.
3.
Job Placement: If the job placement rate reported above is low,
can a course of action be identified that would improve this
situation? Provide a summary of procedures utilized by the
institution to help place program graduates in jobs or additional
educational programs. Include activities supported by both the
student’s academic department as well as the institution’s
placement office. This summary should include the institution’s
procedures and program organization for continuing contact and
follow-up with graduates.
Job placement is not a significant source of concern since our graduates have many
options available to them. After graduation and one year of residency training,
graduates are eligible for a state medical license and can then open their own practice
of medicine. Most graduates spend 3 to 8 years in residency training before they
actually begin working as a medical professional. Graduates are practicing medicine, in
the military, in private practice, in group practice, as a hospitalist and all across the
United States.
IV.
RESOURCE DEVELOPMENT (If applicable)
Please prepare the following materials: 1) Program vision and mission
statements with a strategic plan to achieve the program’s vision and mission, and 2) a
specification of the resources needed to accomplish the program’s vision, with an
evidence-based rationale as why these resources are needed and how they will help
the program to accomplish its vision. The mission and vision statements, strategic plan,
and needed resources with evidence-based rationale must be included in the program
review when submitted. Additionally, the chair and dean must make an additional
presentation to either the Academic Planning Committee or to the Graduate Council
before final votes are taken.
23
Appendix I
Required/Elective Course Work in the Program
School of Medicine
Degree Program:
Doctor of Medicine
Courses Required in Major (By
Course Number and Title)
Total
Required
Hours
Courses Required Year 1
Person responsible for the report: _Karen L. Bledsoe________
Elective Credit Required by the
Major (By Course Number and
Title)
Courses Required Year 4
Elective
Hours
36 Hrs for
electives
Gross Anatomy (ACB 720)
8
ACLS (EMS 720)
1
Molecular Basis of Medicine (IDM 725)
8
Emergency Medicine (EMS 744)
4
Introduction to Patient Care I & II (IDM 716)
7
Internal Medicine (MED 744)
4
Behavioral Medicine (PSI 701)
2
Surgery (SUR 744)
4
Ethics (IDM 761)
1
Microanatomy & Ultrastructure (ACB 724)
4
Neuroscience (IDM 777)
6
Physiology (PHS 701)
8
Courses Required Year 2
Approach to Patient Care (MED 725)
12
Clinical Skills (MED 755)
6
Immunology (MCB 743)
3
Microbiology (MCB 720)
6
Pathology (PTH 720
13
Pharmacology (PCM 720)
8
Related Fields Courses
Required
Total
Related
Hours
24
Courses Required in Major (By
Course Number and Title)
Psychopathology (PSI 721)
Total
Required
Hours
2
Courses Required Year 3
Family Medicine Clerkship (FCH 742)
8
Internal Medicine Clerkship (MED 742)
8
Obstetrics & Gynecology (OBG 742)
8
Pediatric Clerkship (PED 742)
8
Psychiatry & Behavioral Medicine (PSI 742)
8
Surgery Clerkship (SUR 742)
8
Elective Credit Required by the
Major (By Course Number and
Title)
Elective
Hours
Related Fields Courses
Required
Total
Related
Hours
25
(No more than two pages; Minimum type 8 point Arial)
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: _Natavoot Nick Chongswatdi MD______________ Rank: __Assistant Professor____________
Status (Check one): Full-time__X_ Part-time_____ Adjunct _____
Current MU Faculty: Yes ___
No ___
Highest Degree Earned: ____Doctor of Medicine______ Date Degree Received: _August 12, 2005____
Conferred by: ___Marshall University Joan C. Edwards School of Medicine_______________________
Area of Specialization: __Family Medicine__________________________________________________
Professional Registration/Licensure__23192_______
Agency: _WVBOM_______________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
___0_____
___0_____
___4_____
___4_____
___0_____
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them and what percentage of the course you taught. For
each course include the year and semester taught (summer through spring), course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2008-2009
Alpha Des. & No.
Title
Occupational Medicine Lectures
Enrollment
Occupational Workshop/Grand Rounds
OB Lecture in Primary Care
Mentor/Preceptors
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent activities.)
26
2)


Activities that have enhanced your teaching and or research.
FM Grand Rounds
Sports Medicine Conference
3)
Discipline-related books/papers published (provide a full citation).
4)
Papers presented at state, regional, national, or international conferences.
5)
6)
Professional development activities, including professional organizations to which you belong and state, regional, national, and international conferences attended. List any
panels on which you chaired or participated. List any offices you hold in professional organizations.
AAFP
AMA
WVAMA
Externally funded research grants and contracts you received.
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.



8)


Community service as defined in the Greenbook.
Soccer tournament
High School Football Games
27
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: _________Mitchell L. Berk._______ Rank: _______________Professor___________________
Status (Check one): Full-time_X_ Part-time__ Adjunct __ Current MU Faculty: Yes____X____ No____
Highest Degree Earned: _Ph.D.______ Date Degree Received: _._____________August, 1978______
Conferred by: ______________________The George Washington University ____________________
Area of Specialization: _____________________Anatomy ___________________________________
Registration/Licensure Agency: _______PhD_____________
Years non-teaching experience
___1___
Years of employment other than Marshall
___4__
Years of employment at Marshall
__27__
Years of employment in higher education
__31__
Years in service at Marshall during this period of review
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them and what percentage of the course you taught. For
each course include the year and semester taught (summer through spring), course number, course title and enrollment.
(Expand the table as necessary)
Year/Semester
Alpha Des. & No.
Title
Enrollment
2008 and 2009
ACB 720 (620)
Gross Anatomy and Embryology (team taught-3/8)
80
2008 and 2009
ACB 724 (624)
Microscopic Anatomy and Ultrastructure (team taught-1/2)
80
2008 and 2009
IDM 777 (ACB 630)
Neuroscience (team taught-114
80
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1) If your degree is not in your area of current assignment, please explain.
28
(For each of the following sections, list only events during the period of this review and begin with the most recent activities.)
2) Activities that have enhanced your teaching and or research.
3) Discipline-related books/papers published (provide a full citation).
4) Papers presented at state, regional, national, or international conferences.
5) Professional development activities, including professional organizations to which you belong and state, regional, national, and international
conferences attended. List any panels on which you chaired or participated. List any offices you hold in professional organizations:
Attended the Annual Meeting of the American Association of Clinical Anatomists, July 2009
6) Externally funded research grants and contracts you received.
7) Awards/honors (including invitations to speak in your area of expertise) or special recognition:
Best Professor of the Spring Semester of 2008 from Class of 2011
Outstanding Pre-clinical Professor, 2008 from Class of 2008
29
8) Community service as defined in the Greenbook
Member of Curriculum Subcommittee of the First Year Medical Courses (2009) Director of Human Gift Registry of Marshall
University (2009) Course director, Microscopic Anatomy (2008, 2009) Course director, gross anatomy and Embryology (2009)
30
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: __Laura L. Richardson______________ Rank: Associate Professor________________
Status (Check one): Full-time__X__ Part-time_____ Adjunct _____ Current MU Faculty: Yes _X__ No ___
Highest Degree Earned: _Ph.D.________ Date Degree Received: _1993________________
Conferred by: _Georgetown University_____________________________________________
Area of Specialization: _Cell Biology_________________________________________________
Professional Registration/Licensure___N/A_____
Agency: _______________________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
__37____
__28____
___9____
___9____
___5 _
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them and what
percentage of the course you taught. For each course include the year and semester taught (summer through spring), course number, course title
and enrollment. (Expand the table as necessary)
Year/Semester
2009/Fall
2009/Fall
2009/Spring
2008/Fall
2008/Fall
2008/Spring
Alpha Des. & No.
IDM 725
BMS 600
ACB 724
IDM 720
BMS 600
ACB 724
Title
Molecular Basis of Medicine
Foundations of Biomedical Science
Microscopic Anatomy
Medical Cell and Molecular Biology
Foundations of Biomedical Science
Microscopic Anatomy
Enrollment
81
25
81
81
41
73
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent activities.)
2)
3)
4)
5)
Activities that have enhanced your teaching and or research.
Professional Development workshops (listed below), Research Boot Camp, Cancer Biology Seminar Series, meetings
attended (listed below)
Discipline-related books/papers published (provide a full citation).
Qin, J., *Richardson. LL., Jasin, M., Handel, M.A., Arnheim, N. Mouse strains with an active H2-Ea
spot exhibit increased levels of H2-Ea-specific DNA breaks in testicular germ cells. Mol Cell Biol. 24:1655-1666, 2004. (*Both
authors contributed equally to this work.)
Fan J, Graham M, Akabane H, Richardson LL, Zhu GZ. Identification of a novel male germ cell-specific gene TESF-1 in mice.
Biochem Biophys Res Commun. 340:8-12, 2006
Fan, J., Akabane, H., Graham, S.N., Richardson, L.L., Zhu, G.-Z. Sperm Defects in Mice Lacking a Functional Niemann-Pick C1
Protein. Mol Reprod Dev. 73:1284-1291, 2006
Papers presented at state, regional, national, or international conferences.
Fan J., Akabane, H., Richardson, L.L., Zhu, G-Z.. Identification of a novel male germ cells specific gene TESF-1. 37th Annual
Meeting of the Society for the Study of Reproduction, Vancouver, BC, August, 2004.
Hiroto, A., Graham, S., Richardson, L., Zhu, G.-Z. Sperm defects in mice lacking function of Niemann-Pick C1 protein. 38th Annual
Meeting of the Society for the Study of Reproduction, Quebec City, Quebec, July, 2005.
Jordan Nash, Chris Barry and Laura L. Richardson. Expression of Ski and Sno Proto-oncogenes in Male Germ Cells and Testicular
Tumors. 14th European Testis Workshop, Bad Aibling, Bavaria, Germany, April 22-26, 2006
Amy N. Nash and Laura L. Richardson. Expression of Ski and Sno Oncogenes in Testicular Tumors. 47th Annual Short Course on
Medical and Experimental Mammalian Genetics, Bar Harbor, ME, July 2006.
Amy N. Nash and Laura L. Richardson. Ski Target Genes Revealed by siRNA Knockdown in NCCIT cells. COBRE/INBRE Annual
Meeting, Charleston, WV, Nov. 2007.
Amy N. Nash and Laura L. Richardson. Effects of Decreased Ski on Invasive Properties of Testicular Cancer Cells. 41st Annual
SSR Meeting, Kailua-Kona, HI, May 2008.
A.N. Nash, R.A. Johnson, and L.L. Richardson Invasive Potential of Testicular Cancer Cells: Effects of Bone Morphogenetic Protein
(BMP) and Decreased SKI Expression. XX North American Testis Workshop, Philadelphia, PA, April 2009.
Professional development activities, including professional organizations to which you belong and state, regional, national, and
international conferences attended. List any panels on which you chaired or participated. List any offices you hold in professional
organizations.
Professional Organizations:
American Society for Cell Biology
31
6)
7)
8)
Society for the Study of Reproduction
American Society of Andrology
American Association of Anatomists
Association of Anatomy, Cell Biology and Neurobiology Chairpersons
Meetings Attended:
International:
14th European Testis Workshop, Bad Aibling, Bavaria, Germany, April 22-26, 2006
National:
38th Annual Meeting of the Society for the Study of Reproduction, Quebec City, Quebec, July 27-24, 2005
39th Annual Meeting of the Society for the Study of Reproduction, Omaha, Nebraska, July 29-August 1, 2006
XIX North American Testis Workshop, Tampa, FL, April 18-21, 2007
32nd Annual Conference of the American Society of Andrology, Tampa, FL, April 21-24, 2007
2008 Annual Winter Conference of the Association of Anatomy, Cell Biology and Neurobiology Chairpersons, Costa Rica,
January 16-19, 2008
41st Annual Meeting of the Socitey for the Study of Reproduction, Kailua-Kona, HI, May 2008.
2009 Annual Winter Conference of the Association of Anatomy, Cell Biology and Neurobiology Chairpersons, Quito, Ecuador,
January 13-20, 2009
XX North American Testis Workshop, Philadelphia, PA, April 1-4, 2009
26th Meeting of the American Association of Clinical Anatomists, Cleveland, OH, July 14-17,
2009
EPSCoR Building Diversity in Higher Education: Strategies for Broadening Participation in the Sciences and Engineering,
Charleston, WV, October 21-22, 2009
Regional:
11th Annual WV-EPSCoR Conference, Charleston, WV, May 11-12, 2004.
24th Annual UK Symposium in Reproductive Science and Women’s Health, Lexington, KY, May 19-20, 2005
Local:
17th Annual School of Medicine Research Day, Joan C, Edwards School of Medicine, Marshall University, 2004
21st Annual School of Medicine Research Day, Joan C, Edwards School of Medicine, Marshall University, 2008
2004 Annual Sigma Xi Research Day, Marshall University
2005 Annual Sigma Xi Research Day, Marshall University
Workshops
“Effective Question Writing”, Faculty Development Program, Joan C. Edwards School of Medicine, Marshall University, March 2007
“Using Small Group Strategies to Enhance Teaching and Learning”, Faculty Development Program, Joan C. Edwards School of
Medicine, Marshall University, December, 2006
AAMC Mid-Career Women Faculty Professional Development Seminar, Lansdowne, VA, July, 2005
“Becoming an Effective Course Director”, Faculty Development Program, Joan C. Edwards School of Medicine, Marshall
University, June 2004
“Creating Your Style: What is Your Teaching Perspective/Learning Perspective” Faculty Development Program, Joan C. Edwards
School of Medicine, Marshall University, September 2004
Externally funded research grants and contracts you received.
Principal Investigator, “The Role of SKI in Testicular Cancer Metastasis”, NASA Space Grant Consortium Graduate
Fellowship for Amy Nash, $12,000, 2008-2009
Principal Investigator Project 4 “SKI/SNO Transcription Factors in Testicular Cancer”, NIH NCRR COBRE #1 P20
RR20180-01 $1,128,772 9/2004-9/2009
Principal Investigator, “Role of SKI and SNO in Testicular Cancer”, MU EPSCoR Seed Grant, $20,000, 8/2003-7/2004
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook. Could not find definition in Greenbook.
32
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: _________Jessie Shields____________________ Rank: Assistant Professor_______
Status (Check one):Full-time__X__ Part-time_____ Adjunct _____Current MU Faculty: Yes _X_ No ___
Highest Degree Earned: ____Doctor of Medicine_______ Date Degree Received: ______2003_______
Conferred by: ________________________________________________________________________
Area of Specialization: _________Pediatrics___________________________
Professional Registration/Licensure_____M.D.__________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
Agency:____WV Board of Medicine__
________
________
____3___
____3___
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment.
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
MSIII: Pediatric lecture every 8-week clerkship
MSII: Clinical Coordination/Integration
Pediatric lecture to students and residents; 2 per year
Supervising Attending for ambulatory clinic, newborn nursery, and inpatient service
Conduct teaching rounds on inpatient service
Assist in conducting interviewing workshops
Faculty Advisor
Student Mentor
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
Co-Investigator, WV – CARES Project
MRSA: Colonization Rates Among Healthcare Workers Before and After Hypochlorate Eradication
Mentor for resident research projects
Sub-Investigator; 3 GlaxoSmithKline research studies
Sub-Investigator; 3 MedImmune research studies
3)
4)
5)
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Coordinator, WV Chapter of the American Academy of Pediatrics PROS(Pediatric Research in the Office Setting)
Member, MUSOM Curriculum Committee
Member, Pediatric Resident Selection Committee
Member, Pediatric Curriculum Committee
PROS National Meeting, October 2008, April 2009
6)
7)
8)
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
33
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: ___John Wilkinson IV__________________________ Rank: __Assistant Professor_________
Status (Check one): Full-time__X__ Part-time_____ Adjunct _____ Current MU Faculty: Yes _X__
No ___
Highest Degree Earned: ____Ph.D.________________ Date Degree Received: ____ May, 1996_____
Conferred by: ________ Boston University School of Medicine ________________________________
Area of Specialization: _____Microbiology_____________________________________________
Professional Registration/Licensure_______________
Agency: _______________________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
__ 5______
__10______
__ 2_____
__11______
_ 2.5______
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2009 / Winter
Alpha Des. & No.
BMS ?
Title
Cancer Biology, 2 lectures/~20 = 10%%
Enrollment
~10
2008 / Fall
IDM 720
BMS 600
IDM 720
BMS 600
Medical Cell and Molecular Biology, 6 lectures/ 31 = 19.4%
Cellular and Molecular Biology, 5 Lectures/ 76 = 6.6%
Medical Cell and Molecular Biology, 3 lectures/ 31 = 9.7%
Cellular and Molecular Biology, 6 Lectures/ 74 = 8.1%
73
24
~73
27
2007 / Fall
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
My degree is in microbiology. My dissertation work was in the area of biochemistry, my post-doctoral work has involved
toxicology, biochemistry, murine models and extensive tissue culture work, all focused on Cancer Biology. The topics I teach
involve cell biology, cancer biology, and biochemistry.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
2008
Member, IACUC, Marshall University School of Medicine. Term: Jan, 2008 – present.
2008
Judge (Clinical Science, oral presentations), Research Day 2008, Marshall University School of Medicine.
2007
Judge (Clinical Science, oral presentations), Research Day 2007, Marshall University School of Medicine.
2007
Judge (poster presentations), Sigma Xi Event, 2007, Marshall University School of Medicine.
2005
Chair, “Iron and Disease” Session, East Coast Iron Club, University of Pennsylvania.
2004
Member, Committee for Mentoring Evaluation (K. Drotschmann, Chair). We evaluated mentoring roles and
responsibilities in the department. We produced mentoring guidelines and established the process of mentor evaluation
by trainees within the department.
2004
Member, Barrier Committee, Animal Resources Program, Wake Forest University School of Medicine. Principal architect
of new room entry procedures designed to maintain the integrity of the specific pathogen free barrier facility. Term: 20042006.
3)
Discipline-related books/papers published (provide a full citation).
Jiao Y, Wilkinson J 4th, Di X, Wang W, Hatcher H, Kock ND, D'Agostino R Jr, Knovich MA, Torti FM, Torti SV. Curcumin, a cancer
chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. Blood. 113:462-9, 2009.
**Wilkinson J. IV, Xiumin, D., Schönig, K., Buss, J.L., Kock, N.D., J. Mark Cline, Saunders, T.L., Bujard, H., Torti, S.V., and Torti,
F.M. Tissue-specific expression of ferritin H regulates cellular iron homeostasis in vivo. Biochem J, 395:501-507, 2006.
Yan Jiao, John Wilkinson IV, E. Christine Pietsch, Joan L. Buss, Roy P. Planalp, Frank M. Torti, Suzy V. Torti. Iron chelation in
the biological activity of curcumin. Free Rad. Biol. Med., 40:1152-60, 2006.
4)
Papers presented at state, regional, national, or international conferences.
34
“Transgenic Ferritin Affects Iron Homeostasis”, presented in mini-symposia at the International Bio-Iron Meeting, Hilton Hotel,
Prague, Czech Republic, May, 2005.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
2008
Member, Educators Academy, Marshall University School of Medicine
2008
Attended “AACR Epigenetics and Cancer” conference, Boston MA.
2005
Active Member of the American Association for Cancer Research, 2005-present.
2004
Member, International Bio-Iron Society, 2004- present
2001
Member, East Coast Iron Club, 2001- present (Chair, panel on Iron and Disease, 2005)
6)
Externally funded research grants and contracts you received.
2005
Co-Investigator, 1 RO1 CA101829-01A2, PI Karin Drotschmann/Scarpinato “Repair Proteins: Interface between Cell
death & Survival”. Administrator: NIH/NCI, Term: 1/1/2005 –12/31/2009. My role (10% effort) was to assist in the use of
the tetracycline based model system. This role was completed in Dec, 2006.
2004
Principal Investigator, K01 Mentored Research Scientist Development Award, “Transgenic Ferritin H Impacts Iron and
Oxidative Stress”. Administrator: NIH/NIDDK. Term: 3/01/04 – 2/29/07
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Cellular Differentiation and Development Center
3/1/2008 -2/28/2009
(Internal Grant)
$20,000 total
Hepatic Labile Iron and Oxidant Stress: In Vivo Response to Ferritin
The goal of this project is to determine the impact of transgenic ferritin expression in the liver.
8)
Community service as defined in the Greenbook.
I volunteer as Assistant Editor for the Unitarian Universalist Fellowship of Huntington Newsletter
35
Appendix II
Faculty Data Sheet
(No more than TWO pages per faculty member)
Name:___Maiyon Park___________________________________Rank:_Assistant Professor_________
Status: (Check one) Full-time__X___; Part-time_____; Graduate Assistant._____
Highest Degree Earned: __Ph.D._______Date Degree Received:__May/1998______________
Conferred by:____University of Michigan_____________________
Area of Specialization:____Biology_________________________________________________
Professional Registration/Licensure________ Agency:____________________________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
__5_years_____
__5_years_____
__1_year____
__5_years____
To determine compatibility of credentials with assignment:
1
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each
of them and what percent of the course you taught. For each course include the year and semester taught, course
number, course title and enrollment.
Year/Semester
Course Number & Title
Enrollment
None applicable
(NOTE: Part-time; adjunct; graduate assistant faculty do not need to fill in the remainder of this document.)
2
If your degree is not in your area of current assignment, please explain.
(NOTE: Begin with the most recent activities in each of the following sections.)
3
Professional development activities during the past five years, including professional organizations to which you belong
and state, regional, and national conferences attended. List any offices you hold in professional organizations.
HHMI/Department of Pharmacology at the University of Washington, Seattle, WA (Research Associate)
4
List awards/honors (including invitations to speak in your area of expertise) or special recognition in the last five years.
Park, M., and Moon, R. T., The planar cell polarity gene strabismus determines cell fate and cell behaviour in vertebrates
embryo. Keystone Symposia. March 5-10, 2002, Taos, New Mexico. (oral presentation)
Park, M., Moon. R. T. The planar cell polarity gene strabismus participates in neural patterning in vertebrates. Wnt
meeting, Memorial Sloan-Kettering Cancer Center, New York, NY, May 18-20, 2001. (poster presentation)
Park, M., Moon, R. T. Determining the function of the planar cell polarity gene strabismus in vertebrate development. 59th
Developmental Biology Meeting, University of Colorado, Boulder, June 7-11, 2000. (poster presentation)
5
Indicate any other activities that have contributed to effective teaching.
Training undergraduate students in the lab.
6
List professional books/papers published during the last five years.
Park, M., Moon, RT. The planar cell polarity gene strabismus regulates cell behaviour and cell f
embryos. Nature Cell Biology. 2002 Jan; 4(1):20-25.
ate in vertebrate
Venkstesh, TV., Park, M., Ocorr, K., Nemaceck, J., Golden, K., Wemple, M., Bodmer, R. Cardiac enhancer activity of the
homeobox gene tinman depends on CREB consensus binding sites in Drosophila. Genesis. 2000 Jan; 26(1): 55-66.
Kuhl, M., Sheldahl, LC., Park, M., Miller, JR., Moon, RT. The Wnt/Ca2+ pathway; a new vertebrate Wnt signaling pathway
takes shape. Trends Genet. 2000 Jul; 16(7): 279-83. Review.
36
Sheldahl, L., Park, M., Malbon CC., Moon, RT. Protein kinase C is differentially stimulated by Wnt and Frizzled homologs
in a G-protein dependent manner. Curr. Biol. 1999 Jul; 9(13): 695-698.
7
List papers presented at state, regional, and/or national organization conferences during the last five years.
Same as above.
8
List externally funded research (grants and contracts) you received during the last five years.
NIH COBRE Grant, Grant Number: 1 P20 RR020180-01
Principal Investigator: Maiyon Park /Niles, Richard M PHD
Project Title: Transcription Factors in Cancer (Project 3: Sap: a potential zebrafish oncogene)
37
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: ___Pier Paolo Claudio_________ Rank: _____Associate Professor__________
Status (Check one): Full-time__x___ Part-time___ Adjunct __
Current MU Faculty: Yes _x_ No ___
Highest Degree Earned: _____M.D._____ Date Degree Received: _____June, 1989_____
Conferred by: __University of Naples “Federico II”, Italy__
Area of Specialization: ________
Professional Registration/Licensure_______________
Agency: _______________________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
___0_____
__20_____
___3_____
__13_____
___3_____
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2009/Spring
Alpha Des. & No.
BMS 652
Cancer Colloquium
11
2009/Fall
BMS 652
Cancer Colloquium
6
Spring/2009
BMS 651
Cancer Biology Cluster Course (2 Hours)
6
Spring/2009
Cancer Ground Rounds lecture: “Cancer gene therapy”
15
Spring/2009
Lecture to MU Medical Residents: “Novel Cancer
Therapeutics from the Bench to the Bedside”
Cancer Colloquium
50
2008/Fall
BMS 652
Title
Enrollment
11
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
Agreements of Research Scholarship Exchange with: 1) the University of Naples, “Federico II”, Italy, 2) C.E.I.N.G.E. Biotechnology
Institute, Naples, Italy, 3) University of l’Aquila, Italy, 4) Research Center C.R.O.B- IRCCS in Rionero in Vulture, Italy, 5) CNR
Roma, Italy, 6) CNR Siena, Italy.
3)
Discipline-related books/papers published (provide a full citation).
Most representative list out of 21 scientific articles published since I joined MU:
1.
2.
3.
4.
5.
6.
7.
De Falco, G., Leucci, E., Lenze, D., Piccaluga, PP, Claudio, PP, Onnis, A., Cerino, G., Nyagol, J., Mwanda, W., Bellan,
C., Hummel, M., Pileri, S., Tosi, P., Stein, H., Giordano, A., Leoncini, L. Gene expression analysis identifies novel
RBL2/p130 target genes in endemic Burkitt's lymphoma cell lines and primary tumors. Blood. 2007 May 7;
Claudio P.P. and Denning D. (2007): Nasopharyngeal carcinoma. In Cancer Research, an encyclopedic reference book.
Springer Ed. 615-618.
Giovanni Abbadessa, Paraskevi Vogiatzi, Lorenza Rimassa and Pier Paolo Claudio. Antiangiogenic drugs currently used
for colorectal cancer: what other pathways can we target to prolong responses? Drug News and Perspectives, June 2007,
20 (5), 1-7.
Antonio Graziano, Vincenzo Desiderio, and Pier Paolo Claudio. Stem cells in tissue engineering for therapeutic use, a
promising tool or an approachable reality? Drugs of the Future 31(12): 1117, 2006.
Emanuela Vattemi and Pier Paolo Claudio Advances and Perspectives of Gene- Based therapy for Brest Cancer. Drugs
of the Future 32(6): 507, 2007.
Emanuela Vattemi and Pier Paolo Claudio Tumor Suppressor Genes as Cancer Therapeutics. Drugs News Perspectives
Oct;20(8):511-20, 2007.
Paraskevi Vogiatzi, Pierpaolo Aimola, Scarano M. Irene and Pier Paolo Claudio. Epigenome: from the control of cell
growth to cancer. Drug News Perspectives Dec;20(10):627-33, 2007.
38
8.
Gilberto Sammartino, Gaetano Marenzi, Candace Howard, Oreste Trosino, Corrado Minimo, Luigi Califano, and Pier
Paolo Claudio. Chondrosarcoma of the jaw: an anterior mandibular localization. A case report with a four-year follow-up.
Journal of Maxillofacial Surgery 2008 Nov;66(11):2349-55.
9. . S. E. Kelly, Di Benedetto A., Valluri, J.V., Claudio, P.P. Selection and Proliferation of Stem Cells. Gravitational and
Space Biology, 2008.
10. Manuela Vattemi and Pier Paolo Claudio. The feasibility of Gene Therapy in the Treatment of Head and Neck Cancer.
Head and Neck Oncology. Invited Review Article. Head Neck Oncol. 2009 Jan 12;1(1):3.
11. Manuela Vattemi and Pier Paolo Claudio. CONTUSUGENE LADENOVEC. Monograph, Drugs of the Future 2009,
34(3):1-6.
Book Chapters:
1) Claudio P.P. and Denning D. (2009): Nasopharyngeal carcinoma. In Cancer Research, an encyclopedic reference
book. Springer Ed. 615-618.
2) Vogiatzi P. and Claudio P.P. Regulation of cell cycle by retinoblastoma tumor suppressor. In: Signal Transduction:
Pathways, Mechanisms, and Diseases. Springer Ed. (2009, in press).
4)
Papers presented at state, regional, national, or international conferences.
1) Candace M. Howard, Flemming Forsberg, Ji-Bin Liu, Daniel A. Merton, Corrado Minimo, Pier Paolo Claudio. Using a
Commercial Ultrasound Contrast Agent for Viral Mediated Gene Transfer In Vitro and In Vivo. Proceedings 6th
International Symposium on Therapeutic Ultrasound. 30th August - 2nd September 2006 . Oxford, UK.
2) Pierpaolo Aimola, Candace M. Howard, Pier Paolo Claudio. Ultrasound contrast mediated gene therapy in prostate
cancer. Cancer Therapeutics: The Road Ahead. A Nature Conference. October 8-10, 2007, Palazzo dei Congressi Di
Capri, Capri, Italy.
3) S. E. Kelly, Di Benedetto A., Valluri, J.V., Claudio, P.P. Rapid selection and proliferation of cancer stem cells. Life in
Space for Life on Earth Conference. 22 - 27 June 2008, Angers – France.
4) Claudio P.P. Rapid selection and proliferation of cancer stem cells. Invited talk to C.E.I.N.G.E., Naples, Italy. May 2009.
5) Claudio P.P. Rapid selection and proliferation of cancer stem cells. Invited talk to CNR Rome, Italy. May, 2009.
5)
Professional development activities, including professional organizations to which you belong and state,
regional, national, and international conferences attended. List any panels on which you chaired or participated.
List any offices you hold in professional organizations.
1999 – present
Expert-Evaluator of the European Commission for the V Framework Program (Science, Research and Development)
2000- present
Expert-Evaluator of the INTAS Program (Science, Research and Development)
2000-present
Grant evaluator for the Department of Veteran Affairs. Livermore, CA.
2004-present
Grant evaluator NIH, Bethesda, MD
6)



7)
2007
2008
2009
2009
Externally funded research grants and contracts you received.
NIH 1R21CA131395-01 (Claudio PP., PI). 04/01/2009 – 03/31/2011 “Ultrasound guided site-specific gene delivery in prostate
cancer”. The major goals of this project are to characterize in vitro and in vivo the response of prostate cancer to gammaradiation following ultrasound guided site-specific p130 gene transduction.
NIH R-03 CA140024 (Claudio PP., PI). 08/14/2009 – 07/31/2011. Ultrasound guided gene delivery in pancreatic cancer”. The
major goals of this project are to characterize in vitro and in vivo the response of pancreatic cancer to gamma-radiation
following ultrasound guided site-specific mda-7/IL-24 gene transduction.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
International Award “Sebetia-Ter” for Biomedical Sciences, Naples, Italy
Lion’s Club Fondi Award for Stem Cell Research, Fondi (LT), Italy.
Rapid selection and proliferation of cancer stem cells. Invited talk to C.E.I.N.G.E., Naples, Italy. May 2009.
Rapid selection and proliferation of cancer stem cells. Invited talk to CNR Rome, Italy. May, 2009.
8)
Community service as defined in the Greenbook.
Journal Reviewer of 19 journals since 2005.
Journal Editorial service
Since 2005
Molecular Biology Section Editor of International Journal of Biomedical Science
Since 2005
Drugs News and Perspectives (E d i t o r - U S A )
Since 2005
D r u g s o f To d a y ( E d i t o r U S A )
Since 2005
Drugs of the Future (Editor USA).
Since 2006
Journal Experimental & Clinical Cancer Research (Editor-USA)
Since 2008
Current Signal Transduction Therapy (Editor-USA)
39
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: ____Beverly C. Delidow____________________ Rank: ____Assoc. Prof._________
Status (Check one): Full-time__X__ Part-time_____ Adjunct _____ Current MU Faculty: Yes _x_
No ___
Highest Degree Earned: _____Ph.D.________________ Date Degree Received: ____1988_________
Conferred by: _University of California, Berkeley___________________________________
Area of Specialization: ____Physiology___________________________________________________
Professional Registration/Licensure_______________
Agency: _______________________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
____6___
____6___
___16___
____22__
____5___
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
Fall 07
Alpha Des. & No.
BMS 660
Presentation Skills
Title
Enrollment
Fall 07
IDM 720
Medical Cell Biology – team taught, 2 lec hours
Fall 07
BIC 720
Fall 07
BMS 600
Spring 08
BMS 661
Medical Biochemistry – team taught, 9 lec hrs, 6 h
discussion
Foundations of Biomedical Science – team taught, 2 lec
hours
Presentation Skills – 50%
8
Spring 08
BIC 643
Molecular Signal Transduction – team taught, 85%
3
Fall 08
BMS 660
Presentation Skills
6
Fall 08
BMS 600
Fall 08
BIC 720
Fall 08
IDM 720
Foundations of Biomedical Science – team taught, 2 lec
hours
Medical Biochemistry – team taught, 9 lec hrs, 3 h
discussion
Medical Cell Biology – team taught, 2 lec hours
Spring 09
BMS 661
Presentation Skills – 50%
5
Spring 09
BMS 651
Cancer Biology – team taught, 30%
5
8
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
My postdoctoral training was in Molecular Biology, which is more closely related to Biochemistry than Physiology. My research is in
cell and molecular biology, which is also related to modern biochemistry.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
Participated in external workshops on communication, writing effectively, and productivity.
Attended AAMC Workshop for MidCareer Women Faculty (December 2007)
3)
Discipline-related books/papers published (provide a full citation).
4)
Papers presented at state, regional, national, or international conferences.
Platform talks:
40
Retinoic Acid Induces The Inhibitor Sfrp1 In Human Melanoma. Deon Uffort, Johnathan Gunno, Ashley D. Daniels and Beverly
C. Delidow. Platform talk, PASPCR, Memphis TN, Sept. 4-7 2009.
Retinoic acid induces coordinate expression of Wnt inhibitory genes in melanoma Ashley D. Dills and Beverly Delidow,
PASPCR annual meeting, Chicago, Sept 13-16, 2007
Posters:
RETINOIC ACID INDUCES THE INHIBITOR SFRP1 IN HUMAN MELANOMA Johnathan Gunno, Deon Uffort, Ashley Dills and
Beverly C. Delidow Marshall University Sigma Xi Research Day, Apr 30-May 1, 2009.
Retinoic acid induces expression of Wnt inhibitory genes in melanoma
Ashley D. Dills, John D. Gunno, Lisa Davenport, and Beverly Delidow.. Marshall University Sigma Xi Research Day, May 1-2, 2008
The Regulation of Inhibitor Proteins of the Wnt/Beta Catenin Signaling Pathway by Retinoic Acid. Clifton Umstead, Lisa
Davenport, Ashley Dills, Dr. Beverly Delidow
WV-INBRE Symposium, Marshall Univ., Aug. 2, 2007
Retinoic acid induces coordinate expression of Wnt inhibitory genes in melanoma
Ashley D. Dills, Clifton Ulmstead, Lisa Davenport and Beverly Delidow.
WV COBRE-INBRE meeting, Charleston, Nov 1-2, 2007
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
American Association for the Advancement of Science
American Society for Biochemistry and Molecular Biology
American Society for Cell Biology
Endocrine Society
PanAmerican Society for Pigment Cell Research
Society for Melanoma Research
Sigma Xi (Treasurer of the local chapter)
6)
Externally funded research grants and contracts you received.
1. COBRE, Project 1: "ß-catenin function and retinoic acid in melanoma" National Institutes of Health (R. Niles, COBRE director),
$1,003,394, 09/23/04 – 07/31/09
2. NSF Advance, M. Harrison, PI; appx $1,200,00; 8/06 – 7/09, and appx $450,000 8/09-7/11; BDelidow, coPI for Faculty
Development
3. ADVANCE minigrant: $1000, For travel to the AAMC MidCareer Faculty Women Conference, December 13- 16, 2007, Scottsdal
AZ
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
2008 Graduate Faculty Achievement Award 2008 – presented by the Biomedical Sciences Graduate Student Organization
8)
Community service as defined in the Greenbook. – Cabell County Library events, Literature groups, Consulting Rosarian
of the American Rose Society, Officer in the Huntington Rose Society
41
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: _Philippe Georgel___________________________ Rank: _Associate Professor____________
Status (Check one): Full-time_ Part-time____ Adjunct __X_
Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: _PhD____________________ Date Degree Received: _June 1993___
Conferred by: _Oregon State University______________________________________________
Area of Specialization: _Biochemistry and Biophysics_____________________________________
Professional Registration/Licensure_______________
Agency: _______________________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
_16_____
_16_____
__7_____
_11_____
________
Year/Semester
2007 Spring
Alpha Des. & No.
BSC448
Title
Immunology Team-taught (50%)
40
Enrollment
2007 Spring
BSC662
Seminar Team-taught (50%)
20
2007 Spring
BMS651
Oncology Team-taught (5%)
4
2007 Spring
BIC638
Nucl. Ac. Prot. Syn Team-taught (5%)
5
2007 Fall
BSC450/550
Molecular Biology
35
2008 Spring
BSC662
Seminar Team-taught (50%)
46
2008 Fall
BSC450/550
Molecular Biology
25
2009 Spring
BSC451/BMS670
DNA cloning Team-taught (50%)
5
2009 Fall
BSC450/550
Molecular Biology
36
2009 Fall
BSC660
Communication Bio Sci Team-taught (50%)
20
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
2)
Activities that have enhanced your teaching and or research.
- Director and coordinator of the Seminar series for the Cell Differentiation and Development Center (Fall 2007-present).
- Capstone advisor for 3 students
- Awarded MU Faculty Senate Summer Research Award (May 2008)
- Advisor for two Ms and 2 PhD students
3)
Discipline-related books/papers published (provide a full citation).
- Papers: 1. Rapid biophysical analysis of macromolecular complexes using multiple loadings of Quantitative Agarose Gel
Electrophoresis (QAGE). Adkins, N.L., Hall, J.A. and Georgel, P.T. Journal of Biochemical and Biophysical Methods. Vol. 70.
Pp721-726 (2007).
2. Role of nucleic acid binding in Sir3-dependent interactions with chromatin fibers. Adkins, N.L., McBryant, S., Johnson, C. N.,
Leidy, J.M., Woodcock, C.L., Robert C.H., Hansen, J.C., and Georgel, P.T. Biochemistry, Vol. 48. Pp 276-288, (2009).
3. Chromatin Stability at Low Concentration Depends on Histone Octamer Saturation Levels. Hagerman, T., Fu, Q., Molinié, B.,
Lindsay, S., Georgel, P.T. Biophysical Journal, Vol. 96. Pp 1944-1951, (2009)
- Reviews: 1. Towards an integrated and multidisciplinary analysis of epigenetic variation in complex diseases: development of the
Cell Differentiation and Development Center (CDDC) at Marshall University. Philippe T. Georgel and Eric R. Blough. Proceedings of
the 2007 StaR Symposium, Pp 111-116 (2007). Non-peer reviewed
2. Atomic Force Microscopy and Energy Requirements for Nucleosome Sliding. Meagan Watts, David Neff, Michael L. Norton, and
Philippe T. Georgel. Proceedings of the 2007 StaR Symposium, Pp 40-45 (2007). Non-peer reviewed
3. Role of chromatin/epigenetic modifications on DNA accessibility. Georgel, P.T. Drug News Perspectives Vol. 20. Pp 549-556
(2007)
4. Sulforaphane Effects on Prostate Cancer Prevention and Treatment. Molinie, B., Ward-Horne, M., Patterson W., and Georgel,
P.T. Proceedings of the 2009 StaR Symposium, Pp 75-83 (2009).
42
5. Genetic and Epigenetic Regulations of Prostate Cancer by Genistein. Molinié, B. and Georgel, P.T. Drug News Perspectives Vol.
22. Pp 247-254 (2009)
4)
Papers presented at state, regional, national, or international conferences.
1. Towards an integrated and multidisciplinary analysis of epigenetic variation in complex diseases: development of the Cell
Differentiation and Development Center (CDDC) at Marshall University. STaR Symposium, Morgantown (September 18, 2007)
2. Atomic Force Microscopy and Energy Requirements for Nucleosome Sliding. STaR Symposium, Morgantown (September 18,
2007)
3. Detection of Cellular Markers of Prostate Cancer. Multifunctional Nanomaterials International Symposium, Roanoke, WV. (April
11-13, 2008)
4. Sir3p-dependent spreading is DNA-mediated. Adkins, N.L., McBryant, S., Robert, C.H., Johnson, C.N., Woodcock, C.L., Hansen,
J.C., and Georgel, P.T. Epigenetics and Chromatin Dynamics Conference (Canadian Society of Biochemistry, Molecular & Cellular
Biology), Banff, Canada, March 6-9, 2008
5. Sir3-dependent spreading is DNA-mediated. N.L. Adkins, S. McBryant, C.N. Johnson, C.L. Woodcock, C.H. Robert, J.C. Hansen,
P.T. Georgel. NCI Symposium on Chromosome Biology, October 30-31, 2008, Bethesda, MD
6. Chromatin-Remodeling Proteins as Potential Regulators of Sublingual Gland Differentiation in Mouse. J. Adam Hall, Nicholas L.
Adkins, Philippe T. Georgel. NCI Symposium on Chromosome Biology, October 30-31, 2008, Bethesda, MD
7. Retinoic Acid Receptor-B2 in Melanoma Nutrients and Epigenetic Regulation. Asilomar Chromatin and Chromosomes Meeting,
December 11-14, 2008. Asilomar, Pacific Grove, CA.
8. Epigenetic Regulations: More Than Just DNA Methylation and Histone Modifications: How Does Structure Affects Function?
Kuwait University, School of Medicine, Kuwait, January 19, 2009.
9. Epigenetic Regulations: More Than Just DNA Methylation and Histone Modifications University of Manitoba, Manitoba Institute of
Cell Biology. Winnipeg, Canada, August 27, 2009.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Member of the “Sigma Xi” Research Society; Nominated Expert of International Standing by the Australian Research Council;
Member of the Biophysical Society; DOD Breast Cancer Panel 2007-present (participant); NSF reviewer;; Reviewer for: Biochimica
and Biophysica Acta, Biochemistry and Cell Biology, FEBS Letters, Biophysical Journal, Development, Journal of Proteome
Research, Experimental Cell Research; Associate Editor for Biochemistry and Cell Biology.
6)
Externally funded research grants and contracts you received.
Towards an integrated and multidisciplinary analysis of epigenetic variation in complex diseases: development of the Cell
Differentiation and Development Center (CDDC) at Marshall University (WV EPSCoR, PI Georgel, P.T., Blough E. Awarded in June
2007, $2,350,000)
Energy Requirements for Nucleosome Sliding (WV EPSCoR PI: Georgel, P.T., URSP.2008.WV.01, Awarded on August 20, 2007,
$5,000)
Epigenetic Regulation of p21CIP1 Expression by Sulforaphane in Prostate Cancer (Internal COBRE grant, PI: Georgel, P.T, Awarded
May 2008, $12,000)
Marshall University SURE program “Prostate Cancer and Epigenetics” PI: William Patterson 3 rd., Sponsor: Dr. Georgel, Philippe
(Budget $4,000)
NIH F31 Pre-Doctoral fellowship Ruth Kirstein “CHD1, Chromatin Dynamics and Salivary Gland Differentiation” PI: J. Adam Hall.
Sponsor/Advisor: Dr. Philippe Georgel (Budget: ~$ 35,000).
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Chair of the Budget and Academic Policy Committee at Marshall University.
Nominated Expert of International Standing by the Australian Research Council.
Invited speaker at Kuwait University, School of Medicine, Kuwait, January 19, 2009 (see above, section 4)
Invited speaker at the STaR symposium (Morgantown, September 18, 2007)
Invited participant to the Systems Biology of Steroid Receptors in Human Disease (NIH, NCI, September 21-22, 2009)
Outside PhD committee member and invited speaker at the University of Winnipeg, Canada (September 2009)
8)
Community service as defined in the Greenbook.
Assisting during COS open House (Spring 2007)
Jury member for the WV Science Fair 2007
Consulting for preparation of grant proposal with NIH and Kuwait University
(December, 18, 2008)
Assisting during MUSOM open House (Spring 2008)
43
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: ___Wanda Elaine Hardman________________ Rank: _Associate Professor____________
Status (Check one): Full-time_XX_ Part-time__ Adjunct ___
Current MU Faculty: Yes _XX_
No _
Highest Degree Earned: __Ph.D.__________ Date Degree Received: _Conferred May 1993___
Conferred by: __Univ. of Texas Health Science Center, San Antonio____________________
Area of Specialization: ___Cell Biology______________________________
Professional Registration/Licensure_______________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
Agency: _______________________________
____12___
____12___
_____4___
____16___
_____4___
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
08,09 Fall
Alpha Des. & No.
BIC 720
Title
Biochemistry, Medical students, 19 lecture hours
08,09, Fall
BMS 600
Fall 07,to Spring 09
BMS 680
Biochemical, Cellular and Molecular Foundations
biomedical science,Graduate Students, 8 lecture hours
Seminar, 17 class hours/ semester
Spr. 07, Spr 09
BMS 651
Cancer Cell Biology, Graduate, 4 lecture hours
Enrollment
70
of
40
45
5
Graduate and undergraduate students
Graduate students – Juliana Akinsete – PhD Biomedical Sciences, primary mentor
Capstone project for Ted Witte, Environmental Sciences Master’s student
Graduate committees for 4 students: Amy Nash; Yue Huang, Anne Olshanski,
Nick Adkins
Mentor for undergraduate students: Bianca Lycans, capstone project
Ronald Reyes – Chemistry, Capstone project
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
Professional development activities:
Lecture from Dr. Larry Greenberg, George Town school of medicine, Thursday August 31 at noon in MEB 116B, “Stimulating our
students to think in higher cognitive levels” 2007
Half day seminar on test question writing and use of question statistics. 2007
Cancer in Nutrition” 2 day seminar, Univ. of North Carolina. 2007
ABC of Teaching and learning in medicine
“Learner centered” teaching to provide “patient centered” care., August 6, 2007
Teri Turner MD and Nancy S. Searle, EdD from Baylor School of Medicine
3)
Discipline-related books/papers published (provide a full citation).
Peer reviewed
Hardman, WE Omega 3 fatty acids effects on cancer therapy. J. Nutr. 134: 3427S-3420S, 2004
Cameron, IL, Sun, LZ, Hardman, WE and Williams, CD. Therapeutic Electromagnetic Field (TEMF) and gamma irradiation on
human breast cancer xenograft growth, angiogenesis and metastasis. Cancer Cell Int. 2005 Jul 26;5:23.
Hardman, WE, Sun, L.Z., Short, N. and Cameron, IL. Dietary omega-3 fatty acids and ionizing irradiation on human breast cancer
xenograft growth and angiogenesis. Cancer Cell Int. 2005 Apr 28;5(1):12.
Cameron, IL, Short, N, Sun, LZ and Hardman, WE. Endothelial cell pseudopods and angiogenesis of breast cancer tumors Cancer
Cell Int. 2005 May 26;5(1):17.
Cameron, IL, Kent, JE, Philo, R, Barnes, CJ, and Hardman, WE. Numerical Distribution of Lymphatic Nodules in Human Sigmoid
Colon, Rectosigmoidal Junction, Rectum and Anal Canal. Clinical Anatomy, 2006: 19(2), 164-170.
Hardman, WE. Dietary canola oil suppressed growth of implanted MDA-MB 231 human breast tumors in nude mice. Nutr and
Cancer, 2007, 57(2), 177-183.
Hardman WE and Ion, G. Walnut consumption for growth suppression of human MDA-MB 231 xenografts. Nutr and Cancer. 2008,
60(5), 666-674.
44
Varney, ME, Hardman, WE and Sollars, VE. Omega 3 fatty acids reduce myeloid progenitor cell frequency in the bone marrow of
mice and promote progenitor cell differentiation. Lipids in Health and Disease. 2009, 8:9.
Ion, G., Akinsete, J.A. and Hardman, W.E. Maternal consumption of canola oil suppressed mammary gland tumorigenesis in C3(1)
TAg mice. Breast Cancer Research, submitted 8/2009.
Book Chapters
Markov, MS, Williams, CD, Cameron, IL, Hardman, WE and Salvadore, JR. Can Magnetic Fields Inhibit Angiogenesis and Tumor
Growth? In: Bioelectric Medicine. Paul J Rosch and Marko S. Markov (eds) Marcel-Dekker, New York, 2004.
Hardman, WE. Omega 3 fatty acids as an adjuvant to cancer therapy. In: Focus on Dietary Fats Research. M. V. Landow, editor,
Nova Science Publishers, New York 2006
Hardman, WE. Omega-3 PUFAs in combination with chemotherapic agents. In: Dietary Omega-3 Polyunsaturated Fatty Acids and
Cancer. Calviello, G. editor, Springer. In press: June 2009
4)
Papers presented at state, regional, national, or international conferences.
Hardman, WE, Exposure to omega 3 fatty acids during gestation and lactation may reduce lifetime risk for mammary cancer. Proc.
Am. Assoc. for Cancer Research 45: 2004.
Hardman, W. Elaine, Maternal or offspring consumption of omega 3 fatty acids to prevent breast cancer. Proc. Am. Assoc. for
Cancer Research: 2005
Akinsete, J., Ion, G., and Hardman, WE, Maternal Consumption of Canola Oil Reduces Mammary Gland Cancer Risk in C31 Tag
Offspring. Frontiers in Cancer Prevention Research 2008.
Walnut consumption decreases mammary gland tumor incidence, multiplicity and growth in the C(3)1Tag transgenic mouse,
Gabriela Ion, Juliana A. Akinsete, Ted Witte, and W. Elaine Hardman
American Association for Cancer Research Annual meeting, 2009
5)
Professional development activities, including professional organizations to which you belong and state,
regional, national, and international conferences attended. List any panels on which you chaired or participated. List any
offices you hold in professional organizations.
Attendance and presentation at: Frontiers in Cancer Prevention Research Conference, 2006, 2007, 2008
American Association for Cancer Research Annual meeting, 2004, 2005, 2009
American Institute for Cancer Research International Meeting, 2004, 2005, 2006, 2009
Member, American Association for Cancer Research
International Federation for Cell Biology, Treasurer, 2000 to 2009
National Cancer Institute, Study Section J, Education, ad hoc member, 2003, 2004. Regular membership. June, 2004 to June 2009
American Institute for Cancer Research, Annual Meeting Program Committee, Symposium organizer, 2004 meeting
American Institute for Cancer Research, Study Section 2, 2003 to present
Scientific Advisory Board, California Walnut Council, 2004 to present
6)
Externally funded research grants and contracts you received.
Title: A dietary strategy to delay or prevent mammary cancer BC024128 Dates: Aug 1, 2003 to July 31, 2005
Total Budget: $110, 250
Agency: DOD – Breast Cancer Research Program
Title: Omega 3 fat to prevent or slow breast cancers BC032032
Dates: Apr 1, 2005 to Apr 30, 2008
Total Budget: $429,173
Agency: DOD – Breast Cancer Research Program
Title: Walnut consumption to reduce cancer risk
Dates: Dec. 1, 2005 to Nov 30, 2006
Total Budget: about $60,000 Agency: Matching grants, Am. Institute for Cancer Research and the Calif. Walnut Council
Title: Post-doctoral fellowship for Gabriela Ion Attenuation of preadipocytes/breast cancer cells communication
with role in cancer prevention Dates: Jan 15, 2007 – Jan 14, 2010
Total Budget: $80,000
Agency: Cancer Research and Prevention Foundation
Title: Walnut consumption for benefit against prostate and breast cancer Dates: July 1, 2007 – June 30, 2010
Total Budget: $120,000
Agency: Am. Inst for Cancer Research / Calif Walnut Commission
Title: Omega-3 fat to reduce risk for breast cancer 1R01CA114018-01A2 Dates: Sept. 14, 2007 to Aug. 31, 2011
Total Budget: $266,000/year, $1,064,000 total,
Agency: National Cancer Institute
Title: Administrative supplement to Omega-3 fat to reduce risk for breast cancer 1R01CA114018-01A2
Dates: Sept. 14, 2007 to Aug. 31, 2010
Total Budget: $40,886/year, $122,658 total, Agency: NCI/NIH
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Hardman, WE. Omega 3 fatty acids and cancer therapy. Presentation to the International Research Conference on Food, Nutrition
& Cancer, sponsors: American Institute for Cancer Research and the World Cancer Research Fund International,
Washington, DC, July, 2004.
Hardman, WE Omega 3 fatty acids and cancer. Invited speaker to Arkansas Cancer Research Center, Director’s Symposium, Nov.
8, 2004.
Hardman, WE Omega 3 fatty acids and cancer. Invited speaker to International Seafood Conference, Dec. 2005, Washington, DC.
Hardman, WE Walnuts consumption to reduce cancer growth, Invited speaker to California Walnut Council Scientific meeting, Aug
2006.
Hardman, WE Walnuts consumption to reduce cancer growth and prevent cancer, Invited speaker to California Walnut Council
Scientific meeting, Aug 2008.
Multiple citations in newspaper, magazines, radio and TV for work on canola oil or walnuts and cancer.
45
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: __Susan H. Jackman __________________ Rank: ____Professor____________________
Status (Check one): Full-time___x
__ Part-time_____ Adjunct _____
Current MU Faculty: Yes __x_
No ___
Highest Degree Earned: ___Ph.D.__________________ Date Degree Received: _____1984________
Conferred by: ___Iowa State University_______________________________________________
Area of Specialization: _____Immunology_________________________________________________
Professional Registration/Licensure_______________
Agency: _______________________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
________
___1____
___19___
________
___5____
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
07-08/Fall
Alpha Des. & No.
MCB 743
Immunology
Title
64
Enrollment
07-08/Fall
MCB 643
Immunology
3
08-09/Fall
MCB 743
Immunology
67
08/-09/Fall
MCB 643
Immunology
1
08-09/Spring
08-09/Spring
BMS 679
MCB 648
Special Topics - Immunology
Molecular Aspects of Pathogenesis
1
1
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.




Attendance at in-house seminars (08-09):
Providing Effective Feedback: Proof is in the Pudding
Power-Pointing in the Right Direction
Assessing Your Learners
Scholarly Writing: Publishing Medical Education Research
Webcast seminars (08-09):
MedEdPortal Online Training Workshop
Longitudinal Evaluation of Student Progress: McMaster University Model
Assessment That Matters: Beyond the Knowledge of Recall and Factual Information
Principles That Drive Innovation in Assessment and Evaluation
Evaluating Learning in the Classroom
Applying Principles of Continuous Quality Improvement in the Course Evaluation Process
Students' Perspective of Assessment
Attendance at seminars (07-08):
ABC’s of Teaching and Learning in Medicine – full day workshop
Autism Spectrum Disorders: Basic Information to Promote Successful Interactions
Preparing Effective Presentations
Tips for Writing Learning Objectives
Team-Based Learning 101
Participated in webcast seminars (07-08):
Generational Differences: Implications for Teachers and Learners
New Tools for Teaching the Next Generation
Creative Application of Technology in Medical Education
Fostering Professionalism and Ethics in the New Generation
Learning Societies for Collaboration
46
3)
4)
5)
6)
7)
8)
Faculty Development and Preparing Faculty for the Next Generation
 Attendance at seminars (06-07):
Using the NBME Format in How to Write and Analyze Test Items
Using Small Group Strategies to Enhance Teaching and Learning
Stimulating Our Students to Think in Higher Cognitive Levels
 Participated in webcast seminars (06-07):
Classroom Assessment: Finding Out How Well They Are Learning What We Are Teaching
Learning Styles and Teaching
Approaches in the Physical and Virtual Lecture Hall
Say No to Boring Lectures Whether Live or Online
Discipline-related books/papers published (provide a full citation).

Yu, C and S.H. Jackman (mentor). Classification of Cystic Fribrosis Isolates of P. aeruginosa Based on Temperature
Sensitivity. Ethnicity and Disease. 2008. 18:S1-28-S1-29.

Yu, C. and Jackman, S.H. End of mucoidy: the role of RpoN in promoting alginate production in Pseudomonas
aeruginosa. 2007. Ethnicity and Disease. 17:S5-70

Staton, PJ, Carpenter AB, and Jackman, SJ., IL-7 is a critical factor in modulating lesion development in Skn-directed
autoimmunity, J. Immunol. 176:3978-3986, 2006.
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.

Member of The American Association of Immunologists, The Society of Investigative
Dermatology, Society of
Leukocyte Biology, Sigma Xi, International Association of Medical Science Educators, The Team-Based Learning Collaborative

Team-Based Learning Collaborative conference, 2009

International Association of Medical Science Education Annual Meeting, 2008

American Association for Cancer Research: “Tumor Immunology: An Integrated Perspective (07)
Externally funded research grants and contracts you received.

Research Supplies Stipend Grant: NIH/NIDDK/Drew University National High School Student Summer Research
Apprentice Program

Research Supplies Stipend Grant: NIH/NIDDK/Drew Expended Pipeline Program
Awards/honors (including invitations to speak in your area of expertise) or special recognition.

Certificate of Teaching Excellence by JCESOM, 2009

Invited seminar: "Team Based Leaning: TBL - The New Buzzword in Medical Education" for the JCESOM Professional
and Institutional Enhancement Seminar (PIES) series

MSII student award for Fall Semester Course, 2006

MSII student award for “Teacher of the Year, Fall 2004”
Community service as defined in the Greenbook.

Mentor for the NIH/NIDDK/Drew University National High School Student Summer Research Apprentice Program (JuneAugust, 2007; June-August, 2006)


Mentor the NIH/NIDDK/Drew Expended Pipeline Program (October-May, 06-07)
Demonstrated blood group typing to the Huntington High School Science Club
47
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: ___Michael R. Moore_______________________________________Rank: Professor___________________________
Status (Check one): Full-time___X__ Part-time_____ Adjunct _____
Current MU Faculty: Yes __X_
No ___
Highest Degree Earned: __Ph.D.________________________ Date Degree Received: December, 1975_________________
Conferred by: __University of Georgia______________________________________________________________________
Area of Specialization: _____Biochemistry____________________________________________________________
Professional Registration/Licensure____N/A___________
Agency: _______________________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
___3_____
___5_____
___31_____
___31_____
___5_____
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2007/fall-team-20%
Alpha Des. & No.
BIC 720
Human Biochemistry
Title
Enrollment
~85
2007/fall-team-4%
BIC 643
Molecular Signal Transduction
5
2007/fall-team-11%
BMS 600
51
2008/fall-team-20%
(course director)
BIC 720
Biochemical, Cellular and Molecular Foundations of
Biomedical Science
Human Biochemistry
2008/spring-11%
BMS 651
Cancer Biology
83
7
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
Not applicable
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
Activities that have enhanced your teaching and or research.
-Attended 4 presentations/workshops on teaching methods/effectiveness put on by the School of
Medicine’s Office of Professional Development in Medical Education
-Spent a 6 month sabbatical leave, January through June, 2005, doing research on progesterone
and breast cancer in the Department of Pathology at the University of Colorado School of Med.
Discipline-related books/papers published (provide a full citation).
Moore MR, Spence JB, Kiningham KK, and Dillon JL (2006) Progestin Inhibition of Cell Death in
Human Breast Cancer Cell Lines, Journal of Steroid Biochemistry and Molecular Biology.
98, 218-227.
Holley AK, Kiningham KK, Spitz DR, Edwards DP, Jenkins JT, Moore MR (2009) Progestin
Stimulation of Manganese Superoxide Dismutase and Invasive Properties in T47D
Human Breast Cancer Cells, Journal of Steroid Biochemistry and Molecular Biology. 117,
23-30.
Papers presented at state, regional, national, or international conferences.
Holley AK, Kiningham KK, Spitz DR, Edwards DP and Moore MR (2006) Progestin Stimulation
of Manganese Superoxide Dismutase in T47D Human Breast Cancer Cells, Abstracts of
the annual meeting of The Endocrine Society, Boston, MA
Holley AK and Moore MR (2007)Progestins Down-regulate the Transcription Factor Activating
Enhancer-Binding Protein 2γ (AP-2γ) in T47D Human Breast Cancer Cells, annual
meeting of The Endocrine Society, Toronto, Canada
48
Teter MA, Holley AK and Moore MR (2007) Progestin Stimulation of Migration of T47D Human
Breast Cancer Cells, poster presentation at the West Virginia INBRE Research
Symposium, Marshall University, July, 2007
Teter MA, Holley AK and Moore MR (2007) Progestin Stimulation of Migration of T47D Human
Breast Cancer Cells, poster presentation at the West Virginia STAR Symposium, West
Virginia University, September, 2007, prize winning presentation
Holley AK, Kiningham, KK, Spitz, DR, Edwards DP, Teter MA and Moore MR (2008) Progestin
stimulation of MnSOD in T47D Human Breast Cancer Cells, poster presentation at the
Keystone Symposium on Nuclear Receptors, Steroid Sisters, Whistler, BC, Canada
Estep AG, Holley AK, Jenkins JT, Teter MA, Moore MR (2008) The Role of Manganese
Superoxide Dismutase in Progestin Stimulation of Metastasis-related Characteristics of
T47D Human Breast Cancer Cells, poster presentation at the West Virginia INBRE
Research Symposium, West Virginia University, July, 2008.
Holley AK, Kiningham KK, Spitz DR, Edwards DP, Jenkins JT, Moore MR (2009)Progestin
stimulation of manganese superoxide dismutase and invasive properties in T47D human
breast cancer cells, poster presentation at the annual meeting of The Endocrine Society,
Washington, D.C., June 2009
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Member of the American Society for Biochemistry and Molecular Biology
Member of The Endocrine Society
6)
Attended all of the conferences listed above in part (4) except for the West Virginia STAR
Symposium in 2007
Externally funded research grants and contracts you received.
Co-investigator of grant from WV INBRE program of NIH, "Progestin/glucocorticoid inhibition of
breast cancer cell death", funding $2,000 from June 8, '04 to August 8, '04.In addition, the salary
of the undergraduate student working on this project in my lab was paid by INBRE.
Co-investigator on grant from Center of Biomedical Research Excellence (PI RM Niles) program
of NIH, P20 RR020180.Title of my project “Progestin Inhibition of Breast Cancer Cell Death”;
$20,000, August 1, 2005- July 31, 2006; pilot grant to MR Moore from COBRE
Co-investigator on 5P20RR016477-07 Rankin (PI), West Virginia INBRE program of NIH, pilot
grant to Moore from this grant to fund an undergraduate’s salary and supplies for 2 months’
summer research,06/04/07-08/04/07;Goal: To determine the role of progestins in breast cancer
migration and invasion.
7)
8)
Co-investigator on 5P20RR016477-08 Rankin (PI),West Virginia INBRE program of NIH,
06/02/08 – 07/31/08,pilot grant to Moore from this grant to fund an undergraduate’s salary and
supplies for 2 months’ summer research; Goal: To determine the role of progestins in breast
cancer migration and invasion.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Invited seminar, June, 2008: Progestins and Breast Cancer. Joan C. Edwards Cancer
Center Grand Rounds. Marshall University.
Community service as defined in the Greenbook.
49
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: __Richard M. NIles__________________________________________ Rank: Professor___________________________
Status (Check one): Full-time__X___ Part-time_____ Adjunct _____
Current MU Faculty: Yes _X__
No ___
Highest Degree Earned: __Ph.D.________________________ Date Degree Received: __1972_______________
Conferred by: ____University of Massachusetts Amherst____________________________________________________________________
Area of Specialization: ______Pathology___________________________________________________________
Professional Registration/Licensure_______________
Agency: _______________________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
_34_______
__17______
__17______
_34_______
__5______
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
Fall 2007
Alpha Des. & No.
BMS600
Cell and Molecular Biology
Title
50
Enrollment
Fall 2008
BMS 600
Cell and Molecular Biology
50
Fall 2007
BIC720/620
Human Biochemistry
68
Fall 2008
BIC 720/620
Human Biochemistry
72
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
Activities that have enhanced your teaching and or research.
None
Discipline-related books/papers published (provide a full citation).
Niles, R.M. Vitamin A (Retinoids) Regulation of Mouse Melanoma Growth and Differentiation. J. Nutr. 133: 282-286,
2003
Niles, R.M., McFarland, M., Weimer, M.B., Redkar, A., Fu, Y.-M., and Meadows, G.G. Resveratrol is a Potent Inducer of
Apoptosis in Human Melanoma Cells. Cancer Letters 190: 157-163, 2003
Boskovic, G. and Niles, RM. Identification of Tbx-2 as an Immediate Early Gene Target of Retinoic Acid in B16 Mouse
Melanoma Cells. Exp. Cell Res. 295: 281-289, 2004
Niles, R.M. Signaling Pathways in Retinoid Chemoprevention and Treatment of Cancer. Mutat. Res. 555:81-96, 2004
Herdman, M., Marcelo, A., Niles, R.M., and Kiningham, K. Thimerosal Induces Apoptosis in a Neuroblastoma Model via
the c-Jun N-Terminal Kinase Pathway. Toxicol Sci 92: 246-253, 2006.
Niles, R.M., Cook, C.P., Meadows, G.G., Fu, Y.-M., McLaughlin, J.L., and Rankin, G.O. Resveratrol is Rapidly
Metabolized in Athymic (Nu/Nu) Mice and Does Not Inhibit Human Melanoma Xenograft Tumor Growth. J. Nutrition
136:2542-2546, 2006.
Niles, R.M. Biomarker and Animal Models for Assessment of Retinoid Efficacy in Cancer Chemoprevention. Acta
Pharmacologica Sinica 28: 1383-1391, 2007.
Eastham, L.L., Mills, C.N., and Niles, R.M. PPAR alpha/gamma Expression and Activity in Mouse and Human
Melanocytes and Melanoma Cells. Pharm. Res. 25:1327-1333, 2008.
50
Huang, Y., Minigh, J., Miles, S., and Niles, R.M. Retinoic acid Decreases ATF-2 Phosphorylation and Sensitizes
Melanoma Cells to Taxol- Mediated Growth Inhibition. J. Mol. Signalling 3:3, 2008
Estler, M., Boskovic, G., Denvir, J., Miles, S., Primerano, D.A., and Niles, R.M. Global Analysis of Gene Expression
Changes During Retinoic Acid-Induced Growth Arrest and Differentiation of Melanoma: Comparison to Differentially
Expressed Genes in Melanocytes vs. Melanoma. BMC-Genomics, 9:478 ,2008. Epub
.
Li, J., Orr, B., White, K., Belogortseva, N., Niles, R., Boskovic, G., Nguyen,
H., Dykes, A., and Park, M. Chmp 1A is
a Mediator of the Anti-proliferative
Effects of all-trans Retinoic acid in Human Pancreatic Cancer Cells. Mol.
Cancer 8:7, 2009, Epub
Fan, J, Zhu, G.-Z., and Niles, R.M. Expression and Function of CD9 in Melanoma Cells. Molecular Carcinogenesis, In
Press.
4)
Mills, C.N., Joshi, S.S., and Niles, R.M. Expression and Function of Hypoxia Inducible Factor –alpha in Humna
melanoma Under Non-hypoxic Condition. Molecular Cancer, In Press.
Papers presented at state, regional, national, or international conferences.
Expression and Function of HIF-1alpha in Human Melanoma Under Non-Hypoxic Conditions. Caroline Mills, Sandeep
Joshi, and Richard M. Niles, Department of Biochemistry and Microbiology, Joan C. Edwards School of Medicine,
Marshall University, Huntington, WV 25755. Present at Internation Melanoma Congress, NY, NY, Nov. 2007
HIF-1α Regulates MITF Expression in Human Melanoma
Sandeep S. Joshi, Jun Fan, and Richard M. Niles
From Department of Biochemistry and Microbiology, Joan C. Edwards School of Medicine, Marshall University,
Huntington, WV 25755. To be presented at the 2009 International Melanoma Congress, Boston, MA, Nov. 2009
Regulation of Retinoic Acid Sensitivity in Human Melanoma by HIF-1α
Sandeep S. Joshi, Sarah Miles, and Richard M. Niles
From Department of Biochemistry and Microbiology, Joan C. Edwards School of Medicine, Marshall University,
Huntington, WV 25755. Ti be presented at the 2009 International Melanoma Congress, Boston, MA Nov. 2009
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Member of American Association for Cancer Research
Member of Society for Melanoma Research
Member of American Society for Nutrition
Member of American Association for the Advancement of Science
Member of American Society of Biochemistry and Molecular Biology
Organized and Chaired Session on Vitamins and Treatment/Prevention of Cancer.
AICR/WCRF International Research Conference on Food, Nutrition and Cancer, Washington, D.C. July, 2004
Organized and Chaired Session on Animal Models for the Study of Nutrition and Cancer
AICR/WCFR International Research Conference on Food, Nutrition and Cancer, Washington, DC, July, 2005
Chair
Program Committee
2008, 2009 AICR/WCRF International Research Conference on Food, Nutrition, Physical Activity and Cancer Washington,
DC, Nov. 2008, Nov. 2009
Charter Member NIH Chemo and Dietary
Prevention of Cancer Study Section
2003-2004
Chair, Cell Biology I Grant Review Panel US
Army Prostate Cancer Research Program, April, 2003
Panel Member NCI Special Emphasis Panel
To review RFA grants on Molecular Targets of Nutrients in Prostate Cancer. Nov, 2003
Chair, Cell Biology I Grant Review Panel, US Army Prostate Cancer Research Program, April, 2005
Ad hoc member US Army Breast Cancer Programatic Review Panel, April , 2005
Chair, Cell Biology 4 Grant Review Panel US Army Breast Cancer Research Program, Aug. 2005
Reviewer for numerous publications such as J. Cell. Physiol., Cancer Res., J. Biol. Chem., Science, Oncogene, and Proc
Natl Acad Sci
Ad hoc member of the US Army Breast Cancer Integration Panel, Nov., 2006-2008
6)
Externally funded research grants and contracts you received.
51
Principal Investigator
Resveratrol and Human Melanoma
NIH
$146,000 – 5/1/03 – 3/31/05
Principal Investigator
Center of Biomedical Research Excellence – “Transcription Factors in Cancer”
NIH, NCRR
$9.3 million – 9/23/04 – 7/31/09
Principal Investigator
Use of Phytochemicals to activate expression of silenced genes in melanoma cells, RO3 NIH, NCI
$140,000 – 11/1/06 – 10/30/08
Principal Investigator
STEM Fellows grant
West Virginia Research Challenge Fund
$800,000 – 1/1/09 – 12/31/13
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Signaling Pathways Involved in Vitamin A-Induction of Growth Arrest and Differentiation in Melanoma
Department of Human Nutrition
The Ohio State University
Columbus, OH, May, 2003
Signal Transduction Involved in Vitamin A Regulation of Melanoma Growth and Differentiation
Department of Biochemistry and Molecular Biology
University of South Florida, Jan. 2004
Signaling Pathways in Retinoid-induced Melanoma Growth Arrest and Differentiation
Southern Research institute, Birmingham, AL, June 2004
Use of Gene Arrays to Identify Novel Retinoic Acid-Regulated Genes in Melanoma Cells, WVU, Morgantown, WV, Oct.
2006
Gene Expression and Epigenetics: Retinoid Regulation of Melanoma Growth and Differentiation.
Department of Nutritional Sciences
University of Texas – Austin
Nov 2007
Vitamin A and Melanoma
Center for Protease Research
North Dakota State University
Fargo, ND
June, 2008
Sebetia-Ter Award in Biomedical Sciences
Naples, Italy, May 2008
8)
Community service as defined in the Greenbook.
52
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: ___Michael Norton________________________ Rank: ____Professor______________
Status (Check one): Full-time___ Part-time___Adjunct __X_ Current MU Faculty: Yes _X__
No ___
Highest Degree Earned: _______PhD___________ Date Degree Received: ____1982________
Conferred by: __________Arizona State U_________________________________________
Area of Specialization: ____Chemistry______________________________________________
Professional Registration/Licensure_______________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
Agency: _______________________________
____2____
____7____
___18_____
___20_____
____5____
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2008/Spring
2008/Fall
2009/Spring
2009/Fall
Alpha Des. & No.
CHM 483, BSC 482,Gly
483
CHM 448
CHM 548
CHM 483, BSC 482,Gly
483
CHM 448
Title
Applied Microscopy in Research (Undergraduate)
8
Enrollment
Applied Microscopy in Research (Undergraduate)
34
4
4
12
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
1.
Activities that have enhanced your teaching and or research.
Discipline-related books/papers published (provide a full citation).
Publications
Shen, Wanqiu; Zhong, Hong; Neff, David and Norton, Michael L., NTA Directed Protein Nanopatterning on DNA Origami
Nanoconstructs, J. Am. Chem. Soc., 131 (19), 6660–6661, 2009.
2.
Bellido, Edson P.; Bobadilla, Alfredo D.; Rangel, Norma L.; Zhong, Hong; Norton; Alexander Sinitskii, Alexander and J. M.
Seminario.; Current-voltage-temperature characteristics of DNA origami, Nanotechnology 20, 175102, 2009.
3.
Bobadilla, Alfredo D; Bellido, Edson P.; Rangel, Norma L.; Zhong, Hong; Norton, Michael; Sinitskii, Alexander and Seminario,
Jorge M.; DNA origami impedance measurement at room temperature; J. Chem. Phys., 130 171101 (2009). Selected for the
Vir. J. Nan. Sci. & Tech., Vol. 19, Issue 20, Organic-Inorganic hybrid nanostructures (2009); and for the May 15, 2009 issue of
Vir. J. Bio. Phys. Res. (2009)
4.
Hong, Sungmin; Jauregui, Luis A.; Rangel, Norma L.; Cao, Huan; Day, B. Scott; Norton, Michael L.; Sinitskii, Alexander S.;
and Seminario, Jorge M.; Impedance measurements on a DNA junction, J. Chem. Phys. 128(20), 201103-201106, 2008.
5.
Santagata, N.M., Pengshun Luo, Lakhani, A.M., DeWitt, D.J., Day, B.S., Norton, M.L., Pearl, T.P.; Organizational
Structure and Electronic Decoupling of Surface Bound Chiral Domains and Biomolecules, IEEE Sensors Journal, 8(6), 758766, 2008.
6.
Norton, Michael; Day, B. Scott; Cao, Huan; Rahman, Mashiur; and Gin, Aaron; Arrays of Nanoarrays: Elements of Binding,
IEEE Sensors Journal, 8(6), 874-879, 2008.
53
4)
5)
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Externally funded research grants and contracts you received.
6)
1.
Title: Directed Sequential Assembly Via DNA Nanostructures Based Nanostructures
U.S. Army Research Office - DEPSCoR
$ 508,133
Period 05/31/05 - 05/31/09
Location: Marshall University
Commitment
academic
2.5 months
2.
Title: Sensing Biological, Chemical, and Radiation Hazards in Harsh Environments
U.S. Army Research Office – Subaward with the University of South Carolina
$ 74,977 Period 07/15/08 - 06/14/09
Location: Marshall University
Commitment
0 months
3.
Title: Integrated Sensing Using DNA Nanoarchitectures
U.S. Army Research Office
Estimated Budget $ 854,363 Period 05/1/08 - 12/31/12
Location: Marshall University
Commitment
3 months
PI: Michael Norton
4.
Title: Transcription as Sequencing (TAS)
U.S. Army Research Office
$ 445,521
Period 01/01/09 – 12/31/2011
Location: Marshall University
Commitment
summer 1.4 months
PI: Michael Norton
7)
8)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
54
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: ____Donald A. Primerano_______________________ Rank: ___Professor_________________
Status (Check one): Full-time _X__ Part-time____ Adjunct ____ Current MU Faculty: Yes _X
No ___
Highest Degree Earned: _______PhD________________ Date Degree Received: _____1982________
Conferred by: __Duke University Department of Microbiology and Immunology_____________________
Area of Specialization: _Human Genetics, Genetic Basis of Complex Diseases, Cardiovascular Disease_
Professional Registration/Licensure______NA______
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
Agency: _________NA___________________
___6____
___6____
___20.75__
___20.75__
___20.75__
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
Alpha Des. & No.
Title
Enrollment
2007 Fall
MCB 630/MCB 730
Medical Microbiology (Team taught, my %age = 20)
69 in 2007
2008-09Fall Spring
MCB 631/632/732
Medical Microbiology (Team taught, my %age = 20)
76 in 2008-09
2009-10Fall Spring
MCB 631/632/732
Medical Microbiology (Team taught, my %age = 20)
93 in 2008-09
2007 Fall
BMS 600
Cell and Molecular Biology (team taught, my %age = 4)
~40 in 2007
2008 Fall
BMS 600
Cell and Molecular Biology (team taught, my %age = 4)
~45 in 2008
2009 Fall
BMS 600
Cell and Molecular Biology (team taught, my %age = 4)
~50 in 2009
2007 Spring
IDM724/BMS614
Human Genetics (team taught my %age = 32)
71 in 2007
2008-09Fall Spring
MED 725
APC- Human Genetics (team taught, my % age = 2%)
76 in 2008-09
2009-10Fall Spring
MED 725
APC- Human Genetics (team taught, my % age = 2%)
93 in 2009-10
2007 Spring
BIC638
Nucleic Acids and Protein Synthesis (team taught, 40%)
5 in 2007
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
(a) Participation in team grant writing with COBRE and INBRE especially mock study sections
(b) regular lab meetings with the Genomics Core Facility
(c) attending biomedical science seminars
3)
Discipline-related books/papers published (provide a full citation).
1. LA Dvoracek, JI Kreisberg, J McKinney, G Schmid, AD Francis, KL Kacmarik HM Lee, MS Detrick, DA Primerano, N Santanam
and R Kreisberg. Lovastatin inhibits Oxidized-L-A-phosphatidylcholine B-arachidonoyl-gamma-palmitoyl (ox-PAPC)-Stimulated
Interleukin-8 mRNA and Protein Synthesis in Human Aortic Endothelial Cells by Depleting Stores of Geranylgeranyl Pyrophosphate
Atherosclerosis. Atherosclerosis accepted July 2009
2. Y. Huang, Kan Huang, G. Boskovic, Y. Dementieva, J. Denvir, D. A. Primerano, G.-Z. Zhu. Proteomic and genomic analysis of
PITX2 interacting and regulating networks. FEBS Letters 583:638-642 (2008)
3. Estler, M, Boskovic G, Denvir J, Miles S, Primerano DA, and Niles RM. Global Analysis of Gene Expression Changes During
Retinoic Acid-Induced Growth Arrest and Differentiation of Melanoma: Comparison to Differentially Expressed Genes in
Melanocytes vs. Melanoma. 2008. BMC Genomics 9:478-490.
4. Sikorsky JA, DA Primerano, TW Fenger, and J Denvir. 2007. DNA damage reduces Taq DNA polymerase fidelity and PCR
amplification efficiency. Biochem. Biophys. Res. Comm. 355: 431-437.
5. Sikorsky JA, DA Primerano, TW Fenger, and J. Denvir. 2004. Effect of DNA Damage on PCR Amplification Efficiency with the
Relative Threshold Cycle Method. Biochem. Biophys. Res. Comm. 323: 823-830
4)
Papers presented at state, regional, national, or international conferences.
1. LL Richards-Waugh, DA Primerano, Y. Dementieva, J. Kraner, GO Rankin. Unexpected Death due to Methadone Overdose
May Be Associated with Genetic Polymorphisms of the CYP3A4 Gene. Presented as a Poster at
the Annual Society of
Toxicology Meeting in Baltimore on March 15-19 2009.
2. Richards-Waugh, DA. Primerano, Y. Dementieva, JC Kraner, and GO Rankin. Genetic Polymorphism of the CYP3A4 Gene May
Contribute to Methadone-related Deaths. Presented as a poster at the Society of Forensic Toxicologists meeting in Phoenix, AZ on
10/26/2008.
3. M.Estler, G.Boskovic, J.Denvir, S. Miles, D. Primerano, and R.M. Niles. Global Gene Expression Changes During Retinoic AcidInduced Growth Arrest and Differentiation of Melanoma: Comparison to Differentially Expressed Genes in Melanocytes vs.
Melanoma. NISBRE Symposium. Bethesda August 2008.
4. M. Yousufuddin, H. Ratliff, J. Stapleton, F. Malik, S. Hasan, Z. Khan, G. Rosencrance, J. Denvir, G. Boskovic, and D. Primerano.
Transcriptional Alterations in Human Heart: A Prelude to Understanding the Molecular Pathways of Cardiac Aging. J Am Geriatr
55
Soc. 2007 April;55 (4 Supplement):S114
5. Gene Fingerprinting of Human Heart in Obesity. Heather L Ratliff DO, Mohammed Yousufuddin MD, Jeremy Stapleton DO,
Firasat Malik MD, Sulaiman Hasan MD, Zafrullah Khan MD, Gregory Rosencrance MD, Gregory Clarke MD, Goran Boskovic PhD,
Jim Denvir PhD, Donald Primerano PhD. Presented as a poster at the WV Chapter of the American College of Physicians in
October 2006.
6. ASHG (10/2006) and NISBRE Meeting (07/2006): Identification of Genes Contributing to Obesity Associated Cardiovascular
Disease (OCARD). H.M. Lee, M. Davis, M.R. Flood, D. Calica, B. Freeman, M. Huff, S. Dodson, A. Clark, A. Magers, R. Kreisberg,
P. Wehner, T.L. Green, D.A. Primerano, J. Denvir, L. Wei, and Y. Dementieva.
7. NISBRE Meeting (07/2006) Marshall University Genomics Core Facility. G. Boskovic, J. Denvir and D. Primerano
5)
Professional development activities, including professional organizations to which you belong and state,
regional, national, and international conferences attended. List any panels on which you chaired or participated.
List any offices you hold in professional organizations.
PANELS:(1)WV-INBRE Steering Committee Member.(2)University of Kentucky COBRE External Advisory Committee
GRANT REVIEWS: Mary Babb Randolph Cancer Pilot Grant Reviewer
CONFERENCES ATTENDED:
Workshop on Efficient Management and Utilization of Core Facilities. NIH Campus. Bethesda, Maryland. July 2009
American Society for Human Genetics Annual Meeting. October 2008. Philadelphia.
American Society for Human Genetics Annual Meeting. October 2007. San Diego.
American Society for Human Genetics Annual Meeting. October 2006. New Orleans.
6)
Ongoing:
Title:
Period:
Role:
Title:
Period:
Role:
Externally funded research grants and contracts you received.
West Virginia IDeA Networks of Biomedical Research Excellence (WV-INBRE) Phase II
5/1/09 - 4/30/14
Amount: approx $3.0M/year Agency: NIH/NCRR
Co-P.I. (G. Rankin, P.I.)
COBRE Administrative Supplement: WV Cancer Genetics Networks
10/1/09 - Amount: approx $3.0M/year Agency:NIH/NCRR
Co-P.I. (R. Niles, P.I.)
RESEARCH SUPPORT (completed)
Title: West Virginia Biomedical Research Infrastructure Network (WV-BRIN) ACoRN Director
Period: 10/1/01 - 6/30/04 Amount: approx $1,000,000/year
Agency: NIH/NCRR, Role: Co-P.I. (30% Effort)
Title:
WV-Idea Network of Biomedical Research Excellence (WV-INBRE)
Agency: NIH/NCRR
Period:
7/01/04 to 6/30/09 Amount: approx $2.5 million/year
Role:
Co-P.I. and Director of Appalachian Cardiovascular Research Network
Title:
Transcription Factors in Cancer (COBRE)
Agency: NIH/NCRR
Period:
10/01/04 to 7/31/09 Amount: approx $1.6 million/year
Role:
Co-I./Director of Genomics Core Facility (R. Niles, P.I.)
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
2009 Certificate of Teaching Excellence awarded by JCESOM
8)
Community service as defined in the Greenbook.
Clerk of Session at Spring Valley Presbyterian Church
56
Appendix II
Faculty Data Sheet
(for the period of this review)
Name: ___Vernon E. Reichenbecher, Ph.D._____________ Rank: ___Professor________________
Status (Check one): Full-time__X__ Part-time_____ Adjunct _____ Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: ____Ph.D._________________ Date Degree Received: __September, 1976__
Conferred by: ____Duke University________________________________________
Area of Specialization: ____Biochemistry/Genetics_______________________________________
Professional Registration/Licensure___N/A_________
Agency: _______________________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
___N/A__
___5____
___28___
___28___
___5____
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2007, fall
Alpha Des. & No.
BIC 720
Human Biochemistry (23%)
Title
75
Enrollment
2008, spring
FSC 618
Comparative Sciences (8%, Firearms Lectures)
15
2008, spring
BMS 685
Introduction to Research (75%)
15
2008, fall
BIC 720
Human Biochemistry (23%)
80
2008, fall
BMS 600
Foundations of Biomedical Science (5%)
50
2009, spring
FSC 618
Comparative Sciences (8%, Firearms Lectures)
15
2009, spring
BMS 685
Introduction to Research (75%)
15
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain. N/A
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
I have attended at least one faculty teaching development workshop each year. I attended “Small Arms Firing School” two times.
3)
Discipline-related books/papers published (provide a full citation).
Vernon Reichenbecher, contributing author, P.C. Champe and R.H. Harvey, editors, Lippincott’s Illustrated Review of Biochemistry
(3rd ed.), I wrote/updated five chapters concerning molecular biology (2004).
Medical Genetics Online Lectures, 2nd ed.., Kaplan Educational Centers. My seven-hour review of Medical Genetics has been
updated and revised and made available by DVD and online by Kaplan Medical (2006); 3rd. ed. (2009).
Coauthor: Biochemistry and Medical Genetics USMLE Step I Lecture Notes, Kaplan Medical (updated, 2009).
4)
Papers presented at state, regional, national, or international conferences.
V. Reichenbecher, “Computer animations in the teaching of biochemistry,” Academy of Medical Educators, JCESOM (2005).
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Member of:
57
American Society for Cell Biology
Genetics Society of America
American Association for the Advancement of Science
West Virginia Academy of Science
Association of Biochemistry Course Directors
International Association of Medical Science Educators
Sigma Xi
Charter Member, Marshall University School of Medicine Academy of Medical Educators
I attended the national “Medical Biochemistry Education Strategies Workshop” in April, 2008 and April, 2009
6)
Externally funded research grants and contracts you received. N/A
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Invited talk: “Teaching Medical Biochemistry at Marshall University” at the national “Medical Biochemistry Education Strategies
Worshop” in April, 2008
Award: Best Professor for Fall 2008 (awarded by medical school class of 2012)
8)
Community service as defined in the Greenbook.
Member: First United Methodist Church
58
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: _____Vincent E. Sollars_______________________________________ Rank: _Asst. Professor
Status (Check one): Full-time_X_ Part-time____ Adjunct ____
Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: _____Ph.D._________________ Date Degree Received: ___May 2000______
Conferred by: ___University of Kansas_____________________________________________________
Area of Specialization: ___Genetics_______________________________________________________
Professional Registration/Licensure___N/A_________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
Agency: _____N/A_______________________
___0____
___0____
___5____
___5____
___5____
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2007/Fall
Alpha Des. & No.
IDM 720
Medical Cell Biology (5%)
Title
75
Enrollment
2008/Spring
BMS 670/BSC 480
Molecular Cloning Laboratory (10%)
10
2008/Spring
IDM 724/BMS 614
Human Genetics (65%)
90
2008/Fall
MED 725
Approach to Patient Care (10%)
90
2008/Fall
IDM 720
Medical Cell Biology (5%)
80
2009/Spring
BMS 651
Cancer Cell Biology (10%)
10
2009/Spring
BMS 670/BSC 480
Molecular Cloning Laboratory (10%)
10
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)




3)



Activities that have enhanced your teaching and or research.
2007-2008: Accepted as a candidate into the Academy of Medical Educators at Marshall University School of Medicine in the
summer of 2007. Designated a Master Educator and a member of the Academy of Medical Educators upon completion
2006: Six session workshop provided to the medical school faculty by Dr. Steven Fish for improvement of medical teaching
Four training courses to enhance research.
Six other workshops designed to increase the effectiveness of teaching.
Discipline-related books/papers published (provide a full citation).
Omega 3 fatty acids reduce myeloid progenitor cell frequency in the bone marrow of mice and promote progenitor cell
differentiation (2009). Melinda E. Varney, W. Elaine Hardman, and Vincent E. Sollars. Lipids in Health and Disease 8(9).
Defect in early lung defense against Pseudomonas aeruginosa in DBA/2 mice is associated with acute inflammatory lung injury
and reduced bactericidal activity in naïve macrophages (2007). Kari R. Wilson, Jennifer M. Napper, James Denvir, Vincent E.
Sollars, and Hongwei D. Yu. Microbiology 153(4), pp. 968-979.
Analysis of Pre-leukemic Expansion of Myeloid Progenitors in Inbred Strains of Mice (2006). Vincent E. Sollars, Edward
Pequignot, Jay L. Rothstein, and Arthur M. Buchberg. Mammalian Genome 17(8), 808-821.
1/13/09
59




4)




5)

6)







7)


8)



Diversity in secreted PLA2-IIA activity among inbred mouse strains that are resistant or susceptible to ApcMin/+ tumorigenesis
(2005). Marina Markova, Revati A. Koratkar, Karen A. Silverman, Vincent E. Sollars, Melina MacPhee-Pellini, Rhonda Walters,
Juan P. Palazzo, Arthur M. Buchberg, Linda D. Siracusa and Steven A. Farber. Oncogene 24, 6450-6458.
The Epigenomic Viewpoint on Cellular Differentiation of Myeloid Progenitor Cells as it Pertains to Leukemogenesis (2005).
Vincent E. Sollars. Current Genomics 6 (3), 137-144.
Epigenetic modification as an enabling mechanism for leukemic transformation (2005). Vincent E. Sollars. Frontiers in
Bioscience 10, 1635-1646.
Multigenerational selection and detection of altered histone acetylation and methylation patterns: toward a quantitative
epigenetics in Drosophila (2004). Mark D. Garfinkel, Vincent E. Sollars, Xiangyi Lu, and Douglas M. Ruden. Methods Mol Biol
287, 151-168.
Papers presented at state, regional, national, or international conferences.
Thirteen poster presentations at various meeting at all levels relating to my research projects.
Two invited talks at state meetings relating to my research projects.
Poster presentation at the 2008 Annual International Association of Medical Science Educators.
Two cover art illustration for scientific journals.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Member of the following organizations: International Association of Medical Science Educators (IAMSE), Reuters Insight, a
research consultancy, American Association for Cancer Research, The American Society of Hematology, Marshall University,
Joan C. Edwards School of Medicine Alumni Association, American Association for the Advancement of Science, Genetics
Society of America, and University of Kansas Alumni Association
Externally funded research grants and contracts you received.
R03 CA129790-01A1 (PI – Sollars, VE; 04/01/08-03/31/10): “Nostalgia in the Wnt signaling pathway; fatty acids, epigenetics,
and leukemia” was awarded by the NIH in the amount of $140,000.
(PI – Sollars, VE; 6/01/09-5/31/10): “Survivin as a mediator of dietary omega-3 fatty effects on hematopoiesis” was awarded by
the NASA West Virginia Space Grant Consortium through the Graduate Research Fellowship Program in the amount of
$12,000 direct costs.
(PI – Sollars, VE; 5/16/07-5/15/09): “Comparing the myeloid progenitor cell compartment among inbred strains of mice to
identify possible leukemia susceptibility genes” was awarded by the NASA West Virginia Space Grant Consortium through the
Graduate Research Fellowship Program in the amount of $24,000 direct costs.
(PI – Sollars, VE; 5/16/07-5/15/09): “Epigenetic gene regulation by Hsp90 in myeloid cell differentiation” was awarded by the
NASA West Virginia Space Grant Consortium through the Graduate Research Fellowship Program in the amount of $24,000
direct costs.
R03CA124637-01 (PI – Niles, RM; 10/01/06-9/30/08): “RARbeta in Melanoma: Epigenetic Regulation by Nutrients” is an NIH
grant for $100,000 direct costs through the R03 mechanism. Role: Co-Investigator.
A Pilot grant from Centers of Biomedical Research Excellence (COBRE - P20 RR020180; Niles, PI) (8/01/05 – 7/31/06) for
$20,000 sponsored by NIH/NCRR. Role: Co-Investigator.
West Virginia Research Challenge Award (7/01/2004 – 6/30/2007) from the State of West Virginia for $250,000. Role: CoInvestigator.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
2008: Designated a Master Educator by Marshall University School of Medicine
2004: Work from my Ph.D. dissertation was presented at the Nobel Symposium entitled “Epigenetic Reprogramming in
Development and Disease” on June 19-21 in Stockholm by my Ph.D. mentor Dr. Douglas Ruden
Community service as defined in the Greenbook.
Reviewed manuscripts for Current Signal Transduction Therapy, Current Genomics, and Frontiers in Bioscience
Reviewed Book proposal by The Company of Biologists Ltd
Served on 9 grant review panels
1/13/09
60
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: _______Hongwei Yu____________ Rank: ______Professor_______
Status (Check one): Full-time_*__ Part-time_____ Adjunct _____
Current MU Faculty: Yes _*_
No ___
Highest Degree Earned: ______Ph.D.__________ Date Degree Received: _____June 1994_______
Conferred by: _______________University of Calgary__________________
Area of Specialization: ___________Molecular Pathogenicity__________________
Professional Registration/Licensure_______________
Agency: _______________________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
___6____
___6____
___10___
___16___
___10___
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
07-09/Fall
Alpha Des. & No.
MCB620/720
Medical Microbiology
Title
65
Enrollment
07-09/Spring
MCB622
Current Topics in Molecular Biology
3
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
Activities that have enhanced your teaching and or research: Attending the annual meeting of microbiology conference.
Discipline-related books/papers published (provide a full citation).
1.
Head, N. E. and H. Yu. 2004. Cross-sectional analysis of clinical and environmental isolates of Pseudomonas aeruginosa:
Biofilm formation, virulence and genome diversity Infect. Immun. 72: 133-144.
2.
Wilson, K. R., J. M. Napper, J. Denvir, V. E. Sollars, and H. D. Yu. 2007. Defect in early lung defense against Pseudomonas
aeruginosa in DBA/2 mice is associated with increased pulmonary inflammation and reduced bactericidal activity in naive
macrophages. Microbiol. 153: 968-979.
3.
Qiu, D., V. M. Eisinger, D. W. Rowen, and H. D. Yu. 2007. Regulated proteolysis controls mucoid conversion in Pseudomonas
aeruginosa. Proc. Natl. Acad. Sci. USA 104: 8107-8112.
4.
Poschet, J. F., G. S. Timmins, W. Ornatowski, J. Fazio, E. Perkett, K. R. Wilson, H. D. Yu, H. R. de Jonge, and V. Deretic.
2007. Sildenafil corrects cascade of critical defects in cystic fibrosis. AJP: Lung. 293: L712-L719.
5.
Qiu, D., V. M. Eisinger, N. E. Head, G. B. Pier and H. D. Yu. 2008. ClpXP proteases positively regulate alginate overexpression and mucoid conversion in Pseudomonas aeruginosa. Microbiol. 154: 2119-2130 .
6.
Qiu, D., F. H. Damron, T. Mima, H. P. Schweizer, and H. D. Yu. 2008. PBAD-based shuttle vectors for functional analysis of toxic
and highly-regulated genes in Pseudomonas and Burkholderia spp. and other bacteria. Appl. Environ. Microbiol.74: 7422-7426.
7.
Damron, F. H., D. Qiu, and H. D. Yu. 2009. Pseudomonas aeruginosa sensor kinase KinB negatively controls alginate
production through AlgW-dependent MucA proteolysis. J. Bacteriol. 191: 2285-2295.
8.
Damron, F. H., J. Napper, M. A. Teter, and H. D. Yu. 2009. Lipotoxin F of Pseudomonas aeruginosa is an AlgU-dependent and
alginate independent outer-membrane protein involved in resistance to oxidative stress and adhesion to A549 human lung
epithelia. Microbiol.155: 1028-1038.
9.
Dunlap, B. S., H. D. Yu, and Y. Elitsur. 2009. The probiotic content of commercial yogurts in West Virginia. Clin Pediatr (Phila)
48: 522-527
1/13/09
61
4)
5)
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
20031989-
Member, International Membership Committee (IMC), ASM, Washington, DC
Member, American Society for Microbiology (ASM), Washington, DC.
6)
Externally funded research grants and contracts you received.
NASA NNG04GN56H (Mentor), Genetic Regulation of P. aeruginosa Biofilms in Space (Stipend for Nathan Head),
08/01/04-07/30/07, $72,000 Direct Cost, (Yu, PI).
NASA WV Space Grant Consortium, Genetic Analysis of Biofilms in Space (Augmentation Grant), 08/01/06-07/31/07,
$20,000 Direct Cost, (Yu, PI).
Cystic Fibrosis Foundation YU04I0, Protection against P. aeruginosa Lung Colonizations in Mice, 04/01/04-3/31/06,
$86,400 Direct Cost, (Yu, PI).
NIH/NIDDK R15 DK58128-03, Genetic Basis of P. aeruginosa Lung Infection in Mice, 04/01/04-03/31/06, $131,283 Direct
Cost, (Yu, PI).
NASA WV Space Grant Consortium, Imaging Analysis of Biofilm Structure, 07/01/04-06/30/05, $20,000 Direct Cost, (Yu,
PI).
NASA NNG04GA01H, Control of Space Biofilms (Stipend for Denise Bouvrette), 09/01/03-08/30/04, $24,000 Direct Cost,
(Yu, PI).
NIH/NIGRI-CIDR, Mapping a Single Locus Conferring Susceptibility to P. aeruginosa Lung Infection, 04/01/04-03/31/05,
$8,976 Direct Cost, (Yu, PI).
NIH/NIDDK R15 DK58128, Aerosol Infection Mouse Model for Cystic Fibrosis, 04/01/02-03/31/04, $165,186 Direct Cost,
(Yu, PI).
1.
2.
3.
4.
5.
6.
7.
8.
1/13/09
62
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: __Guo-Zhang Zhu_____________________ Rank: __Associate Professor______________
Status (Check one): Full-time _X__ Part-time___ Adjunct ___ Current MU Faculty: Yes _X__
No ___
Highest Degree Earned: _Ph.D._____________ Date Degree Received: ____June 1997_______
Conferred by: _Shanghai Institute of Biochemistry, Chinese Academy of Sciences_____
Area of Specialization: _Molecular Biology________________________
Professional Registration/Licensure_______________
Agency: _______________________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
___6____
___6____
___6____
___6____
___5____
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2007/fall
Alpha Des. & No.
BSC 661
Graduate Seminar I
Title
21
Enrollment
2008/spring
BSC 481/BMS 670
Molecular Cloning Lab
10
2008/fall
BSC 322
Principles of Cell Biology
60
2009/spring
BSC 301
Vertebrate Embryology
28
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
Workshops related to teaching: 8/15/2007, Don Morris Room/Memorial Student Center, “Using Effective Learning
Environments to Engage and Motivate Students”. 10/19/2007, Drinko library 349, “How to Produce Beautiful Documents
with LaTeX”. Faculty Development Workshops (8/2003 to 12/2006), sponsored by MU Center of Teaching Excellence.
Workshops related to research: 10/18/2007, BBSC 343 “Conflict of Interest”. 11/15/2007, BBSC 343 “Technology Transfer
at MU”. Grant writing workshops (8/2003 to12/2006), sponsored by MURC.
3)
Discipline-related books/papers published (provide a full citation).
1.
2.
3.
4.
5.
6.
7.
1/13/09
Guo-Zhang Zhu, Surabhi Gupta, Diana Gold Myles, Paul Primakoff. Testase 1 (ADAM 24) a sperm surface
metalloprotease is required for normal fertility in mice. Mol Reprod Dev. 2009, 76(11): 1106-1114.
Yue Huang, Kan Huang, Goran Boskovic, Yulia Dementieva, James Denvir, Donald A. Primerano, Guo-Zhang Zhu.
Proteomic and genomic analysis of PITX2 interacting and regulating networks. FEBS Lett. 2009, 583(4): 638-42.
Zhigang Jin, Jianli Shi, Amit Saraf, Wenyan Mei, Guo-Zhang Zhu, Stefan Strack, Jing Yang. The 48 kDa alternative
translation isoform of PP2A:B56epsilon is required for Wnt signaling during midbrain-hindbrain boundary formation. J Biol
Chem. 2009, 284(11): 7190-200.
Jing Yang, Chin Yee Chan, Bo Jiang Xueyuan Yu, Guo-Zhang Zhu, Yiping Chen, John Barnard, Wenyan Mei. hnRNP I
inhibits Notch signaling and regulates intestinal epithelial homeostasis in zebrafish. PLoS Genetics. 2009 Feb;
5(2):e1000363.
Yue Huang, Jun Fan, Jing Yang, Guo-Zhang Zhu. Characterization of GPR56 protein and its suppressed expression in
human pancreatic cancer cells. Molecular and Cellular Biochemistry. 2008, 308(1-2):133-139.
Jun Fan, Hiroto Akabane, Xuehai Zheng, Xuan Zhou, Li Zhang, Qiang Liu, Yong-Lian Zhang, Jing Yang, Guo-Zhang Zhu.
Male germ cell specific expression of a novel Patched-domain containing gene Ptchd3. Biochemical and Biophysical
Research Communications. 2007, 363:757-761.
Hiroto Akabane, Jun Fan, Xuehai Zheng, Guo-Zhang Zhu. Protein kinase C activity in mouse eggs regulates gamete
membrane interaction. Molecular Reproduction and Development. 2007, 74:1465-1472.
63
8.
9.
4)
Jun Fan, Hiroto Akabane, Stephanie N. Graham, Laura L. Richardson, Guo-Zhang Zhu. Sperm Defects in Mice Lacking a
Functional Niemann-Pick C1 Protein. Molecular Reproduction and Development. 2006, 73:1284–1291.
Jun Fan, Matthew Graham, Hiroto Akabane, Laura L. Richardson and Guo-Zhang Zhu. Identification of a novel male germ
cell-specific gene TESF-1 in mice. Biochemical and Biophysical Research Communications. 2006, 340: 8-12.
Papers presented at state, regional, national, or international conferences.
1. Guo-Zhang Zhu, Terry Boyce, Hiroto Akabane. Expression and localization of Pten in mouse gametes. 41st Annual
Meeting Society for the Study of Reproduction, 27–30 May 2008, Kailua-Kona, Hawaii.
2. Yue Huang, Guo-Zhang Zhu. PITX2 is overexpressed in human thyroid cancer and functions in cell proliferation. 99th
Annual Meeting of American Association for Cancer Research,12-16 April 2008, San Diego, California.
3. Hiroto Akabane, Jun Fan, Guo-Zhang Zhu. Protein kinase C activity in mouse eggs regulates gamete membrane
interaction. 39th Annual meeting of Society for the Study of Reproduction. July 29-August 1, 2006, Omaha, Nebraska.
4. Hiroto Akabane, Guo-Zhang Zhu. Expression of GPR56 in mouse sperm. The Second Asia-Pacific Forum on Andrology.
October 26-30, 2006. Shanghai, China.
5. Yue Huang, Guo-Zhang Zhu. Expression and regulation of G protein-coupled receptor 56 in human pancreatic cancer
cells. The 5th Asian-Pacific Organization for Cell Biology Congress. October 28-30, 2006. Beijing, China.
6. Jun Fan, Guo-Zhang Zhu, Richard Niles. Tetraspanin CD9 expression in melanoma and melanocytes and retinoic acid
treatment. 97th Annual meeting of American Association for Cancer Research, April 1-5, 2006, Washington DC.
7. Jun Fan, Hiroto Akabane, Stephanie N. Graham, Laura L. Richardson, Guo-Zhang Zhu. Sperm defects in mice lacking
function of Niemann-Pick C1 protein. 38th Annual Meeting of Society for the Study of Reproduction”. July 24-27, 2005.
Quebec, Canada.
8. Hiroto Akabane, Jun Fan, Guo-Zhang Zhu. Egg PKC-mediated regulation of gamete membrane interaction. Gordon
Research Conference: Fertilization and Activation of Development. July 17-22, 2005.Holderness School, Plymouth, NH.
9. Jun Fan, Hiroto Akabane, Guo-Zhang Zhu. Identification of a novel male germ cell-specific gene TESF-1. 37th annual
meeting the Society for the Study of Reproduction, August 2-5, 2004. Vancouver, Canada.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Membership in Society for the Study of Reproduction, American Association for the Advancement of Science and the
American Society for Cell Biology.
Conferences attended: 29th Annual Meeting of American Society for Reproductive Immunology, 5-9 June 2009, Orlando,
Florida. 41st Annual Meeting Society for the Study of Reproduction, 27–30 May 2008, Kailua-Kona, Hawaii. Gordon
Research Conference: Mammalian Gametogenesis & Embryogenesis. June 16-23, 2006. New London, Connecticut.
Gordon Research Conference: Reproductive Tract Biology. June 18-23, 2006. Connecticut College, Connecticut. 38th
Annual Meeting of Society for the Study of Reproduction”. July 24-27, 2005. Quebec, Canada. Gordon Research
Conference: Fertilization and Activation of Development. July 17-22, 2005. Holderness School, Plymouth, NH. 37th
annual meeting the Society for the Study of Reproduction, August 2-5, 2004. Vancouver, Canada.
6)
Externally funded research grants and contracts you received.
1. West Virginia NASA Space Grant Consortium, Research Seed Grant, 7/2008~12/2009, $20,644 (cost-share $10,644).
2. West Virginia NASA Space Grant Consortium, Research Seed Grant, 8/2006~7/2007, $20,000 (cost-share $10,000).
3. West Virginia State EPSCoR RCF, Research Group Initiation Grant, Co-Investigator, 4/2006~3/2007, $50,000.
4. West Virginia State EPSCoR RII Research Challenge Fund, 07/01/2006 to 06/30/2010, $184,333.
5. West Virginia State EPSCoR Research Challenge Fund, 11/1/2006 to 06/31/2007, $5,000.
6. NIH/NIDCR, Spore in Head and Neck Cancer, (PI, Dr. David None Sidransky, Johns Hopkins University), “The Role of
PITX2 in Thyroid Cancer”. $24,920, 09/16/2008 to 07/31/2009.
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Invited seminar: Molecular Basis of Sperm-Egg Membrane Interaction” Shanghai Institute of Biochemistry and Cell
Biology, Chinese Academy of Sciences, 5/27/2005.
8)
Community service as defined in the Greenbook.
1/13/09
64
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name:
Lawrence Blake Sypher
Rank:
Professor
Status (Check one): Full-time x Part-time_____ Adjunct _____
Highest Degree Earned:
Conferred by:
Ph.D.
Date Degree Received:
Current MU Faculty: Yes x
No ___
1998
City University of New York
Area of Specialization:
Family Practice/Biomedical Ethics
Professional Registration/Licensure_______________
Agency: _______________________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
10
5
12
17
7-12
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
1998/1999 Spring
Alpha Des. & No.
IDM 761
Title
Biomedical Ethics
Enrollment
75-85
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
2009
2008
2007
2006
2005
4)
2009
2009
2008
2007
2006
1/13/09
Activities that have enhanced your teaching and or research.
Discipline-related books/papers published (provide a full citation).
Sypher LB. Common Errors in Ethics Consultation. West Virginia Network of Ethics Committees
Newsletter, Spring 2009: 3-6.
Sypher LB. The Cost of Health Care: The Elephant in the Room. West Virginia Network of Ethics
Committees Newsletter, Spring 2008: 3-5.
Sypher LB. Health Care, Trust and Disability.
West Virginia Network of Ethics Committees
Newsletter, Summer 2007: 3-6.
Sypher LB. Clinical Ethics in the 21st Century: Why Do We See Families as Problems? West
Virginia Network of Ethics Committees Newsletter, Winter 2006: 1-5.
Sypher LB, Hall, RT, Rosencrance, G. Autonomy, Informed Consent and Advance Directives: A
Study of Physician Attitudes. West Virginia Medical Journal 101 (3): 131-133.
Papers presented at state, regional, national, or international conferences.
Sypher, LB. Prophylactic Ethics. Promoting Patient Centered Care. (Veterans Administration).
Huntington, West Virginia.
Sypher, LB. The Process of Ethical Decision Making. New Ethics Committee Member Training
(West Virginia Network of Ethics Committees Audio Conference Series). Morgantown, West Virginia.
Sypher, LB. Autonomy, Futility and Justice. Seeking Value in End-of-Life Care (West Virginia
Center for End-of-Life Care). Roanoake, West Virginia.
Sypher, LB.
Family Meetings: Common Obstacles and Strategies to Overcome Them.
Communication and the Family Meeting (West Virginia Network of Ethics Committees). Roanoake,
West Virginia.
Sypher, LB. Conducting a Family Meeting. Hospice Council Seminar Series (Hospice of
Huntington). Huntington, West Virginia.
65
2005
Sypher LB.
Autonomy, Informed Consent and Advance Directives: A Study of Physician
Attitudes. Symposium on Theoretical and Applied Ethics (Louisiana State University). Baton Rouge,
Louisiana.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Consultant
Clinical Ethics Committee
Chair, 2008-2010
Cabell-Huntington Hospital
Huntington, West Virginia
President, Advisory Committee
West Virginia Network of Ethics Committees
Morgantown, West Virginia
6)
7)
8)
1/13/09
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
66
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: _____James Bernard Becker, MD________________ Rank: _Associate Professor _________
Status (Check one): Full-time_____ Part-time__X__ Adjunct _____ Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: ___Doctor of Medicine________ Date Degree Received: ____1993_________
Conferred by: __Marshall University School of Medicine ______________________________________
Area of Specialization: ____Family Medicine _______________________________________________
Professional Registration/Licensure___17849_______
Agency: __WV Board of Medicine __________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
_17_______
_22_______
_14_______
_22_______
_16_______
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
Entire Year
Alpha Des. & No.
FCH 742
Title
Family & Community Health
Each Spring
MED 725
Approach to Patient Care
Enrollment
Entire Med School
Class
60
Fall (2007.2008)
IDM 875
Board Review Course (Step II)
25
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research.
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
67
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: _____Kenneth J. Devlin_________________________ Rank: __Instructor_________________
Status (Check one): Full-time_____ Part-time__X___ Adjunct _____
Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: ______MA_________________ Date Degree Received: _____1973________
Conferred by: _________Marshall University _______________________________________________
Area of Specialization: __Clinical Psychology_______________________________________________
Professional Registration/Licensure_Psychology____
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
Agency: WV Bd of Licensure of Psychologists
___35___
___15___
___18___
___18___
___18___
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
Alpha Des. & No.
Family Practice
Residency Program
Title
Behavioral Medicine Coordinator
Enrollment
Direct clinical services, Precept resident physicians in
behavioral medicine, teach behavioral sleep medicine to 3rd
yr med students, Behavioral telehealth services, consulting
psychologist, Sports Medicine Division
Cllinical supervision of Psy.D. intern students of MU
Psychology Department
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
Regional Pain Management Center, Cabell Huntington Hospital, 1990-present
Tug River Health Association, McDowell County, WV, 2006-present
Bureau of Medical Services, West Virginia Department of Health & Human
Resources, 2009-present
3)
Discipline-related books/papers published (provide a full citation).
Psychological Issues in Chronic Pain: Multidisciplinary Treatment Teams, Devlin,K.J.;
Ranavaya, M.I.; Scott, J.
Presurgical Psychological Screening in Spinal Cord Stimulator Implants – A Review
Devlin, K.J.; Ranavaya, M.I.; Clements, C.; Scott, J.; Boukhemkis, R.
Disability Medicine: Volume 3, No. 2, April-June 2003, Jan-Mar 2002
4)
Papers presented at state, regional, national, or international conferences.
Integration of Behavioral Health in Rural Primary Care, Family Practice
Rounds, October 2009
Health Psychology in Primary, Conference, WV Psychological Association, 2009
Sleep Management: Enhancing Health & Treatment Options, Conference
WV Psychological Association, April 2008
Sleep: Impact on Health: Normal Patterns: Disorders & Treatments Conference,
National Association of Social Workers, WV, April 2008
Sleep Medicine in Primary Care, Family Practice Grand Rounds, March 2008
Behavioral Telehealth Project: Mount View-Tug River School Based Health Center
West Virginia Rural Health Conference, 2007
68
5)
Non-Pharmacological Management of Chronic Pain, Hospice, Ashland, KY 2007
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations
Controlled Substances Guidelines, Committee Chairperson, Family & Community
Health, JCESOM.
Health Care Advisory Panel: Psychiatry sub-committee, WV Workers’
Compensation Commission, 2005
State Government Affairs Committee, Chairperson, WV Psychological
Association, 2001-present
Chronic Opioid Guidelines, Panel member, WV Workers’ Compensation
Commission, 2001
6)
Externally funded research grants and contracts you received.
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
8)
Community service as defined in the Greenbook.
United State Army Reserve: combat medic, photographer
69
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: Dilip Nair, M.D. Rank: Associate Professor
Status (Check one): Full-time_x__ Part-time_____ Adjunct _____ Current MU Faculty: Yes _x_
No ___
Highest Degree Earned: M.D. Date Degree Received: May 1992
Conferred by: University of Connecticut School of Medicine
Area of Specialization: Family Medicine
Professional Registration/Licensure WV 17444/OH 35.088137
Agency: WV Board of Medicine/State Medical Board of Ohio
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
0
0
13 yrs, 2mo
13 yrs 2 mo
5
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2009/Summer
Alpha Des. & No.
FCH 735
2007-2009 All year
FCH 742
2007-2009 Fall and
Spring
2007-2009 /Spring
MED 725
IDM 761
Title
Human Behavior and Disease in Tropical Developing
Countries (Sole instructor, 40 hours classroom)
Family Medicine Clerkship (Team-teaching, 4 hrs
classroom, 12-16 hrs clinical per rotation)
Approach to Patient Care (Team-teaching, 7 hours
classroom/year)
Ethics (Team-teaching, 1 hour/semester)
Enrollment
8
70 (6 rotations per
year)
70
70+
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain. NA
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
Participated in Academy of Medical Educators; 2008-2009
3)
Discipline-related books/papers published (provide a full citation).
4)
Papers presented at state, regional, national, or international conferences.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
As for No. 2
6)
Externally funded research grants and contracts you received.
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Elected to Alpha Omega Alpha medical honor society, 2008
Awarded “Clinical Preceptor of the Year, Marshall Family Medicine Residency Program, 2008
8)
Community service as defined in the Greenbook.
Volunteer assistant to Chaplain, Western Regional Jail, Barboursville, WV, 2009
Volunteer educator, Adult Christian Education, Grace Fellowship Church, Hurricane, WV, 2007-9
Home educator, The Master’s Greenhouse, Huntington, WV 2007-2009
70
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: ____Kathleen Marie O’Hanlon____________________ Rank: ___________________________
Status (Check one): Full-time__X__ Part-time_____ Adjunct _____ Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: ____MD___________________ Date Degree Received: ___1986__________
Conferred by: ____Marshall University School of Medicine ____________________________________
Area of Specialization: ______Family Medicine _____________________________________________
Professional Registration/Licensure_____MD_______
Agency: __WVBOM _____________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
________
________
__20____
________
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
1989-present
Alpha Des. & No.
FCH 742
Title
Enrollment
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
3)
Discipline-related books/papers published (provide a full citation).
Authored chapter, “Epilation of Isolated Hairs (Including Trichiasis)” , 2nd Ed.,
Procedures for Primary Care, 2003, edited by Pfenninger and Fowler.
Authored and submitted revised chapter of same for 3rd Edition, 2007
Authored and submitted chapter on “Glycolic Peels” for Primary Care Procedures,
Women’s Health, 2007, Springer Science &Business Media, Cathryn Heath, MD
And Sandra Sulik, MD, MS, Editors.
Authored and submitted chapter on “Chemical Peels” for Dermatologic and Cosmetic
Procedures in Office Practice, Elsevier Science, 2009, Pfenninger, MD,
Usatine, MD and Small, MD Editors
Developed comprehensive “Sexual or Physical Assault Medical Examination”
Documentation form for local and regional medical community use.
4)
Papers presented at state, regional, national, or international conferences.
American Academy of Family Physicians, Annual Assembly, New Orleans, LA, 2003
AAFP Annual Skin Diseases Course, Myrtle Beach, 2004
AAFP Annual Women’s Health Meeting, Savannah, GA, 2005
AAFP Annual Women’s Health Meeting, Albuquerque, NM, 2006
Visiting Grand Rounds Speaker, Mercer SOM, Macon, GA, 2006
AAFP Annual Assembly, “Chemical Peels for the Family Physician,
Washington, DC, 2006
AAFP “Procedural Skills: Hands-on Opportunities”, Phoenix, AZ, 2007
AAFP Annual Skin Problems & Diseases, Galveston, TX, 2007
AAFP “Procedural Skills: Hand-On Opportunities”, Indianapolis, IN, 2007
AAFP Annual Assembly, “Chemical Peels and Medical Aesthetic Skin Care for the
Family Physician”, Chicago, ILL, 2007
AAFP “Skin Problems & Diseases”, Lake Las Vegas, NV, 2008
71
AAFP Annual Assembly, “Chemical Peels, Microdermabrasion and Medical Aesthetic
Skin Care”, San Diego, CA, 2008
AAFP Skin Problems & Diseases, Newport Beach, CA, 2009
AAFP Annual Assembly, “Chemical Peels, Microdermabrasion and Medical Aesthetic
Skin Care”, Boston, MA, 2009
5)
6)
Professional developmental activities, including professional organizations to which you belong
And state, regional, national, and international conferences attended. List any panels on which
You chaired or participated. List any offices you hold in professional organizations.
The Physician Health Committee, Cabell Huntington Hospital, Huntington, WV
2002-present
Executive Committee, Department of Family & Community Health, 2004-present
Curriculum Committee, Marshall University School of Medicine, 2004-2009
Dean’s Advisory Committee, Marshall University School of Medicine
2004-present
Clerkship Director’s Committee, Department of Family & Community Health
2004-present
Chief Editor Procedural Medicine, First Consult-Elsevier Science
2005-2009
Tenure Committee/Family & Community Health, 2009-present
Charles E. Hedrick Outstanding Faculty Award Committee, 2009-present
Externally funded research grants and contracts you received.
7)
Awards/Honors (including invitations to speak in your area of expertise) or special recognition.
MSIII Rotation of the Year, presented by Class of 2010
“Caring Spirit Award” Presented by Brent Marstellar, CEO of Cabell Huntington
Hospital, 2005
8)
Community service as defined in the Greenbook.
Volunteer faculty, Ebenzer Outreach Center
Member, Physician Health Committee, Cabell Huntington Hospital
Member, Hospice Auxiliary Committee, “Friends of Hospice”
Member, Women’s Philanthropic Society, Cabell Huntington Hospital
Member, Women’s Advisory Council, Huntington Museum of Art
Prepared and participated in educational radio broadcast on “Skin and
Skin Cancer”, Tug River, WV
72
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: __John A. Parker, Jr.__________________________ Rank: __Asst. Professor_____________
Status (Check one): Full-time__X__ Part-time_____ Adjunct _____ Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: ___MD_____________________ Date Degree Received: ____May 2008____
Conferred by: __University of Virginia Medical School________________________________________
Area of Specialization: _____Family Medicine______________________________________________
Professional Registration/Licensure___Yes_________
Agency: WV Board of Medicine
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
___7____
___24___
____4___
____4___
____4___
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
Alpha Des. & No.
Title
Enrollment
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
See attached list of CME
3)
4)
5)
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Professional jOrganizations—American Academy of Family Physicians; Christian Medical and Dental Society
Conferences Attended—Weekly Family Medicine Grand Rounds at Cabell Huntington Hospital, AAFP Scientific Assembly
in October of 2008
WV Sports Medicine/Family Medicine Conference November 2008
Jornadas Médicas, Hospital Vozandes Quito, January 2009
6)
7)
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Featured speaker at Jornadas Médicas, Hospital Vozandes Quito, Quito Ecuador January 2009
8)
Community service as defined in the Greenbook.
Read ultrasounds for the Abel Crisis Pregnancy Center in Bluefield, WV
73
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: Fuad Zeid
Rank: Associate Professor
Status (Check one): Full-time X Part-time_____ Adjunct _____ Current MU Faculty: Yes X No ___
Highest Degree Earned: M.D
Date Degree Received: 1988
Conferred by: University of Jordan School of Medicine
Area of Specialization: Pulmonary & Critical Care
Professional Registration/Licensure: WV 19668
Agency: WV Board of Medicine
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
6j
6
8
j
8
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
07-08 Summer
through Spring
08-09 Summer
through Spring
Alpha Des. & No.
Title
Enrollment
Med 742
Clerkship in Internal Medicine – 2 lectures given 6 times
yearly
9 per semester
Med 742
Clerkship in Internal Medicine – 2 lectures given 6 times
yearly
10-11 a semester
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
1)
If your degree is not in your area of current assignment, please explain.
N/A
2)
Activities that have enhanced your teaching and or research.
-Member of residents and fellows curriculum and evaluation committee
-Participation in noon educational conference activities of medical residents and pulmonary fellows.
-Participated in faculty development workshop held at Byrd Educational Center.
3)
Discipline-related books/papers published (provide a full citation).
-Poster accepted at chest meeting November 2009
4)
Papers presented at state, regional, national, or international conferences.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
-Attended Chest Meeting, November 2009
-Fellow, American College of Medicine
-Fellow, American College of Chest Physicians
-Active member of American College of Physicians, American College of Chest Physicians,
American Thoracic Society
-Member Society of Critical Care Medicine
-Member American Thoracic Society
-Critical Care Committee
-Patient Care and Safety committee
-Sentinel Event Committee
74
-Curriculum Committee for medical residents at Marshall University School of Medicine
6)
Externally funded research grants and contracts you received.
N/A
7)
8)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
-Given award of specialist of the year for 2008 as voted by residents
- Sub-specialist of the Year, resident vote 2008
-AOA elected 4/7/05
-Sub- specialist of the Year, resident vote 2004
Community service as defined in the Greenbook.
- Asthma presentation to the public at Cabell Huntington Hospital
-Consultative evaluation of indigent patients referred from Ebenezer reach clinic and St Mary’s
medical center clinic
75
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: Fadi Alkhankan
Status (Check one): Full-time X
Highest Degree Earned: MD
Rank: Assistant Professor
Part-time_____ Adjunct _____ Current MU Faculty: Yes X No ___
Date Degree Received: 1999
Conferred by: Aleppo University Medical School, Aleppo, Syria
Area of Specialization: Pulmonary & Critical Care
Professional Registration/Licensure: WV 23098
Agency: WV Board of Medicine
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
_____
1
1 4
4
1 4
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
Alpha Des. & No.
Title
Enrollment
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
1)
If your degree is not in your area of current assignment, please explain.
N/A
2)
Activities that have enhanced your teaching and or research.
- 3rd year medical student 4 hours rounds on ICU and Floor rotation
-Grand Rounds
-2-1 hour resident lecture per year
3)
Discipline-related books/papers published (provide a full citation).
-Abdullah Altayeh, MD*, Fadi Alkhankan, MD, Todd Gress, MD and Fuad Zeid, MD Chest Supp Abstract. Clinical features
of hospitalized patients with wegener’s granulomatosis: A report of 13 cases from Huntington WV.
-Shadi Obeidat, Nancy Munn, Fadi Alkhankan, Darshana Shah. Submitted for publication at the Generalists in Medical
Education Conference. Decision pending:.Evaluation of Teaching Methods and CXR Interpretation Skills of Senior
Medical Students.
-Altayeh A, Alkhankan F, Triest W, Badin S. South Med J. 2009
interstitial lung diseases in a single patient.
Feb;102(2):180-3. Concurrent smoking-related
-Fadi Al Khankan, MD*, Abdullah Altayeh, MD, Saroj Sigdel, MD and Shadi Badin, MD Bronchoalveolar cell carcinoma
masquering milliary tuberculosis.
-Alkhankan, F.; Smoking cessation project for patients and residents of Marshall University outpatient clinics, September
2004.
4)
Papers presented at state, regional, national, or international conferences.
-Fadi Alkhankan, MD*, Abdullah Altayeh, MD, Saroj Sigdel, MD and Shadi Badin, MD Oral Case presentation at the
American collage of chest physicians national meeting on October 28, 2008 topic was BRONCHIOLOALVEOLAR CELL
CARCINOMA MASQUERADING AS MILIARY TUBERCULOSIS
76
-Fadi Alkhankan, Abdullah Altayeh, Shadi Badin, Fuad Zeid. Presented at the 21st Annual Research Day. March 18, 2008
– MU Medical Center. Huntington, WV -Rocky Mountain Spotted Fever Mimicking Community-Acquired Pneumonia – Oral
Presentation
-Abdullah Altayeh, Fadi Alkhankan, Fuad Zeid, Imran Khawaja. -Paradoxical Pulmonary Embolism – Poster Presentation.
Presented at the 21st Annual Research Day. March 18, 2008 – MU Medical Center. Huntington, WV
-Alkhankan, F.; A case presentation at the WV ACP annual conference, “A progressive pulmonary nodules in a 65 yearold”, Oct 2005.
-Alkhankan, F. ; Salman, A. Zeid F., A case presentation at the WV ACP Annual conference, “Hemothorax as a
complication of Benign Shwannoma”, Oct 2005.
-Alkhankan, F.; Non-Tuberculosis Myobacterial Lung Infections, educational poster at Marshall University, March 2005.
-Zeid F., Ghanem A., Alkhankan F.; A case presentation at the WV ACP annual conference, “Dysphasia in a smoker”, Oct
2004.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
-American College of Chest Physicians (ACCP)
-American Thoracic Society (ATS)
-American College of Physicians (ACP)
-Syrian Medical American Society (SMAS)
6)
7)
8)
Externally funded research grants and contracts you received.
N/A
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
N/A
Community service as defined in the Greenbook.
-Coach little league soccer for Chesapeake elementary school
77
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: __Nesreen A. BenHamed_______________________ Rank: _Assistant Professor__________
Status (Check one): Full-time_____ Part-time_X___ Adjunct _____ Current MU Faculty: Yes X__
No ___
Highest Degree Earned: ___MD____________________ Date Degree Received: _1989____________
Conferred by: _Al-Fateh University School of Medicine _______________________________________
Area of Specialization: __Internal Medicine_________________________________________________
Professional Registration/Licensure____MD________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
Agency: _ABIM_________________
__1+____
__1+____
__7+____
________
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2008-present
Alpha Des. & No.
Title
Clerkship of Internal Medicine
2008
CRIT Feedback Lecture
2008
Grandrounds-faculty development-providing effective
feedback
Enrollment
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research.
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
78
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: _Shannon Browning___________________________ Rank: __Assistant Professor_________
Status (Check one): Full-time__X__ Part-time_____ Adjunct _____ Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: ______MD_________________ Date Degree Received: _2004____________
Conferred by: ____Marshall University Joan C. Edwards School of Medicine ______________________
Area of Specialization: __Medicine/Pediatrics_______________________________________________
Professional Registration/Licensure___WV MD_____
Agency: _WVBOM ______________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
________
________
___1____
________
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
3-2009
Alpha Des. & No.
ACP
Title
Osteoporosis
Enrollment
2nd yr medical
students
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
Activities that have enhanced your teaching and or research.
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Physician Representative for West Virginia Birth to Three, 2009-present
Physician Provider for Children with Special Health Care Needs Program
Clinics, 2009
Curriculum Committee, Internal Medicine Residency Program, 2006-present
Credential Committee, Cabell Huntington Hospital, 2009-present
Residency Evaluation Committee, Internal Medicine Residency Program, 2009-present
Professional Development Activities
CRIT 2009
Chadd Conference, Cleveland, Ohio October 2009
6)
7)
8)
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
79
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: ___Lynne Janice Goebel________________ Rank: __Professor_________________________
Status (Check one): Full-time__X___ Part-time_____ Adjunct _____
Current MU Faculty: Yes X__
No ___
Highest Degree Earned: _MD_____________ Date Degree Received: __6/30/1986_______________
Conferred by: ______Medical College of Pennsylvania___________________
Area of Specialization: _______Internal Medicine and Geriatrics____________
Professional Registration/Licensure_WV 17408_ ___Agency: WVBOM___________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
0___
4___
16__
18__
16__
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2009 Spring
Alpha Des. & No.
MED 725
Diverticulitis lecture (1 hr)
Title
2008 Fall
MED 725
Cachexia and back pain lectures (2 hrs)
2007-09
IDM 715
Intro to patient care (15 hrs per semester)
2007-2009
MED000
Vista course- Ambulatory Care Curriculum for Residents
(100%)
2007-2009
MED 740
Preceptor Third year students (10-20 hrs/semester)
Enrollment
35
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
3)
Discipline-related books/papers published (provide a full citation).
Sale M. Goebel L. Use of Medicare billing for smoking cessation counseling. JAGS. Accepted for publication 10/2009.
Goebel L, Mufson M. Despite guidelines, some elderly people receive more than one dose of pneumococcal vaccine.
JAGS 2008:56:1760-1761.
4)
Papers presented at state, regional, national, or international conferences.
Sale M, Goebel L. Use of Medicare Billing for Tobacco Cessation Counseling. Presented in poster form at the WV ACP
Meeting 2008. Winner Associate Competition. Presented in poster form at the National ACP Meeting Philadelphia, PA
2009 meeting.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
WV Chapter American College of Physicians Meetings 2007, 2008, 2009.- I co-run the Doctor’s Dilemma competition at
these meetings with 2 other physicians. I train student and resident team from Marshall to compete and make up
questions for the competition. I was on the planning committee for the 2009 meeting. I spoke at the 2008 meeting on
Tobacco Cessation.
National American College of Physicians Meetings 2008 and 2009 – attended. My student presented our research at the
2009 meeting after winning the competition at the state level.
Society of General Internal Medicine (SGIM) – member
Southern Society of Clinical Investigators (SSCI) – member
80
6)
Externally funded research grants and contracts you received.
Principal Investigator: Tobacco Cessation Provider Training. Grant from the WVDHHR Division of Tobacco Prevention.
10/06-1/10.
Principal Investigator: Web site for Tobacco Cessation Provider Training to help Pregnant Women Stop Smoking.
WVDHHR Division of Tobacco Prevention. 1/09-1/10.
Vaccine Studies - Investigator
2007. MedImmune, Inc. Protocol MI-CP149. A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation
Study to Evaluate the Safety, Tolerability, Immunogenicity, and Viral Shedding of MEDI-534, A Live, Attenuated Intranasal
Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), In Healthy Children 6 to <24
Months of Age. PI: Mufson.
2007. MedImmune, Inc. Protocol MI-CP135. A Phase 3, Prospective, Randomized Trial To Demonstrate Equivalent
Immunogenicity of Refrigerated FluMist Administered As a Full Dose (0.2 ml) Into One Nostril With a Blow-Fill Seal Ampoule
Device Vs. Splitting the Dose Into Two Nostrils (0.1 ml each) With the Becton Dickinson Accuspray™ in Subjects 1 to <9 Years
of Age. PI: Mufson. Cancelled by sponsor.
2007. MedImmune, Inc. Protocol MI-CP150. An Expanded Phase 1/2A Randomized, Double-Blind, Placebo-Controlled Study
To Evaluate The Safety, Tolerability, Immunogenicity, and Viral Shedding of MEDI-560, A Live, Attenuated Recombinant
Parainfluenza Virus Type 3 (PIV3) Vaccine, Administered Intranasally to Healthy Infants 1 to <12 Months of Age. PI: Mufson.
2007. GlaxoSmithKline Biologicals. Protocol 110058 (MMRV-054 PRI). A Phase II Randomized, Observer Blind, Multicenter
Study of GlaxoSmithKline Biologicals’ Combined Measles-Mumps-Rubella-Varicella Vaccine (MMRV) Versus ProQuad®,
According to a One Dose Schedule, Both Administered Sub-Cutaneously at 12-14 Months of Age, Concomitantly with Hepatitis
A Vaccine (HAV) and Pneumococcal Conjugate Vaccine (PCV) but at Separate Sites. PI: Mufson.
2008. MedImmune, Inc. Protocol MI-CP178. A Phase 1/2A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation
Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, A Live, Attenuated
Intranasal Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy Infants 6 to
<24 Month-Old Children and in 2 Month-Old Infants. PI: Mufson.
2009. GlaxoSmithKline Biologicals. Protocol 111870 (MMR-157 PRI). A Phase II, Randomized, Observer Blind, Controlled,
Multicenter Study to assess immunogenicity and antibody persistence following vaccination with GlaxoSmithKline’s Candidate
Combined Measles, Mumps, and Rubella Vaccine (MMR) Versus M-M-R®II As a First-Dose, Both Administered SubCutaneously at 12-15 Months of Age, Concomitantly with Hepatitis A Vaccine (HAV), Varicella Vaccine (VV) and
Pneumococcal Conjugate Vaccine (PCV) but at Separate Sites. PI: Mufson.
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
5/24/07
Barriers to Smoking Cessation. Pharmacotherapy of Smoking Cessation. Family Practice Grand
Rounds. Cabell Huntington Hospital. Huntington, WV.
4/6/08
What’s New in Tobacco Cessation. WVAFP meeting. Charleston, WV.
9/10/08
Tobacco Cessation Provider Training. Diabetes Symposium and Workshop. Charleston, WV.
9/13/08
Tobacco Cessation Provider Training. WV Dental Hygienists Association Conference. Flatwoods,
WV.
9/18/08
Tobacco Cessation Provider Training. WVPHA Annual Conference. Snowshoe, WV.
10/17/08
What’s New In Tobacco Cessation. WV American College of Physicians Meeting. Morgantown, WV.
11/14/08
What’s New in Tobacco Cessation. Annual Jose I. Ricard Family Medicine and Sports Medicine
Conference. Huntington, WV
2/5/09
Tobacco Cessation Provider Training in Pregnancy. OB/GYN Grand Rounds WVU Morgantown WV
and Fairmont WV.
5/7-5/9/09
CRIT. Chief Resident Immersion Training in the Care of Older Adults. Teaching in Small Groups.
Functional Assessment. Stonewall Jackson Resort. WV.
5/20/09
Smoking Cessation for Pregnant Women. Right From the Start Annual Training Meeting.
Charleston, WV.
10/28/09
Tobacco Cessation Provider Training. Charleston, WV. Invited speaker as part of the WV Diabetes
Symposium.
8)
Community service as defined in the Greenbook.
Participation as above in state conferences as a speaker.
81
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: Arif Goreja
Rank: Associate Professor
Status (Check one): Full-time X Part-time_____ Adjunct _____ Current MU Faculty: Yes X No ___
Highest Degree Earned: M.B.B.S
Date Degree Received: 1990
Conferred by: Allama Iqbal Medical College - Lahore,Pakistan
Area of Specialization: Nephrology
Professional Registration/Licensure: WV 21469
Agency: WV Board of Medicine
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
________
________
5 yrs
________
5 yrs.
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
07-08 Summer
through Spring
08-09 Summer
through Spring
Alpha Des. & No.
Title
Enrollment
Med 742
Clerkship in Internal Medicine – 2 lectures given 6 times
yearly
9 per semester
Med 742
Clerkship in Internal Medicine – 2 lectures given 6 times
yearly
10-11 a semester
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
1)
If your degree is not in your area of current assignment, please explain.
N/A
2)
Activities that have enhanced your teaching and or research.
-Third and fourth year medical students’ lectures and
- 3rd year medical student 4 hours rounds on ICU and Floor rotation
-Grand Rounds
-Monthly 1 hour resident lectures
3)
Discipline-related books/papers published (provide a full citation).
-Not within the last 5 years
4)
Papers presented at state, regional, national, or international conferences.
-Not within the last 5 years
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
-American Society of Nephrology - ASN
-American College of Physicians - ACP
-American Board of Internal Medicine - ABIM
-American Society of Hypertension - ASH
82
6)
Externally funded research grants and contracts you received.
N/A
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
-2006-2007: Teacher of the Year Award from Marshall University, Joan C. Edward’s School of Medicine- from
Internal medicine Residents
8)
Community service as defined in the Greenbook.
N/A
83
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: Imran Khawaja
Status (Check one): Full-time X
Highest Degree Earned: MD
Rank: Professor
Part-time_____ Adjunct _____ Current MU Faculty: Yes X No ___
Date Degree Received: 1986
Conferred by: King Edward School of Medicine, Lahore, Pakistan
Area of Specialization: Pulmonary, Critical Care & Sleep
Professional Registration/Licensure: WV 17786
Agency: WV Board of Medicine
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
_____
1 1
14 4
______
______
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
Alpha Des. & No.
Title
Enrollment
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
1)
2)
If your degree is not in your area of current assignment, please explain.
N/A
Activities that have enhanced your teaching and or research.
- 3rd year medical student 4 hours rounds on ICU and Floor rotation
-Grand Rounds
-2-1 hour resident lecture per year
3)
Discipline-related books/papers published (provide a full citation).
N/A-Last publication in 2000
4)
Papers presented at state, regional, national, or international conferences.
-Obstructive Sleep Apnea in non obese patients, Prevalence and Characteristics. Ghanam A, Badin S,
Asaad I, Khawaja I: February 2005.
-Influence of gender on the clinical presentation and polysomnographic profile of patients
diagnosed with mild obstructive sleep apnea syndrome. Assad I, Badin s, Ghanem A, Gress T, Khawaja I.
Presented at the ACCP conference, salt Lake City, October 2006.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
-American College of Physicians
-American College of Chest Physicians
-Society of Critical Care Medicine
84
-American Sleep Disorders Association
6)
Externally funded research grants and contracts you received.
Sub investigator:
- 2005. Pfizer, Inc. Protocol No. A2171030 Efficacy and Safety of Inhaled Human Insulin
(Exubera®) Compared with Subcutaneous Human Insulin in the Therapy of Adult Subjects with Type 1 or Type 2
Diabetes Mellitus and Chronic Obstructive Pulmonary Disease: A One-Year, Multicenter,
Randomized, Outpatient, Open-Label, Parallel-Group Comparative Trial. IRB# 5025, PI: Zeid
Principal investigator:
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
N/A last award in 1999
8)
Community service as defined in the Greenbook.
N/A
85
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: Alejandro Lorenzana
Status (Check one): Full-time X
Highest Degree Earned: MD
Rank: Assistant Professor
Part-time_____ Adjunct _____ Current MU Faculty: Yes X No ___
Date Degree Received: 1984
Conferred by: Universidad Fransisco Marroquin
Area of Specialization: Pulmonary & Critical Care
Professional Registration/Licensure: WV 22673
Agency: WV Board of Medicine
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
_____
1
<1
4
_____
<1
1
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
Alpha Des. & No.
Title
Enrollment
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
1)
If your degree is not in your area of current assignment, please explain.
N/A
2)
Activities that have enhanced your teaching and or research.
- 3rd year medical student 4 hours rounds on ICU and Floor rotation
-Grand Rounds
-2-1 hour resident lecture per year
3)
Discipline-related books/papers published (provide a full citation).
-N/A last publications in 1996
4)
Papers presented at state, regional, national, or international conferences.
-N/A
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
- American College of Chest Physicians, Fellow
- Society of Critical Care Medicine, Member
6)
Externally funded research grants and contracts you received.
N/A
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
86
-Ranked second in first class of first private
-Medical School in Central America
8)
Community service as defined in the Greenbook.
N/A
87
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: _Charles Meadows, MD________________________ Rank: _Associate Professor__________
Status (Check one): Full-time__X__ Part-time_____ Adjunct _____ Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: ___MD____________________ Date Degree Received: _1998____________
Conferred by: ____Marshall University School of Medicine ___________________________________
Area of Specialization: __Internal Medicine_________________________________________________
Professional Registration/Licensure_____WV_______
Agency: _WV Board of Medicine___________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
__0_____
__0_____
__8_____
__8_____
__5_____
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2007-2008
Alpha Des. & No.
ACB 724
Title
Microanatomy and Ultrastructure, MS-1, 1 lecture hour
80
2007-2009
IDM 716
Molecular Basis of Medicine, MS-1, 2 lecture hours
80
2007-2009
MED 725-726
Approach to Patient Care, MS-2, 8 lecture hours
60
2007-2009
MED 742
rd
3 Year Internal Medicine Clerkship, approx. 3 hours per
block
Enrollment
Approx 3 hours
per block
STEP 2 Board Review Course. 2007-2009. Approx 20 students. Approx 8 lecture hours per year.
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research.
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
88
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: ____Shirley M. Neitch__________________________ Rank: ___Professor________________
Status (Check one): Full-time__X__ Part-time_____ Adjunct _____ Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: ______MD_________________ Date Degree Received: __1977___________
Conferred by: __Medical College of Virginia/Virginia Commonwealth University ____________________
Area of Specialization: _____Internal Medicine/Geriatrics _____________________________________
Professional Registration/Licensure_____MD_______
Agency: _States of WV, KY and VA_________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
__3_____
__3_____
_26_____
_26_____
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2008-2009 each
semester
2008-2009 each
semester
Alpha Des. & No.
Title
IM Clerkship-Geriatrics Curriculum-approx 4 hours
Enrollment
APC 5 hours
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
Activities that have enhanced your teaching and or research.
Attendance at locally sponsored lectures such as offered by the faculty development
Program at JCESOM
Geriatric Leadership Summit sponsored by WV Geriatric Education Center,
August 2009, Glade Springs, WV
Discipline-related books/papers published (provide a full citation).
Goebel, L., Neitch, S., and Mufson, M., Standing Orders in an Ambulatory Setting
Increase Influenze Vaccine Usage in the Elderly. Journal of the American
Geriatrics Society, 53(6), pp 1008-1010, June 2005.www.healthinaging.org
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
UMWA Health and Retirement Funds, Expert Advisory Panel For Prescription
Drug Care Coordination Program, Dec 2001-present.
UMWA Funds Caregivers Program-Consultant, July 2009-present.
Editorial Advisory Board, “MineRx Letter”, Jan 2005-present.
West Virginia Nursing Home Administrators Licensing Board, Secretary
Sept 2005-present
West Virginia Geriatrics Society
89
6)
7)
8)
Board of Directors, from founding to present
Vice President, 2007
President-Elect, 2010
West Virginia Alzheimer’s Outreach and Registry Program, Medical Director. This is
A program of the Blanchette Rockefeller Neurosciences Institute,
WVU, Morgantown, WV.
Externally funded research grants and contracts you received.
Principle investigator for Assessing and Counseling Older Drivers Program,
From American Medical Association, $5,000
Principle investigator for “Chief Resident Immersion Training in the Case of Older
Patients”, from American Geriatrics Society, Hartford Foundation,
$114,000, 2008
Subcontracts from WV Geriatric Education Center, $8,000 yearly, 2008, 2009
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Practicing Medicine in Appalachia, multiple presentations, 2002, 2001, 2008.
Older Drivers: Fears, Facts, and the Future for the West Virginia Silver-Haired Legisature
2004; JCESOM Family Medicine Grand Rounds, 2005; WVGS annual meeting
2005
Cardinal Manifestations of Disease in the Elderly and Older Drivers curriculum modules,
AGES Certification Program. Multiple presentations, 2005, 2006, 2007,
2008, 2009.
Communicating With Your Physician, Governor’s Summit on Aging, Canaan Valley, WV
2006
“Vegameatavitamin”:Can We “Ensure” the Health of Elderly Patients by “Boost”ing
Nutrition? WVU-Charleston Internal Medicine Grand Rounds, 2009
Elderly Drivers:Fears and Facts, Meharry Consortium Geriatric Education Center Annual
Scientific Meeting, Nashville, TN, 2009
Faculty inductee into Alpha Omega Alpha, Medical Honorary Society, 2004
Rockefeller Award from WV Chapter of Alzheimer’s Association, 2008.
Community service as defined in the Greenbook
Board of Directors of Prestera Center for Mental Health Services, Inc., 2010
Author, “One Christian Physician’s Perspective on End-of-Life Care”. The West Virginia
United Methodist, Sept. 2005
Speaker for Huntington WV Rotary Club, and Lavalette WV Women’s Club,
“Outlook on Aging”, 2005, 2009
Speaker for Cabell Huntington Hospital Senior Services on “Health Literacy”, 2009 .
90
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: Adenrele Olajide
Status (Check one): Full-time X
Highest Degree Earned: M.B.B.S
Rank: Assistant Professor
Part-time_____ Adjunct _____ Current MU Faculty: Yes X No ___
Date Degree Received: 1991
Conferred by: University of Ibadan, Ibadan, Nigeria
Area of Specialization: Rheumatology/ Internal Medicine
Professional Registration/Licensure: WV 23599
Agency: WV Board of Medicine
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
4
4
<1
<1
<1
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
Alpha Des. & No.
Title
Enrollment
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain. N/A
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
-Resident lectures
-Medical Grand Rounds
-Student and Residents rounds 4 hours on floor rotations and clinical exposure
3)
Discipline-related books/papers published (provide a full citation).
N/A
4)
Papers presented at state, regional, national, or international conferences.
N/A last presentation in 2003
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
- American College of Physicians
-American College of Rheumatology
6)
Externally funded research grants and contracts you received.
N/A
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
91
8)
Community service as defined in the Greenbook.
N/A
92
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: ___C. Lynn Patterson__________________________ Rank: __Assistant Professor________
Status (Check one): Full-time_____ Part-time__X__ Adjunct _____ Current MU Faculty: Yes __X_
No ___
Highest Degree Earned: ____MD___________________ Date Degree Received: __2001___________
Conferred by: _Marshall University School of Medicine________________________________________
Area of Specialization: __Internal Medicine/Pediatrics_________________________________________
Professional Registration/Licensure_______________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
Agency: _______________________________
____1____
____1____
____4____
____4____
____4____
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2007
Alpha Des. & No.
Title
Enrollment
Physical Examination
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research.
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
93
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: __Terry Patterson_____________________________ Rank: _Professor__________________
Status (Check one): Full-time_X___ Part-time_____ Adjunct _____ Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: __PhD_____________________ Date Degree Received: _1976____________
Conferred by: __Reading/Oxford Universities, United Kingdom _________________________________
Area of Specialization: Neurophysiology & Biochemistry_______________________________________
Professional Registration/Licensure_DABNM____Agency: American Board of Neurophysiological
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
Monitoring____
___42__
___42__
___9mo_
___42__
___9mo_
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
Alpha Des. & No.
Title
Clinical Practice in neurophysiological specialty in deep
brain situations for Parkinson’s Disease and other
movement disorders
Enrollment
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research.
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
94
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: _____Eva Patton-Tackett_______________________ Rank: Assistant Professor___________
Status (Check one): Full-time__X__ Part-time_____ Adjunct _____ Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: ______MD_________________ Date Degree Received: __2005___________
Conferred by: __University of Kentucky, College of Medicine___________________________________
Area of Specialization: _____Internal Medicine/Pediatrics _____________________________________
Professional Registration/Licensure_____MD_______
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
Agency: _WVBOM_______________________
________
___4____
___1____
________
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
*
Alpha Des. & No.
Title
*Lectures to 2nd yr medical students and clinical teaching
with residents
Enrollment
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research.
Board Review Courses in Internal Medicine-ACP, Chicago, 2009; Pediatrics, Med Study
2009
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Poster Presentations-ACP, State, 2007; ACP, National, 2008
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations
ACP-American College of Physicians; AAP-American Academy of Pediatrics..
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
ACP State Poster Winner 2007; Research Day, JCESOM Oral Presentation Winner
Community service as defined in the Greenbook.
95
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name:
Tariq Rehman MD
Rank: Assistant Professor
Status (Check one): Full-time x Part-time_____ Adjunct _____ Current MU Faculty: Yes x No__
Highest Degree Earned: MBBS
Date Degree Received: 5/1999
Conferred by: KING EDWARD MEDICAL COLLEGE, LAHORE, PAKISTAN
Area of Specialization: NEPHROLOGY
Professional Registration/Licensure: 22963
Agency: WV BOM
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
________
5yrs
1 yr
________
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
Alpha Des. & No.
Title
Enrollment
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
1)
If your degree is not in your area of current assignment, please explain.
N/A
2)
Activities that have enhanced your teaching and or research.
- 3rd year medical student 4 hours rounds on ICU and Floor rotation
-Grand Rounds
-6-1 hour resident lectures per year
3)
Discipline-related books/papers published (provide a full citation).
-N/A
4)
Papers presented at state, regional, national, or international conferences.
N/A
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
-American College of Physicians (ACP) – Associate Member
-American Medical Association (AMA) – Associate Member
-American Society of Nephrology (ASN) – Associate Member
-Renal Physician Association (RPA) – Associate Member
-King Edward Medical College Alumni Association of North America (KEMCAANA)
-All Pakistani Physicians of North America (APPNA)
6)
Externally funded research grants and contracts you received.
96
N/A
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
N/A
8)
Community service as defined in the Greenbook.
N/A
97
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: __Thomas C Rushton _________________________ Rank: _Professor, Tenured___________
Status (Check one): Full-time_X___ Part-time_____ Adjunct _____ Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: _MD_____________________ Date Degree Received: ___1989__________
Conferred by: ___University of South Florida College of Medicine_______________________________
Area of Specialization: ____Internal Medicine, Infectious Diseases______________________________
Professional Registration/Licensure___MD________
Agency: ___WV and Fl____________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
__ 0____
__ 0____
__15____
__15____
___5____
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2008 F
Alpha Des. & No.
MED 620/720
Clinical Micro (10%)
Title
80
Enrollment
2008 S
MED 620/720
Clinical Micro (10%)
80
2009 F
MED 620/720
Clinical Micro (10%)
95
Continuously
MED 638
4th Clinical ID Elective (33%)
6
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
-AACGME preparation meeting, BCC, October 2009
-2009 Convenience sample/point prevalence of MRSA in a WV regional jail
-2008 MRSA convenience sample/point prevalence in a local medical center
-Capstone Mentor: Katelin Gifford 2008; Kweama Philander 2009
3)
Discipline-related books/papers published (provide a full citation)
-Rushton, T. Overwhelming post-splenectomy infection (opsi). (2007) WWW.antimicrobe.org accessed 3/24/09.
-Dimassi A. and Rushton, T. Right-sided infective endocarditis due to methicinnin-resistant Staphylococcus aureus in an
injecting drug user: outbreak or slow epidemic? West Virginia Medical Journal, 2009, 105(1): 18-9
4)
Papers presented at state, regional, national, or international conferences.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
-Infectious Disease Society of America 2005 (43rd), 2007 (45th), 2009 (47th)
-Society for Healthcare Epidemiology of America 2005 (15th), 2007 (17th), 2009 (19th)
6)
Externally funded research grants and contracts you received.
-Huntington Foundation, 2007, shared with Menashi Cohenford, PhD, $15,000.
-Pfizer Protocol Number A4001067. An international, multicenter, prospective, observational study of the safety of
Maraviroc used with optimized background therapy in treatment experienced HIV-1 infected patients (POEM). Funding:
reimbursement per patient enrolled. Principal investigator. Status: January 2009-December 2010.
-Roche Laboratories, Inc. Protocol MV21542. Prospective observational study on predictors of early on-treatment
response and sustained virological response in a cohort of treatment naïve HCV-infected patients treated with peglylated
interferons (PROPHESYS 3). Funding, reimbursement per patient enrolled. Principal. Status January 2009-July 2009.
98
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
-Teacher of the year, FALL 2007 (Class of 2010)-2008
-MDR Acinetobacter: war, a worldwide organism and a local outbreak. APIC-WV Conference-2008
-Certificate of Appreciation, Tri-State Fire Academy-2008
-West Virginia University Tropical Medicine Course: GI infections and cases: 2002-present.
8)
Community service as defined in the Greenbook.
-Cabell County Health Department: 5 County Infectious Diseases Consultant
-Infectious Diseases Consultant and Board Member: West Virginia Eye Bank 2003-present
99
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: ___Tekleyes, Fikadu G.________________________ Rank: __Assistant Professor__________
Status (Check one): Full-time_X___ Part-time_____ Adjunct _____ Current MU Faculty: Yes X__
No ___
Highest Degree Earned: __MD_____________________ Date Degree Received: _1996____________
Conferred by: __Addis Ababa University, Faculty of Medicine___________________________________
Area of Specialization: __Internal Medicine_________________________________________________
Professional Registration/Licensure_Yes________
Agency: _West Virginia Board of Medicine______
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
____0____
____N/A__
____2____
____2____
____2____
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
Alpha Des. & No.
Title
Enrollment
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research.
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
100
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: Ralph Webb
Rank: Professor
Status (Check one): Full-time X Part-time_____ Adjunct _____ Current MU Faculty: Yes X No ___
Highest Degree Earned: M.D
Conferred by:
Date Degree Received: 1984
West Virginia University, Morgantown, West Virginia
Area of Specialization: Rheumatology/ Internal Medicine
Professional Registration/Licensure: WV 14506, FL
Agency: WV Board of Medicine
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
4
4
21
21
21
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
07-08 Summer
through Spring
Alpha Des. & No.
Title
Enrollment
Med 742
Clerkship in Internal Medicine – 2 lectures given 6 times
yearly (15%)
9 per semester
08-09 Summer
through Spring
Med 742
Clerkship in Internal Medicine – 2 lectures given 6 times
yearly (15%)
10-11 a semester
07-09
IDM 875
USMLE Step II Review (15%)
30 per term
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
1)
If your degree is not in your area of current assignment, please explain.
N/A
2)
Activities that have enhanced your teaching and or research.
-2nd year medical student Step 2 Board Review lectures
-Third and fourth year medical students’ lectures and
- 3rd year medical student 4 hours rounds on ICU and Floor rotation
-Grand Rounds
3)
Discipline-related books/papers published (provide a full citation).
-N/A last presentation in 1999
4)
Papers presented at state, regional, national, or international conferences.
-N/A last presentation in 2000
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
-American College of Rheumatology (Fellow)
-American College of Physicians (Fellow)
-West Virginia State Medical Association
101
-Cabell County (West Virginia) Medical Society
6)
Externally funded research grants and contracts you received.
-N/A
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
-N/A
8)
Community service as defined in the Greenbook.
-N/A
102
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: ___Kevin W. Yingling__________________________ Rank: ___________________________
Status (Check one): Full-time__X__ Part-time_____ Adjunct _____ Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: ____MD___________________ Date Degree Received: ___1985__________
Conferred by: __Marshall University School of Medicine_______________________________________
Area of Specialization: ___Internal Medicine________________________________________________
Professional Registration/Licensure/Agency:____Registered Pharmacist, WV, 1981; Consultant Pharmacist, WV, 1996; National
Board Medical Examiners, 1986; Physician, OH, 1985, WV 1990; Registration, Visiting Overseas Doctor, General Medical Counsil,
England, 1997-1998_______
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
________
____5___
___19___
________
____5___
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
1990-2009, 2nd
sem
1990-2009, 1st-2nd
sem
2009 2nd sem
Alpha Des. & No.
MED 720
Pharmacology
Title
80
Enrollment
MED 742
MSIII Clerkship
70
MED 744
Clinical Medicine
70
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
**Activities for Numbers 2-8 too extensive for space provided-please see attached CV.
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research.
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
103
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: Mumtaz Zaman
Status (Check one): Full-time X
Highest Degree Earned: MD
Rank: Assistant Professor
Part-time_____ Adjunct _____ Current MU Faculty: Yes X No ___
Date Degree Received: 1990
Conferred by: Dow Medical College, Karachi, Pakistan
Area of Specialization: Pulmonary & Critical Care
Professional Registration/Licensure: WV 21881
Agency: WV Board of Medicine
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
4 4
4 1
5 4
______
______
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
07-08 Summer
through Spring
08-09 Summer
through Spring
Alpha Des. & No.
Title
Enrollment
Med 742
Clerkship in Internal Medicine – 2 lectures given 6 times
yearly
9 per semester
Med 742
Clerkship in Internal Medicine – 2 lectures given 6 times
yearly
10-11 a semester
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
1)
If your degree is not in your area of current assignment, please explain.
N/A
2)
Activities that have enhanced your teaching and or research.
-Third and fourth year medical students’ lectures and
- 3rd year medical student 4 hours rounds on ICU and Floor rotation
-Grand Rounds
-2-1 hour resident lecture per year
3)
Discipline-related books/papers published (provide a full citation).
-Enhancing competence of mechanical ventilation skills among medical residents: An innovative approach – Poster
presentation Chest annual meeting 11/2009
-Low inspiratory capacity to total lung capacity is a risk factor for chronic obstructive pulmonary disease exacerbation –
Poster presentation American Thoracic Society annual meeting 05/2009
-Clinical course and outcome of cocaine-induced pneumomediastinum – Accepted for publication in American Journal of
Medical Sciences 2009 Majd Alnas, MD; Abdullah Altayeh, MD; Mumtaz Zaman, MD
4)
Papers presented at state, regional, national, or international conferences.
-Zaman, M. Enhancing competence of mechanical ventilation skills among medical residents: An innovative approach.
Abstract of the American College of Chest Physicians annual meeting, San Diego, CA, November 2009
104
-Zaman, M. Low inspiratory capacity to total lung capacity is a risk factor for chronic obstructive pulmonary disease
exacerbation. Abstract of the American Thoracic Society meeting, San Diego, CA, May 2009
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
-American Thoracic Society
- American College of Chest physicians
6)
Externally funded research grants and contracts you received.
N/A
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
-Academy of Medical Educators Award 2008
- Elementary statistics certificate course 05/2003
8)
Community service as defined in the Greenbook.
N/A
105
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name:
Bruce A. Ratcliff, MD
Status (Check one): Full-time X
Highest Degree Earned:
Conferred by:
Rank:
Professor
Part-time____ Adjunct ____
MD
Current MU Faculty: Yes ___
No ___
Date Degree Received: June 1966
University of Virginia
Area of Specialization:
Obstetrics & Gynecology
Professional Registration/Licensure WV 9052
Agency: WV Board of Medicine
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
7
26
10
10
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2009-2010
Alpha Des. & No.
OBG 742
3rd year clerkship
Title
Enrollment
75 Students
2008-2009
OBG 742
3rd year clerkship
56 Students
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research.
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
ACOG
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
Goodwill Industries
106
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name:
Lisa Burke, MD
Status (Check one): Full-time X
Rank:
Part-time____ Adjunct ____ Current MU Faculty: Yes ___
Highest Degree Earned: MD
Conferred by:
Assistant Professor
Date Degree Received:
No ___
1993
Marshall University School of Medicine
Area of Specialization:
Obstetrics & Gynecology
Professional Registration/Licensure WV 19438
Agency: West Virginia Board of Medicine
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
N/A
N/A
12
12
12
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2009-2010
Alpha Des. & No.
OBG 742
3rd year clerkship
Title
Enrollment
75 Students
2008-2009
OBG 742
3rd year clerkship
56 Students
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research. CME Conferences & Grand Rounds
Discipline-related books/papers published (provide a full citation). N/A
Papers presented at state, regional, national, or international conferences. N/A
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations. ACOG
Externally funded research grants and contracts you received. N/A
Awards/honors (including invitations to speak in your area of expertise) or special recognition.N/A
Community service as defined in the Greenbook. N/A
107
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name:
William Burns, MD
Status (Check one): Full-time X
Highest Degree Earned:
Conferred by:
Rank: Associate Professor
Part-time____ Adjunct _____
MD
Current MU Faculty: Yes ___
Date Degree Received:
No ___
May 1978
Vanderbilt University School of Medicine
Area of Specialization:
Reproductive Endocrinology
Professional Registration/Licensure WV 20002
Agency: WV Board of Medicine
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
________
15 ½
6½
22
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2009-2010
Alpha Des. & No.
OBG 742
3rd year clerkship
Title
Enrollment
75 Students
2008-2009
OBG 742
3rd year clerkship
56 Students
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research.
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
ACOG & American Society of Reproductive Medicine
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
108
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name:
Yolanda Campbell, MD
Status (Check one): Full-time X
Highest Degree Earned:
Conferred by:
Rank:
Instructor
Part-time____ Adjunct ____
MD
Current MU Faculty: Yes ___
Date Degree Received:
No ___
June 2003
Marshall University School of Medicine
Area of Specialization:
Obstetrics & Gynecology
Professional Registration/Licensure WV 23042
Agency: WV Board of Medicine
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
4
________
2
2
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2009-2010
Alpha Des. & No.
OBG 742
3rd year clerkship
Title
Enrollment
75 Students
2008-2009
OBG 742
3rd year clerkship
56 Students
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research.
Resident and student lectures
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
ACOG
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
109
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name:
David Chaffin, MD
Status (Check one): Full-time X
Highest Degree Earned:
MD
Rank:
Professor
Part-time____ Adjunct _____
Date Degree Received:
Current MU Faculty: Yes ___
No ___
5/84
Conferred by: Johns Hopkins University School of Medicine
Area of Specialization:
Maternal Fetal Medicine
Professional Registration/Licensure WV 17760
Agency: West Virginia Board of Medicine
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
0
10
10.5
20.5
10.5
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2009-2010
Alpha Des. & No.
OBG 742
3rd year clerkship
Title
Enrollment
75 Students
2008-2009
OBG 742
3rd year clerkship
56 Students
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
N/A
3)
Discipline-related books/papers published (provide a full citation).

Baxter, FR, Nerhood R, Chaffin DG. Characterizatiion of babies discharged from Cabell Huntington Hospital
during the calendar year 2005 with the diagnosis of neonatal abstinence syndrome. West Virginia Medical
Journal 2009;105:16-21.

Chaffin DG, Webb DG. Outcomes of pregnancies at risk for hypertensive complications managed using
impedance cardiography. Am J Perinatology 2009;26:717-722
4)
Papers presented at state, regional, national, or international conferences.

Chaffin D, Singh S, Webb D, Dorsey E. Examination of the changes in hemodynamic parameters as
determined by impedance cardiography in 381 hypertensive gravidas. Presentation at ISSHP September 2008.

Stone R, Chaffin D, Webb D, Trader B, Malarky L, Singh S. Stratification of hemodynamics by impedance
cardiography predicts suboptimal outcomes in diabetic pregnancies. Poster SMFM Feb 2008.

Chaffin, D. Hypertension management based on hemodynamic measurements. Poster SMFM Feb 2004.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.

American College of Obstetricians and Gynecologists
Fellow
1995-present

American Institute for Ultrasound in Medicine
1989-present
Society of Maternal Fetal Medicine (associate member)
1993-present

110

North American Society for the Study of Hypertension in Pregnancy
2001 – present
6)
Externally funded research grants and contracts you received.

Prevalence of drug use in pregnant West Virginia patients. Funded by the Office of Maternal, Child and Family
Health, West Virginia
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.

APGO Excellence in Teaching Award 1999, 2008

Grand Rounds, University of Cincinnati 2007

Grand Rounds, Wake Forest University 2008

Grand Rounds, West Virginia University 2008
8)
Community service as defined in the Greenbook.
N/A
111
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name:
Kevin J. Conaway, MD
Status (Check one): Full-time X
Highest Degree Earned:
Conferred by:
Rank: Associate Professor
Part-time____ Adjunct ____
MD
Current MU Faculty: Yes ___
Date Degree Received:
No ___
05/91
Marshall University School of Medicine
Area of Specialization:
Obstetrics & Gynecology
Professional Registration/Licensure WV 18072 & OH 35-066155
Agency: West Virginia State Medical Board & Ohio State Medical Board
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
0
0
14
14
5
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2009-2010
Alpha Des. & No.
OBG 742
3rd year clerkship
Title
Enrollment
75 Students
2008-2009
OBG 742
3rd year clerkship
56 Students
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research.
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
112
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name:
Brenda Dawley, MD
Status (Check one): Full-time X
Highest Degree Earned:
Rank:
Associate Professor
Part-time____ Adjunct ____
MD
Current MU Faculty: Yes ___
No ___
Date Degree Received: 05/90
Conferred by: University of Miami School of Medicine
Area of Specialization: Obstetrics & Gynecology
Professional Registration/Licensure WV 19292 & OH 35-063518
Agency: West Virginia State Medical Board and Ohio State Medical Board
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
15
11
9
9
11
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2009-2010
Alpha Des. & No.
OBG 742
3rd year clerkship
Title
Enrollment
75 Students
2008-2009
OBG 742
3rd year clerkship
56 Students
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
Sexuality Course for Medical Students
Smoking Cessation Counseling
Developed the Laparoscopic Trainer for Residents
3)
Discipline-related books/papers published (provide a full citation).
Fibromuscular Dysplasia Masquerading as Preeclampsia
4)
Papers presented at state, regional, national, or international conferences.
N/A
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Vice Chair – WV Section of ACOG
WV Perinatal Partnership
WV M&M Obstetrics
6)
7)
8)
Externally funded research grants and contracts you received. N/A
Awards/honors (including invitations to speak in your area of expertise) or special recognition. N/A
Community service as defined in the Greenbook. N/A
113
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: Ben M. Edwards, MD
Rank: Assistant Professor Ob/Gyn
Status (Check one): Full-time X Part-time____ Adjunct _____ Current MU Faculty: Yes ___
Highest Degree Earned:
Conferred by:
MD
No ___
Date Degree Received: _________________
West Virginia School of Medicine
Area of Specialization:
Obstetrics & Gynecology
Professional Registration/Licensure WV 11019, KY 24815, OH 35.057871
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
Agency: WV, KY & OH State Licensure
1979-1992
1979-1992
1992-Present
1992-Present
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2009-2010
Alpha Des. & No.
OBG-742
3rd year clerkship
Title
Enrollment
75 Students
2008-2009
OBG 742
3rd year clerkship
56 Students
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research. N/A
Discipline-related books/papers published (provide a full citation). N/A
Papers presented at state, regional, national, or international conferences. N/A
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations. N/A
Externally funded research grants and contracts you received. N/A
Awards/honors (including invitations to speak in your area of expertise) or special recognition. N/A
Community service as defined in the Greenbook. N/A
114
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: Stephen Feaster, MD
Status (Check one): Full-time X
Highest Degree Earned:
Rank: Associate Professor
Part-time____ Adjunct ____ Current MU Faculty: Yes ___
MD
Date Degree Received:
No ___
1971
Conferred by: West Virginia University School of Medicine
Area of Specialization:
Obstetrics & Gynecology
Professional Registration/Licensure WV 9378
Agency: West Virginia Board of Medicine
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
27
27
7
7
7
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2009-2010
Alpha Des. & No.
OBG 742
3rd year clerkship
Title
Enrollment
75 Students
2008-2009
OBG 742
3rd year clerkship
56 Students
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research.
Developed – Basic Surgical Skills, Gyn Laser Course and Simulated Laparoscopy Course
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
West Virginia State Medical, ACOG, Cabell County Medical Society
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
Chairman of the Surgical Case Review Committee at Cabell Huntington Hospital
Member of the Promotions & Tenure Committee
115
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name:
Ted P. Haddox, MD
Rank:
Associate Professor
Status (Check one): Full-time X Part-time_____ Adjunct ____ Current MU Faculty: Yes ___
Highest Degree Earned:
Conferred by:
MD
Date Degree Received:
No ___
1969
West Virginia University Medical School
Area of Specialization:
Obstetrics & Gynecology
Professional Registration/Licensure WV 11474
Agency: West Virginia Board of Medicine
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
15
15
20
20
20
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2009-2010
Alpha Des. & No.
OBG 742
3rd year clerkship
Title
Enrollment
75 Students
2008-2009
OBG 742
3rd year clerkship
56 Students
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research. N/A
Discipline-related books/papers published (provide a full citation). N/A
Papers presented at state, regional, national, or international conferences. N/A
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations. ACOG
Externally funded research grants and contracts you received. N/A
Awards/honors (including invitations to speak in your area of expertise) or special recognition. N/A
Community service as defined in the Greenbook. N/A
116
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name:
David Jude, MD
Rank:
Status (Check one): Full-time X
Highest Degree Earned:
Conferred by:
Professor
Part-time____ Adjunct _____
MD
Current MU Faculty: Yes ___
Date Degree Received:
No ___
1988
Marshall University School of Medicine
Area of Specialization:
Obstetrics and Gynecology
Professional Registration/Licensure
WV 17555
Agency: West Virginia Board of Medicine
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
1.5
2
16
16
All
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2009-2010
Alpha Des. & No.
OBG 742
3rd year clerkship
Title
Enrollment
75 Students
2008-2009
OBG 742
3rd year clerkship
56 Students
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
American College of Obstetricians and Gynecologists
USMLE Step II Item Writing Committee
Full title of Boston Course
APGO/Solvay Educational Scholars
3)
Discipline-related books/papers published (provide a full citation).
Simulation training in the obstetrics and gynecology clerkship.
Jude DC, Gilbert GG, Magrane D.
Am J Obstet Gynecol. 2006 Nov;195(5):1489-92
Jude, D. Echogenic Intracardiac Focus. CREOG Resident Quiz Series. American College of Obstetricians and
Gynecologists. Washington, DC. 2004
Diliberto J, Staats DA, Sirinek L, Becker J, Jude D, Chouinard SC, Smith T, Clark G, Landy R, Birnbaum L. Dioxins and
Endometriosis: Cohort Study of Women in West Virginia. Organohalogen Compounds. 2004; 66: 3240-3244
Stone R, Jude D, Nerhood R, High Maturation Index Pap Tests and Risk of Endometrial Pathology in Postmenopausal
Women, Obstetrics and Gynecology 2007: 109: 3S.
4)
Papers presented at state, regional, national, or international conferences.
Jude, D. Simulation Training in the Obstetrics and Gynecology Clerkship.
APGO/CREOG Annual Meeting. 2006.
Stone R, Jude D, Nerhood R, High Maturation Index Pap Tests and Risk of Endometrial Pathology in Postmenopausal
Women, American College of Obstetricians and Gynecologist Annual Clinical Meeting, May 2007
117
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
ACOG, APGO, CREOG, Alpha Omega Alpha and Central Association Obstetricians and Gynecologists
Attended:
Boston Course (get exact name from certificate)
CREOG/APGO annual meeting
2004,5,6,7
ACOG Annual Clinical Meeting 2007
WV ACOG Jr. Fellow Symposium 2009
Participate:
CHH PMI committee
USMLE Step II Item Writing Committee
MUSOM GMEC
MUSOM Academic Standards Committee
6)
Externally funded research grants and contracts you received.
USEPA and WV DEP
Dioxins and Endometriosis: Cohort Study of Women in West Virginia.
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Teaching Excellence Award in Obstetrics and Gynecology (Presented by the Third Year Medical Students) 2003-2004,
2004-2005, 2005-2006
Attending of the Year, 2003-2004, Presented by the Class of 2005
8)
Community service as defined in the Greenbook.
118
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name:
Hisham A. Keblawi, MD
Status (Check one): Full-time X
Rank: Assistant Professor
Part-time____ Adjunct ____
Highest Degree Earned: MD
Current MU Faculty: Yes ___
No ___
Date Degree Received: 1991
Conferred by: University of Al Fateh
Area of Specialization: Obstetrics & Gynecology
Professional Registration/Licensure WV 22561
Agency: West Virginia Board of Medicine
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
13
13
6
N/A
2
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2009-2010
Alpha Des. & No.
OBG 742
3rd year clerkship
Title
Enrollment
75 Students
2008-2009
OBG 742
3rd year clerkship
56 Students
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
Attending MUSOM Educators Academy
Clerkship Director
3)
Discipline-related books/papers published (provide a full citation).
N/A
Papers presented at state, regional, national, or international conferences.
N/A
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
ACOG
ACOG WV Junior Fellow Section Chair – Ended Fall 2007
Member of CHH Physician Wellness Committee
Member of Royall College of Ob/Gyn – American Representative Committee
MUSOM Representative to Group on Diversity & Inclusion of AAMC
Attended ACOG Annual Meeting 2007 & 2008
Attended AAMC Annual Meeting 2009
4)
5)
6)
7)
8)
Externally funded research grants and contracts you received. – N/A
Awards/honors (including invitations to speak in your area of expertise) or special recognition. – N/A
Community service as defined in the Greenbook. – N/A
119
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name:
Gerard Oakley, MD
Status (Check one): Full-time X
Rank:
Part-time____ Adjunct ____
Highest Degree Earned: MD
Conferred by:
Professor
Current MU Faculty: Yes ___
No ___
Date Degree Received: June 1983
University of Michigan
Area of Specialization:
Gynecologic Oncology
Professional Registration/Licensure WV 18886
Agency: WV Board of Medicine
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
________
26
13
14
13
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
Alpha Des. & No.
Title
2nd year medical school lectures
Enrollment
75 Students
OB 742
3rd year clerkship
75 Students
OB 850
4th year medical school elective
12 Students
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research.
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
ACOG, Society of Air force Clinical Surgeons, Cabell County Medical Society,
West Virginia State Medical Association
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Have had many speaking engagements
Community service as defined in the Greenbook.
120
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: Joseph Werthammer____________________ Rank: Professor & Chair___________________
Status (Check one): Full-time X___ Part-time___ Adjunct ___
Current MU Faculty: Yes ___
No ___
Highest Degree Earned: Doctor of Medicine_______ Date Degree Received: 1973_________________
Conferred by: West Virginia University School of Medicine___________________________
Area of Specialization: Pediatrics/Neonatal-Perinatal Medicine______________________________
Professional Registration/Licensure MD_______________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
Agency: WV Board of Medicine_________
________
___6____
___21___
___27___
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
Alpha Des. & No.
Title
Enrollment
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
Activities that have enhanced your teaching and or research.
Discipline-related books/papers published (provide a full citation).
Frazier MD, Werthammer JW: Post-resuscitation complications in term neonates. J. Peri. 2007; 27:82-84.
Werthammer J, Pritt A, Recchi L, Brown L., Heydarian M. Pulmonary embolism presenting with sudden respiratory failure in two
previously stable neonates. Journal of Neonatal-perinatal Medicine. In Press.
4)
Papers presented at state, regional, national, or international conferences.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Alpha Omega Alpha – Honor Medical Society
Service to Children Award, On Behalf of TEAM for West Virginia
Children – 2007
Best Doctors in America 2009-2010
Who’s Who in Medical Healthcare – 2009-2010
6)
7)
8)
Community service as defined in the Greenbook.
Children's Health Fund - National Advisory Board
Ronald McDonald Children's Charity - Advisory Board
121
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: __James Binder______________________________ Rank: _Associate Professor__________
Status (Check one): Full-time____ Part-time_____ Adjunct _____
Current MU Faculty: Yes _X
No ___
Highest Degree Earned: _Doctor of Medicine__________ Date Degree Received: _1977____________
Conferred by: ________________________________________________________________________
Area of Specialization: _Pediatrics/Child Psychiatry/Child Behavior & Development _________________
Professional Registration/Licensure_____MD_______
Agency: _WVBOD ______________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
________
________
___9____
__15____
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
Alpha Des. & No.
Title
Enrollment
*
*MSIII-Teach history taking, physical exam, diagnostic and therapeutic skills (11 hours per week); Developmental & Behavioral
lectures (2 hours per 8-week clerkship); Interviewing Techniques Workshop (1 hours per week)
Supervising Attending in Ambulatory Clinic
Weekly Interviewing Workshops-first-year residents
Monthly Interviewing Workshop-all resident levels
Supervise faculty development course
Lecture monthly to residents and students on Child Development & Behavior topics
Director, Behavior/Development Elective for residents and 4th year students
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
Annual resident retreat
3)
Discipline-related books/papers published (provide a full citation).
Book: Pediatric Interviewing in a Practical, Relationship-Based Approach; Humana
(Division of Springer)
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Associate Director, Pediatric Residency Program Co-Leader, The WV Chapter of
Physicians for a National Health Program
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Speaker, Family Practice Grand Rounds
Community service as defined in the Greenbook.
4)
5)
6)
7)
8)
122
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: Marie Frazier___________________ Rank: Assistant Professor_______________
Status (Check one): Full-time_X__ Part-time___ Adjunct ____
Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: Doctor of Medicine____________ Date Degree Received: _2001___________
Conferred by: ________________________________________________________________________
Area of Specialization: Pediatrics/Critical Care ______________________________________
Professional Registration/Licensure MD_______
Agency: WV Board of Medicine________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
________
________
_3 yrs__
_3 yrs__
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
MS II
Approach to Patient Care – lecture annually
Pediatric Acute Care Conference – lecture to students, residents, physicians and nurses
MS III
Supervise rounds, PICU and Peds floor, Bedside teaching and lecture format teaching, Mega Review to prepare
for pediatric mini boards.
Pediatric Residents – Critical Care lecture
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
Co-leader for a national collaborative sponsored by NACHRI focusing on the eradication of catheter-associated
blood stream infections in pediatrics patients.
3)
Discipline-related books/papers published (provide a full citation).
Currently in Press:
The Role of Heliox in Pediatric Respiratory Disease; Pediatric Respiratory Reviews; Inflammation Alters Iron
Metabolism in the Lung through Regulation of Hepcid; American Journal of Physiology: Lung Cellular and
Molecular Physiology
4)
Papers presented at state, regional, national, or international conferences.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Society of Critical Care Medicine, American Academy of Pediatrics, Alpha Omega Alpha co-counselor for 20082009, Pediatric Resident Evaluation Committee, WV State American Academy of Pediatrics
6)
Externally funded research grants and contracts you received.
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
2008-2009 Joe Evans Excellence in Teaching Award
8)
Community service as defined in the Greenbook.
Lecture to Daycares in the community to help further the education the teachers and participate in the annual inservice conferences
WV Child Fatality Review Team
123
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: ________Iralane Pippa Lambros
__________ Rank: ____Assistant Professor____________
Status (Check one): Full-time__X_Part-time_____Adjunct _____Current MU Faculty: Yes _X__ No ___
Highest Degree Earned: ______Doctor of Medicine____ Date Degree Received: _May 1992________
Conferred by: ________________________________________________________________________
Area of Specialization: __________Pediatrics_______________________________________
Professional Registration/Licensure_____M.D.____
Agency: ____WV Board of Medicine________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
________
________
___11___
___11___
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment.
MSIII:
Pediatric Dermatology Lecture; every 8 week rotation
Newborn Examination
Bedside Teaching on Inpatient Service and Newborn Nursery
Ambulatory Clinic Attending
MSI and MSII: Mentor Sessions
Pediatric Lecture Series – 3 per year
Dermatology Specialty Clinic Attending
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research.
Pediatric Research in the Office Setting (PROS) Network
National Ambulatory Medical Care Survey
Marshall University Research Day
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Member, MUSOM Admissions Committee
Member, MUSOM Clinical Practice Management Committee
Member, St. Mary’s Hospital Credentials Committee
Member, St. Mary’s Hospital Ad Hoc Committee for ER/Peds Protocol
Member, St. Mary’s Hospital Quality Assurance Committee
Member, University Physicians & Surgeons/Cabell Huntington Hospital Privacy Regulatory Committee
State Representative, American Academy of Pediatrics Healthy Child Care America
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
124
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: Bobby Miller ___________________ Rank: Associate Professor_______________
Status (Check one): Full-time_X__ Part-time___ Adjunct ____
Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: Doctor of Medicine____________ Date Degree Received: _1997___________
Conferred by: ________________________________________________________________________
Area of Specialization: Pediatrics/Critical Care ______________________________________
Professional Registration/Licensure MD_______
Agency: WV Board of Medicine________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
________
________
_5 yrs__
_5 yrs__
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Approach to Patient Care – provide 3 lectures, Respiratory Distress Syndrome, Congenital Heart Disease, and
Genetics in Perinatology
MS III
Supervise rounds, organized reading assignments, oversee procedures performed, review and provide feedback
on H & Ps performed on NICU rotation (14 one week block rotations)
MSIV
Supervise rounds, organize reading assignments, oversee procedures performed, review and provide feedback
on H & Ps performed on NICU sub-internship (7 two week block rotations)
Pediatric Program Director – Oversight of all aspects of resident education and service; additional activities in other
departments as required by the Dean of Graduate Medical Education and the Graduate Medical Education
Committee
Pediatric Residents – Supervise residents at all levels of training for 4 months of required NICU rotations
MED/Ped Resdients – Supervise residents at all levels of training for 3 months of required NICU rotations
Family Practice Residents – Supervise 2nd year family practice residents on 2 week required NICU rotations
Neonatology Lecture Series – Core lectures including embryology, nutrition, vent management, fluid & electrolytes,
neonatal abstinence, IVH, BPD; 4-5 lectures/year
Ethics and Professionalism Lecture Series – Core lectures on ethical issues and professionalism for pediatric residents
every other month
MS II
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
Activities that have enhanced your teaching and or research.
Teaching – Academy of Medical Educators; Develop and implement leadership training for residents and
students Pediatric Interest Group – Faculty advisor and mentor for group of 3rd and 4th year students interested in
pediatrics as a career
Research – “Does prolonged use of SiPAP increases the incidence of BPD in infants less than 1500 gms”
Attended Associateion of pediatric Program Directors Annual meeting to update current knowledge and skills
Attended Society for Pediatric Research/Pediatric Academic Societies meeting to update current knowledge and
skills
Discipline-related books/papers published (provide a full citation).
“The effect of humidified double walled incubators on total fluid requirements and persistent ductus arteriosus
in very low birth weight infants”Samer Abu-sultaneh, Waseem Ostwani, Todd Gress, and Bob Miller. Presented
at: American Academy of Pediatrics, National Conference and Exhibit, Boston, 2009.
4)
Papers presented at state, regional, national, or international conferences.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
American Academy of Pediatrics; American College of Physicians; American Society of Internal Medicine; West
Virginia Chapter of AAP; West Virginia Chapter of the ACP-ASIM
Externally funded research grants and contracts you received.
6)
125
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
“Neonatal Abstinence Syndrome” – Paul B Hall Regional Medical Center, educational outreach through the
Huntington Medical Education Foundation
Nursing Lectures: Congenital Heart Disease – Tri-State Perinatal Association Nurses and St. Mary’s School of
Nursing
8)
Community service as defined in the Greenbook.
Hospice of Huntington
Paramount Arts Center
126
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: Jay Naegele___________________ Rank: Assistant Professor_______________
Status (Check one): Full-time _X__ Part-time___ Adjunct ____ Current MU Faculty: Yes _X_ No ___
Highest Degree Earned: Doctor of Medicine_________ Date Degree Received: 1997______________
Conferred by: ________________________________________________________________________
Area of Specialization: Pediatrics ______________________________________
Professional Registration/Licensure MD_______
Agency: WV Board of Medicine________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
________
________
9 yrs____
9 yrs___
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Mentoring Program – MS I and MS II students
MS III and Residents teaching in outpatient setting, in the newborn nursery and hospital rounds
MS III and Residents lectures Pediatric Rheumatology and Pediatric Growth and Development
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
3)
Discipline-related books/papers published (provide a full citation).
4)
Papers presented at state, regional, national, or international conferences.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Board Member of Kidnitiative Project with WV AAP
6)
Externally funded research grants and contracts you received.
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
8)
Community service as defined in the Greenbook.
127
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: ______Andrew Pendleton______________________ Rank: __Associate Professor_________
Status (Check one): Full-time__X__ Part-time_____Adjunct ____ Current MU Faculty: Yes ___ No _X_
Highest Degree Earned: ___Doctor of Medicine________ Date Degree Received: _May 1989_______
Conferred by: ________________________________________________________________________
Area of Specialization: _______Pediatrics/Hematology-Oncology________________________
Professional Registration/Licensure_____M.D.____
Agency: WV Board of Medicine______
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
________
________
___14___
___14___
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment.
MSIV and Residents: Pediatric Hematology/Oncology Elective
Hematology/Oncology Lectures:
Every 8 weeks to MSIII students
6 x year to students and residents
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research.
Principal Investigator – Children’s Oncology Group, Cabell Huntington Hospital
Co-Principal Investigator, Nationwide Children’s Hospital, Columbus, OH, Children’s Oncology Group
Attend Children’s Oncology Group national meetings
Routinely assist residents with research projects
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Member, Pediatric Resident Curriculum Committee
Member, Surgical Case and Blood Utilization Review Committee
Member, Cabell Huntington Hospital Oncology Committee
Member, Joan C. Edwards Comprehensive Cancer Center Committee
Member, American Society of Clinical Oncology
Member, American Society of Hematology
Member, Cabell Huntington Hospital Tumor Board Committee
American Society of Pediatric Hematology/Oncology
Attend Children’s Oncology Group national meetings
Externally funded research grants and contracts you received.
National Institutes of Health/National Children’s Cancer Foundation-funded Research
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Cabell Huntington Hospital Tumor Board
Community service as defined in the Greenbook.
Attend and participate in activities of the American Leukemia Society, Leukemia and Lymphoma Society, Make-AWish Foundation, Ronald McDonald House and Relay for Life.
128
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: ___Eduardo Pino________________________ Rank: ___Associate Professor_____________
Status (Check one) Full-time __X___ Part-time_____ Adjunct ____Current MU Faculty: Yes _X_ No ___
Highest Degree Earned: __Doctor of Medicine_________ Date Degree Received: ____1983_____
Conferred by: ________________________________________________________________________
Area of Specialization: ___Pediatrics/Critical Care____________________________________
Professional Registration/Licensure____M.D._______
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
Agency: __WV Board of Medicine_________
________
________
___19___
___19___
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment.
Approach to Patient Care – 14 lecture hours
Pediatric Emergencies; every 8 week clerkship rotation
Mini-Board Review; every 8 week clerkship rotation
Bedside Rounds and Teaching in Pediatric Intensive Care Unit and Inpatient Service
USMLE Step 1 Review; 4 hours 2 times per year
USMLE Step 2 Review; 4 hours 2 times per year
Residents as Teachers Workshop (3 sessions per year)
Critical Care Lectures; 6 per year
Supervise Microbiology Rounds
MSII:
MSIII:
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
Activities that have enhanced your teaching and or research.
Catheter Associated Bloodstream Infections – National Collaborative with the National Association of Children’s
Hospitals and Related Institutions (NACHRI).
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Pulse oximetry: Could it be the new Allen’s test? Poster presentation at MUSOM Research Day 2008; Poster
presentation at the American Academy of Pediatrics National Convention and Exposition, 2008.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
President of Medical and Dental Staff, Cabell Huntington Hospital, current
Vice President of Medical and Dental Staff, Cabell Huntington Hospital; Jan 2007-/Dec 2008
Curriculum Committee, Marshall University SOM
Co-Course Director, Approach to Patient Care
Member, Society of Critical Care Medicine
Member, American Academy of Pediatrics (national and state)
Chair, Critical Care Committee, Cabell Huntington Hospital
Chair, Organ and Tissue Committee, Cabell Huntington Hospital
Co- Author, USMLE Step 2 Notes – Pediatrics, Kaplan Medical Course
Co-Author, USMLE Step 3 Notes – Pediatrics, Kaplan Medical Course
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Respiratory Radiology - Genesis Respiratory Symposium, Portsmouth, Ohio; May 2009
Bronchiolitis – Our Lady of Bellefonte Hospital, Ashland, KY; October 2009
Bronchiolitis – Holzer Medical Center, Gallipolis, Ohio; October 2009
129
Diabetic Ketoacidosis – 6th Pediatric Congress, Bogota Colombia; September 2008
Status Epilepticus – 6th Pediatric Congress, Bogota Bolombia; September 2008
Asthma – Genesis Respiratory Symposium, Portsmouth, Ohio; June 2008
Early Goal Directed Therapy in Sepsis – Critical Care Day, Cabell Huntington Hospital, Sept 2007
8)
Community service as defined in the Greenbook.
130
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: Isabel Pino___________________ Rank: Associate Professor_______________
Status (Check one): Full-time_X__ Part-time___ Adjunct ____
Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: Doctor of Medicine__________ Date Degree Received: 1980______________
Conferred by: ________________________________________________________________________
Area of Specialization: Pediatrics ______________________________________
Professional Registration/Licensure MD_______
Agency: WV Board of Medicine________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
________
________
_18 yrs__
_18 yrs__
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
MS II Approach to Patient Care Course – Child abuse lecture; Immunizations; Pictorial Review of the Newborn Exam
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
3)
Discipline-related books/papers published (provide a full citation).
The Enhanced Medical Home: The Pediatric Standard of Care for Medically Underserved Children. 2008 In
Advances in Pediatrics.
4)
Papers presented at state, regional, national, or international conferences.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
WV Children’s Health Project – Medical Director
TEAM for West Virginia Children – Board of Directors
6)
Externally funded research grants and contracts you received.
Grant from The Children Health Fund
Implementation of Fitness in the Classroom
A look at parental attitude and knowledge of the Internet
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
8)
Community service as defined in the Greenbook.
TEAM for WV Children – Board of Directors
Head Start - Advisor
131
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: Jeffrey Shaw___________________ Rank: Associate Professor_______________
Status (Check one): Full-time_X__ Part-time___ Adjunct ____
Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: Doctor of Medicine_________ Date Degree Received: 1983______________
Conferred by: ________________________________________________________________________
Area of Specialization: Pediatrics/Allergy & Immunology______________________________________
Professional Registration/Licensure MD_______
Agency: WV Board of Medicine________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
________
________
_7 yrs__
_7 yrs__
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
MSIII Pediatric Students Allergic Rhinitis and Asthma Lecture – every 8 weeks
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
3)
Discipline-related books/papers published (provide a full citation).
4)
Papers presented at state, regional, national, or international conferences.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
American Academy of Allergy, Asthma and Immunology, The American College of Allergy, Asthma and
Immunology, and the Joint Council of Allergy and Asthma and Immunology
6)
Externally funded research grants and contracts you received.
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
8)
Community service as defined in the Greenbook.
Volunteer volleyball coach, basketball and soccer
132
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: _Jessie Shields_______________________________ Rank: _Assistant Professor__________
Status (Check one): Full-time__X__ Part-time_____ Adjunct _____ Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: __Doctor of Medicine ________ Date Degree Received: __2003___________
Conferred by: ________________________________________________________________________
Area of Specialization: ___Pediatrics______________________________________________________
Professional Registration/Licensure___MD_________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
Agency: _WVBOD_______________________
________
________
___3____
___3____
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
Alpha Des. & No.
Title
Enrollment
*
*
MSIII: Pediatric lecture every 8-week clerkship
MSII: Clinical Coordinatioin/Integration
Pediatric lecture to students and residents-2 per year
Supervising attending for ambulatory clinic, newborn nursery, and inpatient service
Conduct teaching rounds on inpatient service
Assist in conducting interviewing workshops
Faculty Advisor
Student Mentor
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
-Co-investigator, WV-CARES Project
-MRSA: Colonization Rates Among Healthcare Workers Before and After Hypochlorate Eradication
Mentor for resident research projects
Sub-Investigator-3 GlaxoSmithKline research studies
Sub-investigator-3 Medimmune research studies
3)
4)
5)
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
-Coorodinator, WV Chapter of the American Academy of Pediatrics PROS
(Pediatric Research in the Office Setting)
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
6)
7)
8)
133
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: __Monica Valentovic___________________________ Rank: ___Professor________________
Status (Check one): Full-time___x__ Part-time_ Adjunct ___ Current MU Faculty: Yes x___
No ___
Highest Degree Earned: ___PhD___________________ Date Degree Received: ___1983___________
University of Kentucky
Conferred by: ________________________________________________________
Pharmacology and Toxicology
Area of Specialization: _________________________________________________________________
Professional Registration/Licensure_______________
Agency: _______________________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
___31___
____6____
___25____
___31____
___25____
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2009 Fall
Alpha Des. & No.
PMC 610
Title
Introduction to Pharmacology (20%)
17
2009 Fall
FSC608
Drug Toxicology (15%)
8
2009 Fall
PMC 620/720
Medical Pharmacology (15%)
83
2009 Summer
PMC 655
Toxicology Reviews
1
2008 Summer
PMC 655
Toxicology Reviews
2
2008 Fall and
Spring
2008 Fall
PMC 620/720
Medical Pharmacology (15%)
75
PMC 610
Introduction to Pharmacology (20%)
23
2008 Fall
PMC 650
Toxicology (35%)
3
2008 Fall
FSC608
Drug Toxicology (15%)
12
1)
If your degree is not in your area of current assignment, please explain.
2)
Activities that have enhanced your teaching and or research.
Attended Society of Toxicology Meetings 2007, 2008 and 2009
3)
Enrollment
Discipline-related books/papers published (provide a full citation).
M.V. Terneus, K.K. Kiningham, A.B. Carpenter, S.B. Sullivan and M.A. Valentovic. Comparison of S-Adenosyl-L-methionine
and N-acetylcysteine protective effects on acetaminophen hepatic toxicity. J Pharmacol Exp Ther. Jan;320(1):99-107, 2007.
G.O. Rankin, D.K. Anestis, M.A. Valentovic, H. Sun and W.E. Triest. Nephrotoxicity induced by the R- and S-Enantiomers of
N-(3,5-Dichlorophenyl)-2-hydroxysuccinimide (NDHS) and their sulfate conjugates in Male Fischer 344 rats. Toxicology
2007 Oct 30;240(1-2):38-47.
M.V. Terneus, A.B. Carpenter and M.A. Valentovic. Comparison of S-Adenosyl-L-methionine and N-acetylcysteine protective
effects on hepatic damage when administered after acetaminophen exposure. Toxicology. 2Feb 3;244(1):25-34, 2008.
G.O. Rankin, S.K. Hong, D.K. Anestis DK, J.G. Ball and M.A. Valentovic. Mechanistic aspects of 4-amino-2,6-dichlorophenolinduced in vitro nephrotoxicity.Toxicology. 245: 123-129, 2008.
R. C. Harmon, S.P. Duffy, M.V. Terneus, J.G. Ball and M.A. Valentovic. Characterization of a Novel Model for Investigation of
Radiocontrast Nephrotoxicity. Nephrology, Dialysis and Transplantation Mar;24(3):763-8, 2009.
134
4)
Papers presented at state, regional, national, or international conferences.
M.V. Terneus, M. A. Valentovic and A.B. Carpenter . Comparison of S-adenosylmethionine (SAMe) and N-acetylcysteine
(NAC) protective effects when given after acetaminophen (APAP) treatment. Presented at the British Pharmacological Society
Meeting July 8-12, 2007 Glasgow, Scotland
M.A. Valentovic and Marcus V. Terneus. Modulation of oxidative stress by resveratrol and cisplatin in vitro toxicity. Toxicologist
87(S1): Abstract # 452, 2008.
J. Michael Brown and M. A. Valentovic. Effect of SAMe treatment given after Acetaminophen overdose (APAP) on hepatic
transmethylation substrates. Toxicologist 87 (S1): Abstract # 838, 2008.
J. Mike Brown, John G. Ball, Amy Hogsett, Tierra Williams and M.A. Valentovic. Temporal Study of Acetaminophen (APAP)
and S-Adenosyl-L-methionine (SAMe) Effects on Subcellular Hepatic SAMe Levels and Methionine Adenosyltransferase
(MAT) Expression. Toxicologist 101 (S1): Abstract #1128; Society of Toxicology Baltimore, MD March 15-19, 2009
M.A. Valentovic and John G. Ball. Potential Role Of Oxidative Stress In Resveratrol Protection Of Cisplatin In Vitro Renal
Toxicity. Toxicologist 101 (S1): Abstract # 488; Society of Toxicology Baltimore, MD March 15-19, 2009.
Tierra Williams, J. Mike Brown, John G. Ball, Amy Hogsett, Monica Valentovic. S-Adenosylmethionine (SAMe) Reversal of
Acetaminophen (APAP) Effects on Hepatic Glutathione Peroxidase and Hepatic SAMe Levels. Toxicologist 101 (S1):
Abstract #1127 Society of Toxicology Baltimore, MD March 15-19, 2009
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Membership
Society of Toxicology
American Society of Nephrology
American Society of Pharmacology and Experimental Toxicology
NIH STUDY SECTION
NIH ZRG1 DIG March 2007
NIH ZDK1 GRB-N M1 RFA DK-06-004 Biomarkers Development for Diabetes
Complications April 11-12, 2007
NIH ZRG1 DIG-E (10)B July 11, 2007
NIH ZRG1 DIG-E March 24, 2009
6)
Externally funded research grants and contracts you received.
Resveratrol protection of cisplatin nephrotoxicity. NIH COBRE pilot project
Role: PI Amount $20,000 October 1, 2007 – July 31, 2007
Safety of KB203. KeyBayPharma Co. Role: PI Amount: > $7,000
April 2007-December 2008
WV NASA Space Consortium $12,000 (stipend and supplies for J. Mike Brown)
7)
8)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Michigan Technological University – Presidential Council of Alumane
Community service as defined in the Greenbook.
-GRRAND, Golden Retriever Rescue
-Huntington Rose Society
-American Rose Society
135
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: _______Piyali Dasgupta____________ Rank: _____Asst_Professor_______
Status (Check one): Full-time_*__ Part-time_____ Adjunct _____
Current MU Faculty: Yes _*_
No ___
Highest Degree Earned: ______Ph.D.__________ Date Degree Received: _____January 2000_______
Conferred by: __National Institute of Immunology,_J.N. University, India____________
Area of Specialization: __________Cancer Biology __________________
Professional Registration/Licensure_______________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
Agency: _______________________________
___0____
___0____
___2yrs___
_____
___2yrs___
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
08-09/Fall
Alpha Des. & No.
BMS600
Title
Angiogenesis and Metastasis
65
Enrollment
08-09/Spring
PHS701
Pulmonary Physiology
120
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research: Attending the annual meeting of World Conference on Lung
Cancer 2009 and Experimental Biology Conference 2009
3)
Discipline-related books/papers published (provide a full citation).
A.
Chapters In Scholarly Books
1.
Pillai S, Dasgupta P., Chellappan SP (2009) Chromatin immunoprecipitation assays: analyzing transcription factor binding and
histone modifications in vivo. In: CHROMATIN PROTOCOLS Ed. SP Chellappan, Methods Mol. Biol., 523, 323-329. Humana Press
Inc., NJ, USA
Dasgupta, P. and Chellappan, S. (2007) Chromatin immunoprecipitation assays: Molecular Analysis of chromatin modification and
gene regulation, In: CANCER GENOMICs AND PROTEOMICS Ed. Paul Fischer, Methods Mol. Biol., 383, 135-152. Humana Press
Inc., NJ, USA.
2.
B.
Journal Articles
1.
Egleton, R. D., Brown, K.C. and Dasgupta, P. (2009) Angiogenic Activity of Nicotinic Acetylcholine Receptors: Implications in
Tobacco-related Vascular Diseases. Pharmacology & Therapeutics 121, 2, 205-223.
Dasgupta, P., Rizwani, W., Pillai, S., Kinkade,R., Rastogi,S., Banerjee, S., Kovacs, M., Carless, M., , E., Kim, Haura, E., Coppola, D.
and Chellappan, S. (2009) Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human
cancer cell lines. International J. Cancer 124, 1, 36-45.
Egelton, R.D., Brown, K.C., Dasgupta, P. (2008) Nicotinic Acetylcholine Receptors: Multiple Roles in Proliferation and Inhibition of
Apoptosis Trends Pharmacol Sci , 29, 151-158.
Kinkade, R., Dasgupta, P., Carie, A., Pernazza, D., Carless, M., Pillai, S., Lawrence, N., Sebti, S.M., Chellappan, S. (2008) A small
2.
3.
4.
136
5.
6.
7.
8
9
10
11
12
13
14
15
molecule disruptor of
Rb/Raf-1 interaction inhibits cell proliferation, angiogenesis, and growth of human tumor xenografts in nude
mice. Cancer Res., 68, 3810-3818.
Dasgupta, P., Rastogi, S., Joshi, B., Pillai, S., Ordonez, D., Morris, M., Haura, E. and Chellappan, S. (2006) Nicotine induces cell
-arrestin mediated activation of Src and Rb-Raf-1 pathway. J. Clin. Invest., 116, 2208-17.
Dasgupta, P., Kinkade, R., Joshi, B., DeCook, C., Haura, E. and Chellappan, S. (2006) Nicotine inhibits apoptosis induced by
chemotherapeutic drugs by upregulating XIAP and survivin. Proc. Natl. Acad. Sci., USA, 103, 6332-7.
Rastogi, S., Joshi, B., Dasgupta, P*., Morris, M., Wright, K. and Chellappan, S. (2006) Prohibitin facilitates cellular senescence by
recruiting specific co-repressors to inhibit E2F-target genes. Mol. Cell. Biol. 26, 4161-71.
* equal second author
Dasgupta, P., Padmanabhan, J. and Chellappan, S. (2006) Rb function in the apoptosis and senescence of non-neuronal and
neuronal cells: Role in Oncogenesis. Curr. Mol. Medicine 6, 719-29.
Kinkade,R., Dasgupta, P. and Chellappan, S. (2006) The ABCs of Targeting Raf: Novel approaches to Cancer Therapy. Current
Cancer Therapy Reviews 2, 305-14.
Dasgupta, P. and Chellappan, S. (2006). Nicotine-mediated cell proliferation and angiogenesis: New Twists to an Old Story. Cell
Cycle 5, 2324-28.
Joshi, B., Ordonez-Ercan, D., Dasgupta, P., Chellappan, S. (2005) Induction of human metallothionein 1G promoter by VEGF and
heavy metals: differential involvement of E2F and metal transcription factors. Oncogene 24, 2204-17.
Dasgupta, P. (2005) GH-inhibitory activity of novel somatostatin agonists: potential applications in acromegaly. Curr. Med. Chem.Immun. Endoc. & Metab. Agents, 5, 277-91.
Dasgupta P. (2004) Somatostatin analogs: Multiple roles in cellular proliferation, neoplasia and angiogenesis. Pharmacology and
Therapeutics 102, 61-85.
Dasgupta, P., Sun, J., Wang, S., Fusaro, G, Betts, V, Padmanabhan, J., Sebti, S.M. and Chellappan, S. (2004) Disruption of the RbRaf-1 interaction Inhibits Tumor growth and Angiogenesis. Mol. Cell. Biol. 24, 9527-41.
Dasgupta, P, Betts, V., Rastogi, S., Joshi, B, Morris, M., Ordonez, D. and Chellappan, S.P (2004). Direct binding of ASK1 to Rb:
Novel links between apoptotic signaling and cell cycle machinery. J. Biol. Chem 279, 38762-9.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Member, American Society of Pharmacology and Experimental Therapeutics (ASPET), American Association of Cancer Research
(AACR) and New York Academy of Sciences (NYAS)
6)
Externally funded research grants and contracts you received.
Young Clinical Scientist Award Program from Flight Attendant Medical Research Institute ( 2009-2012) Nicotine/Acetylcholine Signaling in Lung
Cancer. Budget: $100,000/year (Dasgupta PI)
American Retina Foundation (2009-2010) Nicotine/Acetylcholine Signaling in ARMD. Budget: $12,000/year (Dasgupta PI).
ASPET-Astellas award Program from American Society of Pharmacology and Experimental Therapeutics:
-nicotinic receptor inhibitors in small
cell lung cancer therapy. Budget: $30, 000 (Dasgupta PI).
Research Starter Grant from the Pharmaceutical Manufacturer’s Association of America. (2007-2009):
-Nicotinic Receptor Signaling in Nonsmall cell Lung Cancer”. Budget: $30,000 a year (Dasgupta PI).
7) Awards/honors (including invitations to speak in your area of expertise) or special recognition.

Awarded the ASPET-Astellas award for Translational Pharmacology the year 2009, from the American Society of Pharmacology
and Experimental Therapeutics.

Selected for The Marshall University Distinguished Artists and Scientists Award (MU-DASA) for the year 2009

Invited for a delivering a research seminar in West Virginia University.
137
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: _______Richard Egleton____________ Rank: ______Assistant Professor_______
Status (Check one): Full-time_*__ Part-time_____ Adjunct _____
Current MU Faculty: Yes _*_
No ___
Highest Degree Earned: ______Ph.D.__________ Date Degree Received: _____ 1994_______
Conferred by: _United Medical and Dental School of Guys and St. Thomas’, University of London
Area of Specialization: ___________Cerebrovascular Biology__________________
Professional Registration/Licensure_______________
Agency: _______________________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
___8____
___12____
___2.5___
___14___
___2___
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
07-09/Fall-spring
Alpha Des. & No.
PMC620/720
Medical Pharmacology
Title
65
Enrollment
07-09/Fall-Spring
BMS665
CODRC Colloquium
5
08-09
PMC 650
Toxicology
3
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain. – N/A
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research:
Attended the following conferences:
2009 Gill Heart Institute Cardiovascular Research Day, University of Kentucky, Lexington KY, October 2008.
Keystone Conference “Metabolism and Cardiovascular Disease” Beaver Run, CO, September 2008.
Gordon Research Conference “Barriers of the CNS”. Tilton, NH June 2008.
VIIth Cerebral Vascular Biology Conference, Ottawa, Canada, June 24th-June 28th, 2007.
3)
Discipline-related books/papers published (provide a full citation).
Published the following articles:
Campos, C.R., Ocheltree, S.M., Hom, S., Egleton, R.D. and Davis, T.P. Nociceptive inhibition prevents inflammatory
pain induced changes in the blood-brain barrier. Brain Res. 1221:6-13, 2008.
Egleton, R.D., K.C. Brown and P. Dasgupta. Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and
inhibition of apoptosis. Trends Pharmacol. Sci. 29(3):151-158, 2008.
Hawkins, B.T. and R.D. Egleton. Pathophysiology of the Blood-Brain Barrier: Animal Models and Methods. Current
Topics in Developmental Biology. 80: 277-309, 2008.
McCaffrey, G. W.D. Staatz, C.A. Quigley, N. Nametz, M.J. Seelbach, C.R. Campos, T.A. Brooks, R.D. Egleton and T.P.
Davis. Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in
vivo. J. Neurochemistry. 103(6): 2540-2555, 2007.
Seelbach, M.J., T.A. Brooks, R.D. Egleton and T.P. Davis. Peripheral inflammatory hyperalgesia modulates morphine
delivery to the brain: A role for P-glycoprotein. J. Neurochemistry 102 (5): 1677-1690, 2007.
Hom, S., M.A. Fleegal, R.D. Egleton, C.R. Campos, B.T. Hawkins and T.P. Davis. Comparative changes in the bloodbrain barrier and cerebral infarction of SHR and WKY rats. Am J Physiol., 292 (5): R1881-R1892, 2007.
138
Hawkins, B.T., T.F. Lundeen, K.M. Norwood, H.L. Brooks and R.D. Egleton. Increased blood-brain barrier permeability
and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycemia and matrix
metalloproteinases. Diabetalogia, 50(1):202-211, 2007.
Hawkins B.T., S.M. Ocheltree, K.M. Norwood and R.D. Egleton. Decreased blood-brain barrier permeability to
fluorescein in streptozotocin-treated rats. Neuroscience Letters, 411(1):1-5, 2007.
4)
Papers presented at state, regional, national, or international conferences.
Following presentations:
Marcelo A. and R.D., Egleton. Blood brain barrier dysfunction in a rat streptozotocin model of diabetes. 2009 Gill Heart
Institute Cardiovascular Research Day, University of Kentucky, Lexington KY, October 2008.
Egleton, R.D., Hom, S. and Marcello, A. Modulation of the brain vasculature by chronic hyperglycemia. Keystone
Conference “Metabolism and Cardiovascular Disease” Beaver Run, CO, September 2008.
Marcelo A and R.D. Egleton. Expression of angiogenic regulatory receptors at the blood brain barrier. Gordon Research
Conference “Barriers of the CNS”. Tilton, NH June 2008.
Polt, R., E.J. Bilsky, J.M. Bidlack. and R.D. Egleton. Penetration of the BBB with gylcopeptide derivatives of
neurotransmitters. VIIth Cerebral Vascular Biology Conference, Ottawa, Canada, June 24th-June 28th, 2007.
Egleton, R.D., K. Norwood, B.T. Hawkins and S. Hom. Diabetes and the Blood Brain Barrier. VII th Cerebral Vascular
Biology Conference, Ottawa, Canada, June 24th-June 28th, 2007.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Member of:
Society for Neuroscience
Controlled Release Society
International Brain Barriers Society
International Society for Cerebral Blood Flow and Metabolism
6)
Externally funded research grants and contracts you received.

Diabetes and Stroke: A Role for the Blood-CNS Barriers (RO1 DK65003)
PI on this grant, $800,000
RO1 funded by NIDDK, with a project period of April 2004 – January 2010.
My role on this grant is to investigate the modulation of blood-CNS barriers during diabetes, and how this can
influence stroke outcome.

Angiogenesis in the diabetic brain
PI on grant, $20,000
An internal grant from Marshall University Nov 2008-Nov 2009
My role in this grant is to investigate changes in markers of angiogenesis in Diabetic animals

A Mechanistic Study of Methamphetamine Neurotoxicity: Involvement of HO-1 & MnSOD (1F30DA025445)
Mentor of Ruth L. Kirchstein F31 MD/PhD Fellowship for Mindy Asbury, $70,618
August 2009-July 2011
7) Awards/honors (including invitations to speak in your area of expertise) or special recognition.


9)
Invited Speaker UT-Houston Medical School Dept. of Integrative Biology & Pharmacology, March, 2009. “Modulation
of Brain Microvasculature in Diabetes”
Invited Speaker Marshall CDDC Symposium, Marshall University, Huntington, WV, November 2008. “Modulation of
the Brain Microvasculature by Chronic Hyperglycemia”

Invited to Gordon Conference “Gordon Conference: Barriers of the CNS”, Tilton, NH, 2008, Fellowship
awarded
Community service as defined in the Greenbook. – N/A
139
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: Todd L. Green
Rank: Associate Professor
Status (Check one): Full-time X Part-time_____ Adjunct _____
Highest Degree Earned: Ph.D.
Current MU Faculty: Yes X
No ___
Date Degree Received: 1986
Conferred by: University of Virginia
Area of Specialization: Microbiology
Professional Registration/Licensure_______________
Agency: _______________________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
24
6
18
18
5
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2009/Fall
Alpha Des. & No.
PHS 666
Title
Physiology of the Cell (co-course director; 16.7%)
3
Enrollment
2009/Fall
BMS 600
Foundations of Biomedical Science (course director; 20%)
25
2009/Fall
FSC 624
Forensic Biochemistry (course director; 13%)
22
2009/Fall
IDM 725
Molecular Basis of Medicine (3%)
81
2009/Spring
PHS 701
Physiology (18%)
70
2009/Spring
PHS 629
Mammalian Physiology (18%)
20
2009/Spring
IDM 777
Neuroscience (3%)
70
2009/Spring
PHS 628
Mammalian Neurophysiology (7%)
20
2009/Spring
BMS 630
Neuroscience (3%)
6
2009/Spring
BMS 670
Molecular Cloning (course director; 57%)
3
2009/Spring
BSC 481
Special Topics – Molecular Cloning (course director; 57%)
3
2008/Fall
BMS 600
Foundations of Biomedical Science (course director; 20%)
23
2008/Fall
FSC 624
Forensic Biochemistry (course director; 13%)
15
2008/Fall
FSC 600
Forensic Cell Biology (course director; 22%)
17
2008/Fall
IDM 720
Medical Cell Biology (11%)
73
2008/Spring
PHS 701
Physiology (16%)
70
2008/Spring
PHS 629
Mammalian Physiology (16%)
20
2008/Spring
IDM 777
Neuroscience (3%)
70
2008/Spring
PHS 628
Mammalian Neurophysiology (7%)
20
2008/Spring
BMS 630
Neuroscience (3%)
6
2008/Spring
BMS 670
Molecular Cloning (course director; 43%)
6
2008/Spring
BSC 481
Special Topics – Molecular Cloning (course director; 43%)
4
1)
If your degree is not in your area of current assignment, please explain.
My degree is in Microbiology, but I teach in a Physiology course. The training I received in graduate school and
as a post-doctoral fellow allowed me to teach in a variety of fields.
2)
Activities that have enhanced your teaching and or research.
I have participated in the Academy of Medical Educators in 2005-06 and in faculty development workshops and
seminars put on by the Associate Dean for Professional Development in Medical Education at the Medical
School.
3)
Discipline-related books/papers published (provide a full citation).
4)
Papers presented at state, regional, national, or international conferences.
140
Carl A Gruetter, Steven C Davis, James R Hayes, Sheena L Clark, Todd L Green. (2009) Comparison of Histamine
Content in B16F10 Melanoma Cells and Nontumorigenic Melan-A Melanocytes. Experimental Biology 2009.
Carl A. Gruetter, Steven C. Davis, Sheena L. Clark, Kristen R. McKee, Todd L. Green. (2008) Comparative Expression of
Histidine Decarboxylase (HDC) Protein in B16F10 Melanoma Cells and Nontumorigenic Melan-A Melanocytes.
Experimental Biology 2008.
T.L. Green. (2006) An evaluation of grading policy in a first year basic science course. 10th Annual Meeting of the
International Association of Medical Science Educators.
Y. Dementieva, P. Wehner, T.L. Green, D.A. Primerano, J. Denvir, L. Wei, M.R. Flood, D. Calica, B. Freeman, M. Huff, S.
Dodson, C. Hill, A. Frances, C. Taylor, B. Connors, K. McIntyre, R. Kreisberg, M. Davis, H.M. Lee. (2006) Identification of
genes contributing to obesity associated cardiovascular disease (OCARD). 56th Annual Meeting of the American Society
for Human Genetics.
Y. Dementieva, P. Wehner, T.L. Green, D.A. Primerano, J. Denvir, L. Wei, M.R. Flood, D. Calica, B. Freeman, M. Huff, S.
Dodson, C. Hill, A. Frances, C. Taylor, B. Connors, K. McIntyre, R. Kreisberg, M. Davis, H.M. Lee. (2006) Identification of
genes contributing to obesity associated cardiovascular disease (OCARD). 1st Biennial National IDeA Symposium of
Biomedical Research Excellence.
Green, T.L., G. Mahmoud, J. Cooke, and L. Grover. (2005) Effect of REM sleep deprivation on IGF-1 levels in rats. 19th
Annual Associated Professional Sleep Societies Meeting.
Mangiarua E.I., R.G. Morrison, T. Green, E. Blough, P.S. Wehner, W.D. McCumbee. (2005)
Role of 12-lipoxygenase in obesity-associated hypertension. Sixteenth Scientific Meeting of the Interamerican Society of
Hypertension.
Chappell, J.M., A. Watson, M. Flood, A. Clark, S. Hesson, B. Hill, J. Jeong, N. Liette, M. Ramey, B. Kahle, G. Wright, T.
Green, M. Studeny, P. Wehner, and E.E. Murray. (2005) Genetics and cardiovascular disease risk factors in obese West
Virginians. 99th Annual Scientific Assembly of the Southern Medical Association.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
American Association for the Advancement of Science
American Society for Cell Biology
American Society for Matrix Biology
American Society for Microbiology
International Association of Medical Science Educators
Sigma Xi
Society for Neuroscience
The Fifth Graylyn Conference on Technology Innovation in Medical Education, 2007
Team-Based Learning Conference, 2007
International Association of Medical Science Educators, 2005-06
Association of American Medical Colleges, 2005
6)
Externally funded research grants and contracts you received.
Ohio Valley Affiliate, American Heart Association, Undergraduate Student Summer Research Fellowship for Amy
Wolfe, 2005, $3000 direct costs
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Best Professor, Spring 2009 – JCESOM Class of 2012
Graduate Faculty Achievement Award, 2007 – Marshall University BMS Graduate Student Organization
141
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: __Lawrence M. Grover________________________ Rank: ___Professor_______________
Status (Check one): Full-time_X___ Part-time_____ Adjunct _____ Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: __Ph.D.___________________ Date Degree Received: __May 1986_______
Conferred by: ___Princeton University_________________________________________________
Area of Specialization: ___Psychology and Neuroscience___________________________________
Professional Registration/Licensure__N/A__________
Agency: _______________________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
__9____
__5_____
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
Alpha Des. & No.
Title
Enrollment
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
Attended Annual Meeting of the Society for Neuroscience, 2004, 2005, 2006, 2007, 2008, 2009.
3)
Discipline-related books/papers published (provide a full citation).
1. Ambros-Ingerson, J., Grover, L.M. & Holmes, W.R. A classification method to distinguish cell-specific responses elicited by
current pulses in hippocampal CA1 pyramidal cells . Neural Computation 20, 1512-1536, 2008.
2. Grover, L.M., Kim, E., Cooke, J.D. & Holmes, W.R. LTP in hippocampal area CA1 is induced by burst stimulation over a broad
frequency range centered around delta. Learning and Memory 20, 69-81, 2009.
3. Cooke, J.D., Grover, L.M., & Spangler, P.R. Venlafaxine treatment stimulates expression of BDNF protein in frontal cortex and
inhibits LTP in hippocampus. Neuroscience 162, 1411-1419, 2009
4)
Papers presented at state, regional, national, or international conferences.
1. Green, T.L., Mahmoud, G., Cooke, J. and Grover, L. Effect of REM Sleep Deprivation on IGF-I Levels in Rats. 2005 Annual
Meeting of the Associated Professional Sleep Societies, June 18-23, Denver, CO.
2. Holmes, W.R. and Grover L.M. Fitting experimental data to models that use morphological data from public databases.
Fourteenth Annual Computational Neuroscience Meeting CNS*2006, July 17-21, Madison, WI.
3. Holmes, W.R. and Grover L.M. The mechanism of LTP affects dendritic computation. Fifteenth Annual Computational
Neuroscience Meeting CNS*2006, July 15-18, Edinburg, UK.
4. Kim, E. and Grover, L.M. Spatial memory formation despite prior Rapid Eye Movement (REM) sleep deprivation. 2006 Annual
142
Meeting of the Society for Neuroscience, October 14-18, Atlanta, GA.
5. Holmes, W.R and Grover, L.M., 2006. Quantifying the magnitude of changes in synaptic level parameters with LTP. 2006 Annual
Meeting of the Society for Neuroscience, October 14-18, Atlanta, GA.
6. Ambros-Ingerson, J., Grover, L.M., and Holmes, W.R. Sensitivity parameter analysis by evolutionary search method in a
hippocampal CA1 pyramidal cell model. 2006 Annual Meeting of the Society for Neuroscience, October 14-18, Atlanta,
GA.
7. Ambros-Ingerson, J., Grover, L.M. and Holmes, W.R. Comparison of match functions applied to records with trains of action
potentials. Sixteenth Annual Computational Neuroscience Meeting CNS*2007, July 7-12, Toronto, Ontario, Canada.
8. Grover, L.M., Kim, E., W.R. and Holmes, W.R. Efficient LTP induction in hippocampal area CA1 over a wide range of burst
intervals, with a peak near delta frequency. 2007 Annual Meeting of the Society for Neuroscience, November 3-7, San
Diego, CA.
9. Ambros-Ingerson, J., Grover, L.M. and Holmes, W.R. The upstroke of the action potential has two events that suggest initiation
occurs at the nodes of Ranvier in hippocampal CA1 pyramidal cells . 2008 Annual Meeting of the Society for
Neuroscience, November 14-19, Washington, DC.
10. Cooke, J.D., Grover, L.M. and Spangler, P.R. Venlafaxine stimulates BDNF in rat frontal cortex and inhibits LTP in
hippocampus. 2008 Annual Meeting of the Society for Neuroscience, November 14-19, Washington, DC.
11. Grover, L.M. and Holmes, W.R. Mechanisms contributing to the progressive suppression of GABA inhibition during burst
stimulation patterns that induce LTP. 2008 Annual Meeting of the Society for Neuroscience, November 14-19,
Washington, DC.
12. Kim, E., Grover, L.M. and Holmes, W.R. Decreased afferent excitability during 100 Hz high frequency stimulation in area CA1 of
rat hippocampus: Consequences for long-term potentiation. 2008 Annual Meeting of the Society for Neuroscience,
November 14-19, Washington, DC.
13. Cooke, J.D., Grover, L.M. and Holmes, W.R. A role for GABAB autoreceptors in LTP induced by primed burst stimulation, but
not repeated burst stimulation. 2009 Annual Meeting of the Society for Neuroscience, October 17-21, Chicago, IL.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Member Society for Neuroscience, 2004 - 2009; Member American Physiological Society, 2004 - 2009; Attended Annual Meeting of
the Society for Neuroscience, 2004-2009
6)
Externally funded research grants and contracts you received.
1. National Aeronautics and Space Administration, Impact of REM Sleep Loss on Memory Functions, NCC5-570, 2001-2007,
$1,034,647 total direct costs (principal investigator).
2. National Institutes of Heath, Models of Signaling Mechanisms in LTP, R01 AA14294, 2002-2008, $866,442 total direct costs (coinvestigator).
3. Wyeth Parmaceuticals, Effects of venlafaxine administration on central and peripheral brain-derived neurotrophic factor in rats,
0600B-102368, 2007-2008, $17,518 total direct costs (principal investigator).
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Invited seminar, "Acute effects of growth hormone on excitatory synaptic transmission in the hippocampus", Texas A&M University,
College Station, TX, 2005.
8)
Community service as defined in the Greenbook.
I could not find a definition of "Community Service" in the August 2009 Greenbook, so here is a list of service activities that meet my
definition of community service:
1. Volunteer photographer, Marshall University WV-INBRE summer undergraduate research program, 2006-2009.
2. Faculty mentor, WV-INBRE undergraduate summer student program, 2005- 2009.
3. Participant in "Brain Expo 2009", Marshall University's contribution to Brain Awareness Week (an annual brain awareness and
education campaign sponsored by the Society for Neuroscience and the Dana Alliance for Brain Initiatives): designed an manned a
station on memory and the brain.
143
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: _________Carl A. Gruetter____________________ Rank: ____Professor_________________
Status (Check one): Full-time_X__ Part-time_____Adjunct _____ Current MU Faculty: Yes _X_ No ___
Highest Degree Earned: __PhD_____________________ Date Degree Received: ____1978_________
Conferred by: ___Tulane University_______________________________________________________
Area of Specialization: _____Pharmacology_________________________________________________
Professional Registration/Licensure_____N/A_______
Agency: _______N/A_____________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
__2_____
__1____
_28_____
_29_____
__5_____
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2009/Spring
Alpha Des. & No.
Title
Enrollment
CODRC Colloquium (20%)
5
2009/Spring
IDM 777
Neuroscience (2%)
65
2009/Spring
PHS 628
Mammalian Neurophysiology (3%)
19
2009/Spring
BMS 630
Neuroscience (2%)
2
2009/Spring
BMS 680
Seminar (3%)
30
2009/Spring
PHS 729
Mammalian Physiology (5%)
65
2009/Spring
PHS 629
Mammalian Physiology (5%)
19
2008/Fall
BMS 665
CODRC Colloquium (20%)
5
2008/Fall
PMC 610
Introduction to Pharmacology (30%)
19
2008/Fall
PMC 720
Medical Pharmacology (20%)
96
2008/Fall
PMC 621
Medical Pharmacology I (30%)
8
2008/Fall
BMS 680
Seminar (3%)
30
2008/Spring
PMC 720
Medical Pharmacology (25%)
60
2008/Spring
PMC 620
Medical Pharmacology (25%)
5
2008/Spring
IDM 777
Neuroscience (2%)
60
2008/Spring
PHS 628
Mammalian Neurophysiology (3%)
25
2008/Spring
BMS 630
Neuroscience (2%)
2
2008/Spring
BMS 680
Seminar (3%)
30
2008/Spring
PHS 641
Recent Advances in Physiology (20%)
5
2007Fall
BMS 680
Seminar (3%)
30
2007Fall
PMC 610
Introduction to Pharmacology (30%)
27
2007Fall
BMS 600
Biochem, Cell, Mol ec Basis of Biomed Sci (1%)
27
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
144
1)
If your degree is not in your area of current assignment, please explain. N/A
2)
Activities that have enhanced your teaching and or research.
3)
Discipline-related books/papers published (provide a full citation).
Tippens AS, Gruetter CA. Detection of histidine decarboxylase mRNA in human vascular smooth muscle and endothelial
cells. Inflamm Res 53:215-216, 2004. Epub May 12, 2004.
Tippens AS, Davis SV, Hayes JR, Bryda EC, Green TL, Gruetter CA. Detection of histidine decarboxylase in rat aorta
and cultured rat aortic smooth muscle cells. Inflamm Res. 53:390-395, 2004 . Epub 2004 Aug 10, 2004.
Davis SC, Clark SL, McKee KR, Green TL, Gruetter CA,. Comparative expression of histidine decarboxylase (HDC)
protein and histamine in B16F10 melanoma cells and nontumorigenic Melan-A melanocytes. Inflamm Res
(Submitted).
4)
Papers presented at state, regional, national, or international conferences.
Tippens AS, Gruetter CA. Detection of histidine decarboxylase mRNA in cultured human aortic smooth muscle and
endothelial cells. FASEB J 18:A594, 2004.
Davis SV, Hayes JR, Green TL, Gruetter CA. Detection of histidine decarboxylase protein (Hdc) in rat aorta and cultured
rat aortic smooth muscle cells. FASEB J 18:A594, 2004.
Davis SV, Martin E, Murad F, Gruetter CA. Inhibition of NO-activated soluble guanylyl cyclase by endogenous
imidizaoles. 2005 Experimental Biology meeting abstracts [on CD-ROM]. FASEB J 18, Abstract #878.9, 2005.
Gruetter CA, Davis SC, Clark SL, McKee KR, Green TL. Comparative expression of histidine decarboxylase (HDC)
protein in B16F10 melanoma cells and nontumorigenic Melan-A melanocytes. FASEB J 22:898.15, 2008.
Gruetter CA, Davis SC, Hayes JR, Clark SL, Green TL. Comparison of Histamine Content in B16F10 Melanoma Cells
and Nontumorigenic Melan-A Melanocytes. Presented: Experimental Biology Meeting, New Orleans, LA, April 2009.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Member: American Society for Pharmacology and Experimental Therapeutics
Meetings Attended :
Experimental Biology 2004, San Diego CA, April, 2004
Experimental Biology 2008, San Diego, CA April, 20008.
Experimental Biology 2009, New Orleans, LA, April 4, 2009
6)
Externally funded research grants and contracts you received.
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Marshall University School of Medicine Teacher of the Year, Spring 2005.
8)
Community service as defined in the Greenbook.
145
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: _____________Jung Han Kim_______________________ Rank: ___Associate Professor________________
Status (Check one): Full-time__X_ Part-time_____ Adjunct _____
Current MU Faculty: __ Yes _X__
No ___
Highest Degree Earned: ____________PhD_____________________ Date Degree Received: _Aug, 1996________
Conferred by: _________________The University of Tennessee-Knoxville___________________________________
Area of Specialization: _Pharmacology, Physiology & Toxicology Nutrition____________________________________
Professional Registration/Licensure_______NA______________
Agency: ____NA___________________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
1996-2001
2001-2009 (UT)
2009-present____
2001-present
0.4 yrs___
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
Alpha Des. & No.
Title
Enrollment
2007/Spring (UT)
Nutrition 313
Vitamins and Minerals (3) (Undergraduate)
40
Nutrition 512
Advances in Vitamin and Mineral Metabolism (3) (Graduate)
16
2008/Spring (UT)
Nutrition 313
Vitamins and Minerals (3) (Undergraduate)
43
Nutrition 512
Advances in Vitamin and Mineral Metabolism (3) (Graduate)
16
2008/Fall (UT)
Life Science 520 (3.6%) Genome Science and Technology 1 (4) (Graduate)
12
2009/Spring (UT)
Nutrition 313
Nutrition 512
Nutrition 621 (20%)
Vitamins and Minerals (3) (Undergraduate)
Advances in Vitamin and Mineral Metabolism (3) (Graduate)
Physiological Basis for Diet and Disease (3) (Graduate)
46
28
13
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
3)
Discipline-related books/papers published (provide a full citation).
J. H. Kim: Quantitative Trait Loci for Obesity and Type 2 Diabetes in Rodents. In Genomics and Proteomics in Nutrition,
pp 15-48, Marcel Dekker 2004.
J. H. Kim, T. P. Stewart, W. Zhang, H. Y. Kim, P. M. Nishina, J. K. Naggert: The Type 2 diabetes mouse model TallyHo
carries an obesity gene on chromosome 6 that exaggerates dietary obesity. Physiol Genomics 2005, 22(2):171-181.
S. Kim, M. Soltani-Bejnood, A. Quignard-Boulange, F. Massiera, M. Teboul, G. Ailhaud, J. H. Kim, N. Moustaid-Moussa,
and B. H. Voy: The adipose rennin-angiotensin system modulates systemic markers of insulin sensitivity and activates the
intrarenal rennin-angiotensin system. J Biomed Biotechnol 2006, (5):Article ID 27012: 1-6.
J. H. Kim, T. P. Stewart, M. Soltani-Bejnood, L. Wang, J. M. Fortuna, O. A. Mostafa, N. Moustaid-Moussa, A. M. Shoieb,
M. F. McEntee, Y. Wang, L. Bechtel, and J. K. Naggert: Phenotypic Characterization of Polygenic Type 2 Diabetes in
TALLYHO/JngJ Mice. J Endocrinol 2006, 191(2): 437-446.
H. Y. Kim, T. P. Stewart, B. N. Wyatt, N. Siriwardhana, A. M. Saxton, and J. H. Kim: Gene expression profiles of a mouse
congenic strain carrying an obesity susceptibility QTL under obesigenic diets. Genes and Nutrition 2009 (Submitted)
4)
Papers presented at state, regional, national, or international conferences.
H. Y. Kim, T. P. Stewart, K. R. Vyas, A. M. Saxton, P. M. Nishina, J. K. Naggert, J. H. Kim: Functional genomic study of
dietary obesity in congenic mice. FASEB J 2005, 19(4): A1498.
J. M. Fortuna, O. A. Mostafa, T. P. Stewart, and J. H. Kim: Lipid-lowering effect on glucose metabolism in the type 2
diabetes mouse model of TALLYHO/Jng. FASEB J 2006, 20(4): A580.
H. Y. Kim, T. P. Stewart, A. Ritchie, J. H. Kim: Genetic characterization of hypertriglyceridemia in diabetic TALLYHO/Jng
mice. FASEB J 2006, 20(5): A1317
H. Y. Kim, T. P. Stewart, A. Saxton, J. H. Kim: Integrative genetics and genomics study of the hypertriglyceridemia in a
new polygenic mouse model for type 2 diabetes. Keystone Symposia; Nuclear Receptor Pathways to Metabolic
Regulation, Steamboat Springs, Colorado, 2007.
J. H. Kim, H. Y. Kim, T. Stewart, A. Saxton: Integrative genetics and genomics study of the hypertriglyceridemia in a
polygenic type 2 diabetes mouse model. FASEB J 2008, 22: 294.1
146
J. H. Kim, T. Stewart, L. Hall, N. Siriwardhana, B. Wyatt: Proteomic analysis of pancreas, liver, and adipose tissue in a
polygenic mouse model of type 2 diabetes. Keystone Symposia; Type 2 diabetes and Insulin resistance, Fairmont Banff
Springs, Banff, Alberta, 2009
B. Wyatt, L. Hall, J. H. Kim: Proteomic analysis of pancreas in a polygenic mouse model of type 2 diabetes. Experimental
Biology, 2009, B134 1 724.11.
N. Siriwardhana, T. Stewart, L. Hall, J. H. Kim: Proteomic analysis of adipose tissue in a mouse congenic strain carrying
an obesity QTL. Experimental Biology, 2009, B135 11 724.12.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
2006
Predoctoral Fellowships Review Committee for American Society for Nutrition (Member)
2006-2008
Steering Committee for the Energy and Macronutrient Metabolism Research Interest Section of the American
Society for Nutrition (Member)
2005
Experimental Biology, San Diego, CA
“Functional genomic study of dietary obesity in congenic mice.”
2005
American Heart Association Research Symposium, Dallas, TX
“The type 2 diabetes mouse model TallyHo carries an obesity gene on chromosome 6 that exaggerates dietary
obesity.”
2006
Experimental Biology, San Francisco, CA
“Lipid-lowering effect on glucose metabolism in the type 2 diabetes mouse model of TALLYHO/Jng.”
“Genetic characterization of hypertriglyceridemia in diabetic TALLYHO/Jng mice.”
2007
Keystone Symposia; Nuclear Receptor Pathways to Metabolic Regulation, Steamboat Springs, CO
“Integrative genetics and genomics study of the hypertriglyceridemia in a new polygenic mouse model for type 2
diabetes.”
2008
Experimental Biology, San Diego, CA
“Integrative genetics and genomics study of the hypertriglyceridemia in a polygenic type 2 diabetes mouse
model.”
2009
Keystone Symposia; Type 2 diabetes and Insulin resistance, Fairmont Banff Springs, Banff, Alberta
“Proteomic analysis of pancreas, liver, and adipose tissue in a polygenic mouse model of type 2 diabetes.”
6)
Externally funded research grants and contracts you received.
2008-2013
1R01DK077202-01A2
National Institutes of Health/ National Institute of Diabetes and Digestive and Kidney Diseases
“Genetics of diet-induced obesity in a new mouse model.”
Principal Investigator, Total Award: $1,000,000 (Direct) 0855300E
Grant-in-Aid, American Heart Association, the Greater Southeast Affiliate
“Diet-Wnt signaling interactions in a novel congenic mouse model of obesity.”
Principal Investigator, Total Award: $165,000, 2004-2007
7-04-RA-52
Research Award, American Diabetes Association
“Metabolic and Genomic Characterization of Early-Onset Hypertriglyceridemia in a New Mouse Model of NIDDM,
TallyHo.” Principal Investigator, Total Award: $300,000
7)
8)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
2004
The local board meeting of the American Heart Association (AHA) in Knoxville
Invited participant as a University of Tennessee researcher funded by AHA
2005
The Knoxville Chapter of the American Diabetes Association.
Invited speaker, “Genetic Studies of Type 2 Diabetes and Blood Triglyceride Levels in TallyHo Mice.”
2005
The local board meeting of the American Heart Association in Knoxville
Invited participant as a UT researcher funded by American Heart Association
147
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: ___Elsa I. Mangiarua___________________________ Rank: __Professor________________
Status (Check one): Full-time__X_ Part-time___ Adjunct __ Current MU Faculty: Yes _x__
No ___
Highest Degree Earned: __Ph.D.__________________ _ Date Degree Received: ___1983_________
Conferred by: __Universidad de Buenos Aires_______________________________________________
Area of Specialization: __Biochemistry_____________________________________________________
Professional Registration/Licensure_______________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
Agency: _______________________________
____16____
____12____
____22____
____26____
_____5___
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2007/Fall
Alpha Des. & No.
BMS600
Title
Cellular and Molecular Biology (4%)
45
Enrollment
2008/Fall
BMS600
Cellular and Molecular Biology (4%)
47
2008/Spring
PHS701/629
Mammalian Physiology (20%)
95
2009/Spring
PHS701/629
Mammalian Physiology (20%)
95
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
Activities that have enhanced your teaching and or research.
3)
Discipline-related books/papers published (provide a full citation).
 Morrison RG, Carpenter AB, Adams VL, Mangiarua EI, Wehner PS, McCumbee WD. Progression of renal damage in the obese
Zucker rat in response to deoxycorticosterone acetate-salt-induced hypertension. Annals of Clinical and Laboratory Science 35:5465,2005.
 Walker EM Jr, Nillas MS, Mangiarua EI, Cansino S, Morrison RG, Perdue R, Triest WE, Wright GL, Studeny M, Wenher P, Rice
KM, Blough ER. Age-associated changes in hearts of male Fisher 344/Brown Norway F1 rats. Annals of Clinical and Laboratory
Science 36:427-437,2006.
 Morrison RG, Mills CN, Moran AL, Walton CE, Sadek MH, Mangiarua EI, Wehner PS, McCumbee WD. A moderately high fat diet
promotes salt-sensitive hypertension in obese Zucker rats by impairing NO production. Clinical and Experimental Hypertension
29:369-381,2007.
 Walker EM Jr, Epling CP, Parris C, Cansino S, Morrison RG, Wright GL, Mangiarua EI, Wehner P, Blough ER. Acetaminophen
protects against iron-induced cardiac damage in gerbils. Annals of Clinical and Laboratory Science 37:22-33, 2007.
4) Papers presented at state, regional, national, or international conferences.
 Mangiarua EI, Morrison RG, Green T, Blough E, Wehner PS, McCumbee WD. Role of 12-lipoxygenase in obesity-associated
hypertension. Sixteenth Scientific Meeting of the Interamerican Society of Hypertension, Cancun, Mexico, April 16 – 21, 2005.
 Morrison RG, Moran AL, Walton CE, Mohamed H. Sadek MH, Paulette S. Wehner PS , Mangiarua EI, McCumbee WD. Nitric
oxide and diet-induced hypertension in the obese Zucker rat. Experimental Biology 2005, San Diego, CA, April 2 – 6, 2005.
 Walker EM Jr, Mangiarua EI, Nillas MS, Arif I, Walker SM, Studeny AA. Cardiovascular effects of selected heavy metals. Ann
Clin Lab Sci 35:220, 2005.
 Nillas MS, Walker EM Jr, Cansino S, Wright GL, Blough ER, Perdue R, Triest WE, Mangiarua EI, Wehner P. Echocardiographic
and electrocardiographic comparison of age-associated changes in rat hearts. Ann Clin Lab Sci 35:223, 2005.
 Walker EM Jr, McGinty JE, Blough ER, Morrison RG, Rice KM, Cansino S, Mangiarua EI, Wright GL, Wehner P. Synergistic
effects of acetaminophen and deferoxamine against iron-induce cardiac damage in gerbils. Association of Clinical Scientists Annual
Meeting, Amelia Island, Jacksonville, FL, May 17-21, 2006.
148
 Kan Huang, Yue Huang, Jessica Frankel, Paulette Wehner, Elsa Mangiarua, William McCumbee. The short-term consumption of
a high fat diet affects endothelial nitric oxide synthase in lean Zucker rats. 2008 Annual Scientific Meeting of The Obesity Society,
Phoenix, Arizona, Oct. 3-7, 2008.
Snodgrass K, Dykes A, Thatcher S, Morrison R, Dalton B, Berti-Mattera L, Mangiarua E. Angiogenic response of peripheral nerve
endothelial cells in diabetic neuropathy. WV-INBRE Summer Research Symposium, Huntington, WV, August 2005.
 Barbour K, Morrison R, Mangiarua E, McCumbee W. The loss of nitric oxide production correlates with the inability of obese
Zucker rats on a high fat diet to resist salt-sensitive hypertension. WV-INBRE Summer Research Symposium, Huntington, WV,
August 2005.
 Surbaugh M, Kim E, Dalton B, Morrison R, Grover L, McCumbee W, Mangiarua E. Activity levels in lean an obese Zucker rats.
WV-INBRE Summer Research Symposium, Morgantown, WV, August 2006.
 Thomas S, Frankel J, Morrison R, Huang K, McCumbee W, Mangiarua E. The effect of a high fat diet on water consumption in
lean Zucker rats. WV-INBRE Summer Research Symposium, Morgantown, WV, August 2006.
 Bennett C, Huang K, Frankel J, Viradia R, McCumbee W, Mangiarua E. Role of inflammation in fatty acid-induced vascular
changes. WV-INBRE Summer Research Symposium, Huntington, WV, August 2007.
 Frankel J, Huang K, Bennett C, Viradia R, Mangiarua E, McCumbee W. The acute effects of a high fat diet on nitric oxide
production in lean Zucker rats. WV-INBRE Summer Research Symposium, Huntington, WV, August 2007.
 Huang K, Frankel J, Wehner PS, Mangiarua E, McCumbee W. A short-term consumption of high fat diet affects endothelial nitric
oxide synthase in lean Zucker rats. Marshall University Joan C. Edwards School of Medicine, Research Day, Huntington, WV, 2008.
 Jaswani L, Huang K, Mangiarua E, McCumbee W. Short-term effects of high fat diet on nitric oxide production in Sprague Dawley
rats. WV-INBRE Summer Research Symposium, Morgantown, WV, July 2008.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
6)
Externally funded research grants and contracts you received.
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
INVITED SPEAKER:
 Marshall University, Joan C. Edwards School of Medicine, Cardiology Seminars, “Natriuretic Peptides”, October 2005.
 Alderson-Broaddus College, “Angiogenic response of peripheral nerve endothelial cells in diabetic neuropathy”, March 2006.
 Davis and Elkins College, “Angiogenic response of peripheral nerve endothelial cells in diabetic neuropathy”, March 2006.
8)
Community service as defined in the Greenbook.
149
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: __William D. McCumbee _________________ Rank: _Professor
____________
Status (Check one): Full-time_X___ Part-time_____ Adjunct _____ Current MU Faculty: Yes X__
No ___
Highest Degree Earned: Ph.D.______________________ Date Degree Received:_1977____________
Conferred by: ________University of Houston_________________________________________
Area of Specialization: _________Physiology______________________________________________
Professional Registration/Licensure_______________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
Agency: _______________________________
_33_____
_ 5_____
_28_____
_33_____
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2007/Spring
2008/Spring
2007/Fall
2008/Fall
2007/Fall
Alpha Des. & No.
PHS 629/701
Title
Mammalian Physiology (25%)
IDM 720
Medical Cell and Molecular Biology (7%)
BMS 600
Cell and Molecular Biology (4%)
2007/Spring & Fall
2008 Fall
PHS 641
Recent Advances in Physiology (10%)
Enrollment
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
Activities that have enhanced your teaching and or research.

Attended lectures in other medical schools

Attended Obesity Society meeting in 2008
Discipline-related books/papers published (provide a full citation).

Morrison, R.G., A.B. Carpenter, V.L. Adams, E.I. Mangiarua, P.S. Wehner, and W.D. McCumbee. Progression
of Renal Damage in the Obese Zucker Rat in Response to Deoxycorticosterone Acetate-Salt-Induced
Hypertension. Ann. Clin. Lab. Sci. 35: 54-65, 2005.

Morrison, R.G., C. Mills, A.L. Moran, C.E. Walton, M.H. Sadek, E.I. Mangiarua, P.S. Wehner, and W.D.
McCumbee. A moderately high fat diet promotes salt-sensitive hypertension in obese Zucker rats by impairing
nitric oxide production. Clin Exp Hypertens. 29: 369-381, 2007.
Papers presented at state, regional, national, or international conferences.

5)
Huang, K, Huang Y, Frankel J, Whener P, Mangiarua E, McCumbee W. The short-term consumption of a high
fat diet affects endothelial nitric oxide synthase in lean Zucker rats. Presented at the Annual Meeting of the
Obesity Society, October 3-7, 2008. Phoenix, AZ.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.\


Obesity Society
Endocrine Society
6)
Externally funded research grants and contracts you received.
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
150


8)
BMS Advisor Award 2006
Spring 2004 Teacher of the Year, presented by the class of 2007
Community service as defined in the Greenbook.
151
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: Gary O. Rankin
Rank: Professor and Chair
Status (Check one): Full-time___X__ Part-time_____ Adjunct _____
Highest Degree Earned: Ph.D.
Current MU Faculty: Yes __X_
No ___
Date Degree Received: 1976
Conferred by: University of Mississippi
Area of Specialization: Pharmacology/Toxicology
Professional Registration/Licensure:
NA
Agency: _______________________________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
___0____
____0____
____31____
____31____
___26 to 31_____
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2007/Fall
2007/Fall
2007/Fall
2008/Spring
Alpha Des. & No.
FSC680
PMC655
PMC610
PMC620
Title
Toxicology/Drug Analysis (15%)
Toxicology Reviews (20%)
Introduction to Pharmacology (20%)
Medical Pharmacology (15%)
12
3
28
1
Enrollment
2008/Fall
2008/Fall
2008/Fall
2008/Summer
PMC621
PMC 620
FSC680
PMC655
Medical Pharmacology (15%)
Introduction to Pharmacology (20%)
Toxicology/Drug Analysis (15%)
Toxicology Reviews (20%)
9
20
12
3
2008/Fall
2009/Spring
PMC650
PMC622
General Toxicology (30%)
Medical Pharmacology (15%)
3
8
I also give a two hour lecture each year as part of the University of Kentucky Advanced Toxicology (TOX 680) course.
1)
If your degree is not in your area of current assignment, please explain.
My PhD degree is in Medicinal Chemistry (drug design), a field directly related to pharmacology/toxicology. However, my two years
of postdoctoral training were in pharmacology/toxicology, which has been my area of teaching/research for the last 25 years.
2)
Activities that have enhanced your teaching and or research.
Yearly attendance at professional organizations such as the Association of Medical School Pharmacology Chairs, Association of
Chairs of Physiology, Society of Toxicology, Experimental Biology; participation in NIH-sponsored meetings (e.g. INBRE PI’s
meetings); review of research grants (e.g. 3-5 study sections/year for NIH), review of research manuscripts (15-30/yr), visits to other
research programs to present research findings and interact with other scientists.
3)
Discipline-related books/papers published (provide a full citation).
1. D. Cui, G.O. Rankin and P.J. Harvison. 2005. Metabolism of the nephrotoxicant N-(3,5-dichlorophenyl) succinimide in rats:
Evidence for bioactivation through alcohol-0-glucuronidation and 0-sulfation. Chem. Res. Toxicol. 18,991 – 1003.
2.. Cui, G.O. Rankin, and P.J. Harvison. 2005. Transamination in the metabolism of the nephrotoxicant N-(3,5dichlorophenyl)succinimide in rat. Drug Metab. Dispos. 33, 1765-1772.
3. R.M. Niles, C.P.Cook, G.G. Meadows, Y-M Fu, J.L. McLaughlin and G.O. Rankin. 2006. Resveratrol is rapidly metabolized in a
thymic (Nu/Nu) mice and does not inhibit human melanoma xenograft tumor growth. J.Nutrition. 136, 2542-2546.
4. G.O.Rankin, D.K. Anestis, M.A. Valentovic, H.Sun, and W.E.Triest. 2007. Nephrotoxicity induced by the R- and S- enantiomers of
N-(3.5-dichlorophenyl)-2 hydroxysuccinimide (NDHS) and their sulfate conjugutes in male Fisher 344 rats. Toxicology. 240, 38-47.
5.G.O. Rankin, C. Racine, A. Sweeney, A. Kraynie, D.K.Anestis, and J.B. Barnett. 2008. In vitro nephrotoxicity induced by propanil.
Environment. Toxicol. 23, 435-442. Epub: Jan.23, 2008.
6.G.O. Rankin, S.K. Hong, D.K. Anestis, J.G. Ball and M. A. Valentovic. 2008. Mechanistic aspects of 4-amino-2, 6-dichlorophenolinduced in vitro nephrotoxicity. Toxicol. 245, 123-129. Epub: December 27, 2007.
152
7. G.O. Rankin, S.K. Hong and D.K. Anestis. 2008. Nephrotoxicity induced by N-(3,5-dichlorophenyl) -3-hydroxy succinamic acid (3NDHSA) in male and female Fischer 344 rats. J.Appl.Toxicol. 28(7), 867-873 Epub: April 16, 2008.
8. H. Luo, G.O.Rankin, L. Liu, M.K. Daddysman, B.-H. Jiang and Y.C. Chen. 2009. Kaempferol inhibits angiogenesis and VEGF
expression through both HIF dependent and independent pathways in human ovarian cancer cells. Nutr. Cancer 61(4),554-563.
9. G.O. Rankin. 2004. Nephrotoxicity induced by C- and N-arylsuccinimides. J. Toxicol. Environ. Health, Part B 7, 399-416. E.E.
10. Robertson and G. O. Rankin. 2006. Human renal organic anion transporters: Characteristics and contributions to drug and drug
metabolite excretion. Pharmacol. & Therapeut. 109(3), 399-412.
11. G.O. Rankin and M.A. Valentovic. 2007. Chemical Spray Safety.National Institutes of Occupational Safety and Health (NIOSH)
Malaysia.#10, 3-4.
In addition to these journal publications, 14 drug reviews were prepared for X-Pharm, an electronic data base, and 4 book chapters
were published.
4)
Papers presented at state, regional, national, or international conferences.
A total of 21 papers were presented at State, national and international conferences.
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Regular Ad hoc NIH PBKD Study Section in 2004 - 2006; ad hoc reviewer for four different NIH reviews (NIEHS, NIDDK, CMBK and
RCMI-IDeA) in 2007; Special Emphasis Panel Reviewer (NIDDK) and for RCMI-IDeA Study Section in 2008; ad hoc reviewer for
three different NIH reviews (Chair for one) in 2009; President, Association of Medical School Pharmacology Chairs, 2004-2007.
President, Mechanisms Specialty Section (Society of Toxicology), 2008- 2009. I attended yearly WV IDeA (COBRE/INBRE)
conferences. Member Association of Chairs of Departments of Physiology; Manuscript reviewer for numerous journals; grant
reviewer for Kidney Research United Kingdom; external reviewer for East Carolina University (pharmacology graduate programs
and a biomedical science M.S. proposal). Council of Academic Societies representative for American Society for Pharmacology and
Experimental therapeutics (2006 –Present).
6)
Externally funded research grants and contracts you received.
A. NIH. West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE). P20 RR016477 (2004-2009), $15,038,326.
B. NIH. West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE). P20 RR016477 (2009-2014), $15,359,372.
C. NIH. Four supplements to the WV-INBRE Award (S1-S4) were made in 2009 totaling $751,506, $529,094, $590,453 and
$651,385, respectively.
7)
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
A. Who’s Who in medical Education, 2005;
B. Invited research presentations at Tulane University, Marshall University, Medical University of South Carolina, AldersonBroaddus College, University of Iowa, and East Carolina University.
8) Community service as defined in the Greenbook.
A. Regular lecturer on chemical spray safety for the American Rose Society.
B. Serve on the Board of Directors for the Huntington Museum of Art and on three committees including Trails, Education and
Landscaping (Co-Chair).
C. Served as a reference for toxicology related matters to the community at large.
153
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: _Travis Salisbury________________________ Rank: Assistant Professor
Status (Check one): Full-time X___ Part-time_____ Adjunct _____
Current MU Faculty: Yes _X__
No ___
Highest Degree Earned: Ph. D.___________Date Degree Received: Spring, 2003
Conferred by: Kent State University__________________________________
Area of Specialization: Physiology, Reproductive Endocrinology______________________
Professional Registration/Licensure_______________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
Agency: _______________________________
6_
6_
2 months__
6_
2 months_
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary) Not Applicable: I will teach starting spring 2010,
Medical Pharmacology (Respiratory and Neuroendocrine)
Year/Semester
Alpha Des. & No.
Title
Enrollment
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
Physiology is strongly linked to Pharmacology. Pharmacology is based on Physiological principles.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
1.
2.
3.
Activities that have enhanced your teaching and or research.
Discipline-related books/papers published (provide a full citation).
Salisbury TB, Binder AK, Grammer JC, Nilson JH. GnRH regulated expression of Jun and JUN target genes in
gonadotropes require a functional interaction between TCF/LEF family members and β-catenin. Molecular Endocrinology
2009 Mar;23(3):402-11
Salisbury TB, Binder AK, Nilson JH. Welcoming beta-catenin to the gonadotropin-releasing hormone transcriptional
network in gonadotropes. Molecular Endocrinology 2008 Jun; 22(6):1295-303.
Salisbury TB, Binder AK, Grammer JC, Nilson JH. Maximal activity of the luteinizing hormone beta-subunit gene requires
beta-catenin. Molecular Endocrinology 2007 Apr; 21(4): 963- 71.
4)
Papers presented at state, regional, national, or international conferences.
Binder, A.K, Salisbury, T.B, Grammer, J.C and Nilson, J.H. 2009. Intracellular calcium signaling is required for GnRH
Mediated Regulation of T-Cell Factor Dependent Transcription in gonadotropes. Presented at the Society of Reproduction
annual meeting, Abstract # 162, Pittsburg, PA
5)
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Member of the Endocrine Society
6)
7)
8)
Externally funded research grants and contracts you received.
The Lalor Foundation Postdoctoral Fellowship, 2005-2007
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
154
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: Eric Blough
Rank: Adjunct
Status (Check one): Full-time___ Part-time___ Adjunct _X___
Current MU Faculty: Yes X
No ___
Highest Degree Earned: PhD__________ Date Degree Received: 1997
Conferred by: Ohio State University
Area of Specialization: Exercise Physiology
Professional Registration/Licensure: n/a
Agency: n/a
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
2
2
5
7
3
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
Alpha Des. & No.
Title
Enrollment
n/a
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research.
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
155
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: ______Phillip R Spangler, MD___________________ Rank: _Assistant Professor __________
Status (Check one): Full-time__X__ Part-time_____ Adjunct _____ Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: _Doctor of Medicine__________ Date Degree Received: _________________
Conferred by: ___Marshall University School of Medicine _____________________________________
Area of Specialization: __Psychiatry _____________________________________________________
Professional Registration/Licensure____WV________
Agency: WV Board of Medicine____________
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
________
___2____
___3____
___3____
________
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2008-2009
Alpha Des. & No.
Title
Psychiatry Interview
2008-2009
Psychosis
2008-2009
Psychopharmacology
2008-2009
Preceptor
Enrollment
All third year med
students
All third year med
students
All third year med
students
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research.
Original research article evaluating the effects of venlafaxirel and citalophram on rat brain BDNF levels and LTP within the
hippocampus (not published)
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
156
Appendix II
Faculty Data Sheet
(Information for the period of this review)
Name: _Elizabeth G. Evans___________________________ Rank: _Assistant Professor__________
Status (Check one): Full-time_X___ Part-time_____ Adjunct _____ Current MU Faculty: Yes _X_
No ___
Highest Degree Earned: _PhD______________________ Date Degree Received: _1982___________
Conferred by: University of Virginia, Institute of Clinical Psychology______________________________
Area of Specialization: __Psychiatry-Child Psychology________________________________________
Professional Registration/Licensure_____WV_______
Years non-teaching experience
Years of employment other than Marshall
Years of employment at Marshall
Years of employment in higher education
Years in service at Marshall during this period of review
Agency: _WVBOM______________________
_26_____
_26_____
__7_____
__7_____
__7_____
List courses you taught during the final two years of this review. If you participated in a team-taught course, indicate each of them
and what percentage of the course you taught. For each course include the year and semester taught (summer through spring),
course number, course title and enrollment. (Expand the table as necessary)
Year/Semester
2007-present
Alpha Des. & No.
Title
Psychiatry Clerkship Lecture on Anxiety
Enrollment
3rd yr class
NOTE: Part-time adjunct faculty do not need to fill in the remainder of this document.
1)
If your degree is not in your area of current assignment, please explain.
(For each of the following sections, list only events during the period of this review and begin with the most recent
activities.)
2)
3)
4)
5)
6)
7)
8)
Activities that have enhanced your teaching and or research.
Supervision of two faculty psychologists working toward licensure
Provide opportunities for students to observe clinical instruction for all age groups
Discipline-related books/papers published (provide a full citation).
Papers presented at state, regional, national, or international conferences.
Professional development activities, including professional organizations to which you belong and state, regional, national,
and international conferences attended. List any panels on which you chaired or participated. List any offices you hold in
professional organizations.
WVPA, past president
Externally funded research grants and contracts you received.
Awards/honors (including invitations to speak in your area of expertise) or special recognition.
Community service as defined in the Greenbook.
Advisory Board Collins Career Center
Hospice of Huntington-Camp NABE
Diocese of Steubenville, OH, coordinator
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
Appendix IIa
Teaching Assistant Data Sheet
GTA Name
Course
No.
(e.g. 101)
Course Name
Year 1
20__- 20__
Year 2
20__- 20__
Year 3
20__- 20__
Year 4
20__-20__
Year 5
20__-20__
Su
Su
Su
Su
Su
Fa
Sp
Fa
Sp
Fa
Sp
Fa
Sp
NOT APPLICABLE
Complete graduate teaching assistant’s name; course number and course name taught; indicate enrollment in the semesters taught.
Expand table as needed.
Fa
Sp
176
Appendix III
Students’ Entrance Abilities
School of Medicine
Mean GPA
Mean MCAT
Reading/Verbal
Reasoning
Mean MCAT
Physics/Physical
Science
Mean MCAT
Biology/Biological
Science
Mean MCAT
Quantitative/Writing
Sample*
2008-09
3.51
8.7
8.3
9.3
Q
2007-08
3.6
8.9
8.7
8.9
M
2006-07
3.5
8.9
8.3
8.7
O
2005-06
3.5
9.1
8.2
8.9
O
2004-05
3.5
9
8.4
9.2
M
Year
*The writing sample of the MCAT is graded using the letters J – T, with T being the highest.
177
Appendix IV
Students’ Exit Abilities
School of Medicine
USMLE STEP 3 EXAMINATION
Taken after graduation – requirement for state medical license
Scores are reported 2-3 post graduation
Year of Graduation
2003
2004
2005
2006
2007*
Number tested
MU Graduates
48
42
38
38
15332
15174
13026
13722
43
40
38
38
14688
14662
12601
13024
13536
MU Graduates
90%
95%
100%
100%
98%
National
96%
97%
97%
96%
96%
National
Number passed
MU Graduates
National
46
14145
45
Percent passing
*Last year available - Scores are reported 2-3 post graduation
178
Appendix V
Assessment Summary Marshall University
Assessment of the Program’s Student Learning Outcomes
5 year summary
Component Area/Program/Discipline: ____________MEDICINE____2010___________________________
Program Level
Program’s Student Learning
Outcomes
Knowledge
Skills
Attitudes & Behaviors
(Professionalism)
Assessment Measures
(Tools)
Written Exams, Oral
Exams, Oral
Presentations,
Observation,
Evaluations,
USMLE Exams,
Clinical Competency
Exam
Observation, Oral
Presentations, Oral
Exams, Evaluations,
USMLE Exams
Clinical Competency
Exam, Employer
Surveys
Oral Presentations,
Evaluations,
Mentoring Evaluation,
Employer Surveys
Standards/Benchmark
Results/Analysis
Action Taken to
improve the
program
“C” or better in all
classes, passage of
USMLE Exams, passage
of Clinical Competency
Exam
Students are
performing at
national norm on
USMLE Exams.
Curriculum has
been inventoried
to identify gaps
and redundancies.
Passage of USMLE Step
II Clinical Skills section,
passage of Clinical
Competency Exam,
satisfactory evaluations
Students are
performing at
national norm on
USMLE Exams.
Satisfactory evaluations,
passage of USMLE
exams, Employer
satisfaction
Students are
performing at
national norm on
USMLE Exams
The standardized
patient program
and simulators
have increased
students’ ability to
practice their
clinical skills.
Students can earn
commendations
for their efforts.
179
Appendix VI
Program Course Enrollment
&
Appendix VII
Program Enrollment
School of Medicine
As reported to the LCME
2004-2005
APPLICANTS
In-State
Total
2005-06
2006-07
2007-08
2008-09
180
719
167
785
198
1,573
189
1,945
209
1,316
ACCEPTANCES
ISSUED
In-State
Total
80
96
83
102
96
123
90
123
94
128
FIRST YEAR
NEW ENROLLMENT
In-State
Total
43
52
50
60
48
64
51
72
57
78
200
44
211
45
227
49
246
42
281
52
TOTAL MEDICAL
STUDENTS
Graduates
*Because students apply to and receive acceptances from multiple medical schools,
acceptances issued are always greater than the number actually matriculating.
180
Figure 1. Trend Line for Total Enrollment and Program Graduates
School of Medicine
300
250
200
Graduates
150
Total Enrollment
100
50
0
2004-05
2005-06
2006-07
2007-08
2008-09
181
Appendix VIII
Job and Graduate School Placement Rates
School of Medicine
RESIDENCY PLACEMENT RATES FOR THE PAST FIVE YEARS
20042005
Primary Care
Family Practice
Grads. with Internship/Residency
in WV
Grads. with Internship/Residency
Outside WV
Internal Medicine
Grads. with Internship/Residency
in WV
Grads. with Internship/Residency
Outside WV
Pediatrics
Grads. with Internship/Residency
in WV
Grads. with Internship/Residency
Outside WV
Obstetrics/Gynecology
Grads. with Internship/Residency
in WV
Grads. with Internship/Residency
Outside WV
Internal Medicine/Pediatrics
Grads. with Internship/Residency
in WV
20052006
20062007
20072008
20082009
5
6
2
5
5
1
3
4
1
1
1
6
4
3
8
6
5
4
2
8
6
1
4
2
1
5
2
4
8
8
2
1
3
2
0
1
3
1
3
0
0
1
4
0
0
182
Grads. with Internship/Residency
Outside WV
Psychiatry
Grads. with Internship/Residency
in WV
Grads. with Internship/Residency
Outside WV
Medical Specialty
Grads. with Internship/Residency
in WV
Grads. with Internship/Residency
Outside WV
General Surgery
Grads. with Internship/Residency
in WV
Grads. with Internship/Residency
Outside WV
Surgical Specialty
Grads. with Internship/Residency
in WV
Grads. with Internship/Residency
Outside WV
Support Specialty
Grads. with Internship/Residency
in WV
Grads. with Internship/Residency
Outside WV
Transitional
TOTAL
2
0
3
0
1
0
3
2
0
1
2
0
2
0
2
0
0
0
0
0
3
0
1
0
1
0
2
3
2
4
4
0
2
6
6
0
0
0
0
0
0
1
1
2
0
0
0
0
1
0
6
0
10
1
5
0
3
2
6
0
44
45
49
42
52
183
Assessment Letters
184
185
186
187
188
189
190
191